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Abstract
Absent or defective craniofacial skeletal muscle can lead to loss of function and
aesthetics. Current therapies are fraught with limitations: for example, the surgical
transfer of tissue is associated with donor site morbidity coupled with a paucity of
available tissue. The potential to engineer skeletal muscle tissue could circumvent
disadvantages related to current techniques. Furthermore, the creation of a muscle test-
bed could provide the means to investigate the response to various manipulations. The
aim of this research was to produce an in vitro human craniofacial skeletal muscle tissue
suitable as a test-bed for novel therapies involving the craniofacial region.
Degradable phosphate-based glass fibre scaffolds of various configurations, combined
with extracellular matrix (ECM) components, were seeded with human craniofacial
muscle-derived cell cultures. Myogenicity was confirmed with immunofluorescent
techniques prior to seeding. The seeded scaffolds were incubated at 37°C in a
humidified atmosphere of 5% CO2 in air for up to 21 days. Modulation contrast
microscopy was used to analyse migration and morphology. Cell attachment and
survival were assessed with the CyQUANT
® and alamarBlue
® assays, and cell
differentiation and maturation were investigated using immunofluorescence and
quantitative RT-PCR.
Parallel arrays of glass fibres coated with ECM components provided the correct
topology to support cell alignment and differentiation. Specifically, compared to control
scaffolds, glass fibre scaffolds promoted upregulation of developmental, fast and slow
myosin heavy chain genes. Further refinement of the system involved glass fibres
embedded within collagen gels, created to mimic the architecture of native skeletal
muscle: cells within these constructs were aligned parallel to the glass fibres, and over
time, the constructs rolled along the short axis to produce a muscle ‘organoid’.
Additionally, the collagen gel contracted along the long axis to reveal tufts of glass
fibres analogous to tendons (mean 13.87% reduction in length). Upregulation of the
myosin heavy chain genes was promoted, albeit at a later timepoint.
In conclusion, degradable glass fibre-ECM scaffolds provided the correct topographical
and biological cues to aid the in vitro engineering of human craniofacial skeletal muscle
tissue.Contents
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1. Introduction
Skeletal muscle, the most abundant type of muscle accounting for 48% of body mass
(Saxena et al., 1999), is attached to the skeleton via tendinous attachments. It controls
voluntary bodily movements and, in addition, upholds the structural contours of the
body and functions as an aid to respiration. The craniofacial skeletal muscles are
important, being utilised for facial expression and tongue, eye and jaw mobility
(Alsberg et al., 2001). Genetic and environmental conditions involving the skeletal
muscles can lead to the loss of function and aesthetics, often accompanied by
considerable distress to the patient. Genetic conditions include the muscular dystrophies
and neuromuscular atrophies, such as myaesthenia gravis, associated with the
characteristic features of progressive weakness and wasting of affected muscle groups
(O’Brien and Kunkel, 2001): involvement of the craniofacial muscles can lead to the
creation and worsening of facial deformity. Environmental factors affecting the skeletal
muscles may occur any time from conception, as exemplified by hemifacial
microsomia, which is often considered to have a non-genetic aetiology (Monahan et al.,
2001). This condition is characterised by defects of the craniofacial hard and soft tissues
leading to both loss of function and aesthetics. Skeletal muscle can also be damaged as
a result of exposure to myotoxic substances, micro- and macro-trauma, ischaemia,
tumour ablation and prolonged denervation. Furthermore, there is the muscle
degeneration associated with the natural process of ageing (sarcopenia).
The aesthetic and functional restoration of the above described conditions remains a
challenge (Emery, 2002; Bach et al., 2004; Jarvinen et al., 2005; Nikolic et al., 2005).
The current gold standard of the surgical transfer of autologous muscle or fat tissue is
associated with limitations, such as donor site morbidity and poor restoration of
function and volume (Faulkner et al., 1994). Therefore, a functional engineered skeletal
muscle tissue with the potential to grow and develop in response to environmental
demands could provide a suitable solution for the management of the aforementioned
conditions (DiEdwardo et al., 1999; Bach et al., 2003).Chapter 1: Literature Review
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In order to understand and appreciate the processes utilised in engineering skeletal
muscle, it is necessary to understand skeletal muscle development and ultrastructure, as
well as its repair and regenerative capabilities.
2. Skeletal Muscle Development and Regeneration
The successful formation of any organised tissue is reliant on a series of co-ordinated
temporal and spatial episodes, throughout which cells are exposed to important signals.
Skeletal, smooth and cardiac muscle are different in terms of their anatomical structure,
physiology, regenerative potential and pathological states. Advances in the
biomolecular sciences have ascertained key mechanisms taking place during muscle
development, repair and regeneration, which have supported scientists in the quest to
engineer the ideal skeletal muscle tissue for use as a test-bed, and ultimately
implantation.
2.1. Embryological Development
The head, trunk and limb skeletal muscles all develop as separate lineages, with the
source of muscle precursor cells (MPCs) dependant on the anatomical site of the
muscle. Skeletal muscle of the vertebrate body is derived from the somites, segmental
blocks of paraxial mesoderm, which form either side of the neural tube (Hawke and
Garry, 2001). The different MPC populations in the somite are first instructed to
become myogenic by positive or negative signals emanating from neighbouring tissues,
such as the neural tube, notochord, dorsal ectoderm and lateral mesoderm (Cossu et al.,
1996), and migrate and proliferate into developing limb buds at their designated
anatomical locations (Bladt et al., 1995). Alternatively, the craniofacial muscles,
including the masseter muscle, are derived from unsegmented paraxial mesoderm and
are innervated by cranial nerves (Jheon and Schneider, 2009).
The process of in vivo myogenesis is complex involving the specific developmental
stages of determination, proliferation, differentiation and maturation. Various
investigations into avian and mammalian myogenesis have demonstrated that MPCs
may be classed into different populations based on specific morphological andChapter 1: Literature Review
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biochemical traits identified in vitro (Cossu et al., 1987). These populations have been
grouped into the following: embryonic MPCs, appearing early in embryonic
myogenesis, foetal MPCs, appearing later on in the process, and adult MPCs, found in
postnatal and adult skeletal muscle (Stockdale, 1992; Edom-Vovard et al., 1999). In
mammals, myogenesis occurs in distinct waves with embryonic MPCs proliferating at
their destination and withdrawing from the cell cycle to align and fuse during primary
myogenesis (Draeger et al., 1987). Foetal (secondary) MPCs follow and, using primary
myotubes (immature myofibres) as a scaffold, line up under their basal lamina to form
secondary multinucleated myotubes (Wilson et al., 1992). The secondary fibres form
their own independent basal lamina. As the individual myofibres become encased
within their basement membranes during the latter stages of embryonic myogenesis,
adult MPCs, also known as ‘satellite cells’, are discernible beneath the myofibre basal
lamina (Schultz, 1989; Grounds, 1991). The muscles then split, become innervated,
achieve their final pattern and mature (DiMario and Stockdale, 1997). Morphological
events in differentiation are associated with the expression of α-sarcomeric actin and an 
array of muscle-specific gene products, especially structural proteins of the contractile
apparatus (Stockdale, 1997).
2.1.1. The Family of Myogenic Regulatory Factors
The myogenic regulatory factor (MRF) family consist of 4 members – MyoD, myf5,
myogenin and MRF4 – which have been shown to play an essential role in myogenesis
(Buckingham et al., 1992; Shih et al., 2008). These transcription factors have been
defined by their ability to induce the expression of muscle-specific genes, such as
myosin, in non-myogenic mesodermal cells (Weintraub et al., 1989; Hasty et al., 1993).
Sharing many common features, including conservation of a basic helix-loop-helix
(bHLH) region frequently found in transcriptional activators, they are biologically
functional as homodimers or heterodimers through the HLH domain and can auto-
activate as well as trans-activate each other (Weintraub et al., 1991, Dias et al., 1994).
Furthermore, the MRFs also interact with other known transcription factors and cell
cycle regulatory proteins to control myogenesis (Weintraub et al., 1991). For instance,
the myocyte enhancer factor 2 (MEF2) family of transcription factors act in conjunction
with the MRFs during the activation of muscle-specific genes (Molkentin et al.,1995).Chapter 1: Literature Review
26
The roles of the individual MRFs are temporally determined with upregulation of Myf5
and MyoD in early embryonic myogenesis leading to the determination and
maintenance of a myogenic lineage from multipotent cells (Rudnicki et al., 1992, 1993;
Rudnicki and Jaenisch, 1995, Megeney and Rudnicki, 1995). Myogenin and MRF4, on
the other hand, play a role in muscle differentiation (Hasty et al., 1993; Nabeshima et
al., 1993): of particular note is the critical function of myogenin in muscle development
and the inability of the other members to compensate for its absence. The temporal
expression of the various MRFs has been effectively demonstrated in key studies of
myogenesis utilising immunocytochemical techniques, both in vitro and in vivo
(Yablonka-Reuveni and Rivera, 1994, 1997; Anderson et al., 1998; Cooper et al.,
1999). MyoD protein expression was detected during the proliferative stage, whereas
myogenin expression was associated with, or just before, the appearance of sarcomeric
myosin (Smith et al., 1993; Yablonka–Reuveni and Rivera, 1994, 1997; Yablonka–
Reuveni et al., 1999). Interestingly, there appears to be a distinction in the temporal
expression patterns of MyoD and myogenin proteins between different MPC
populations undergoing myogenesis, as demonstrated in vitro by chick adult and foetal
MPCs (Yablonka-Reuveni and Paterson, 2001).
The inhibition of myogenesis is mediated by several factors, including transforming
growth factor β1 (TGFβ1) and fibroblast growth factor 2 (FGF-2) (Itoh et al., 1996;
Bouche et al., 2000; Amthor et al., 2002).
2.2. The Post-Natal Capability to Repair and Regenerate
Mammalian myonuclei are terminally differentiated and thus cannot replace themselves.
Nonetheless, adult skeletal muscle has the unique ability to repair and regenerate
(Studitsky, 1964; Carlson, 1986), which is the outcome of the activation, proliferation
and fusion of MPCs that reside beneath the myofibre basal lamina: the satellite cells.
2.2.1. The ‘Satellite Cell’
Although satellite cells were originally identified by Katz (1961), it was Mauro (1961)
who coined the term after noting the topographical association of these cells with theChapter 1: Literature Review
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periphery of myofibres in frogs. Satellite cells present as mitotically quiescent,
undifferentiated mononuclear cells located between the sarcolemma of individual
muscle fibres and their associated basal lamina sheaths (Muir et al.,1965). These cells
are regarded as the normal constituent of all vertebrate skeletal muscle, regardless of
age, fibre type and location (Schultz, 1976). They comprise 2-10% of the nuclei
associated with any particular fibre, however, this proportion does vary with species,
age and muscle group (Bischoff and Heintz, 1994). Of the total number of nuclei in
mature muscle, satellite cells make up 1-5% (Allbrook, 1981; Alameddine et al., 1989).
Interestingly, satellite cells are in greater number within oxidative muscles as compared
to glycolytic muscles, regardless of species (Gibson and Schultz, 1983; Schultz, 1989).
The size of the population is also, in part, regulated directly or indirectly by innervation
or the function of muscle (Schultz et al., 1984). The fibre type distribution of the
regenerated myofibres takes on the characteristics of the host bed, hence it follows that
innervation, recruitment pattern and ultimate fibre type may be an important
determinant of satellite cell distribution. The distribution along individual fibres is even
with the exception of the regions of the motor endplates where cell density is increased
(Wokke et al., 1989). Several reasons have been suggested for this, including
preservation of the junction or synthesis of molecules important for the structure or
function of motor endplates (Wokke et al., 1989).
Numerous animal models have been used to explore and demonstrate the structural and
functional characteristics of regenerating skeletal muscle (Carlson and Gutmann, 1975a,
b; Faulkner et al., 1980). Regardless of the nature, severity and extent of the injury, the
process of myogenesis is comparable, although the outcome and time for regeneration
may vary (Lee et al., 2000). Some in vivo studies have used differential labelling of
satellite cells and myonuclei with
3H-TdR to demonstrate the satellite cell as the sole
source of new MPCs (Schmalbruch, 1976). Debate is ongoing with respect to
heterogeneity of the satellite cell population (Asakura et al., 2001; Asakura and
Rudnicki, 2002; Zammit et al., 2006) with more recent in vivo studies indicating such
existence (Collins et al., 2005). In response to injury, satellite cells become activated
and proliferate to form a pool of MPCs (Lee et al., 2000). Some of the MPCs
differentiate to provide a source of nuclei to damaged myofibres or alternatively fuse
together to form new multinucleated myofibres (Moss and LeBlond, 1971; Snow, 1978;Chapter 1: Literature Review
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Campion, 1984), whereas some daughter cells replenish the satellite cell population
(Baroffio et al., 1995, 1996; Yoshida et al., 1998; Beauchamp et al., 1999) (Figure 1).
The migration of MPCs through the basal lamina of myofibres both within (Phillips et
al., 1990) and between (Watt et al., 1994) skeletal muscles and formation of the
connective tissue network by the proliferating MPCs is key to successful repair and
regeneration (Hughes and Blau, 1990; Li and Huard, 2002; Hill et al., 2003).
2.2.1.1. Satellite Cell Origin and Multipotency
Satellite cells were originally thought to be of somitic origin: classic quail-chick
chimera experiments revealed the association of satellite cell nuclei derived from
implanted quail somite with host chick myofibres (Armand et al., 1983). However,
more recent studies have suggested a non-somitic origin of satellite cells (Ferrari et al.,
1998; De Angelis et al., 1999; Hawke and Garry, 2001; Asakura and Rudnicki, 2002;
LaBarge and Blau, 2002; Polesskaya et al., 2003). Further, it has been proposed that
MPCs may still retain the plasticity to transcend the lineage boundary when exposed to
certain in vitro and in vivo environmental cues (Jackson et al., 1999; Lee et al., 2000;
Geiger et al., 2002; Wada et al., 2002; Cao et al., 2003; Zheng et al., 2007), but it may
be that these cells are from a different population. A minority of cells isolated from the
adult skeletal muscle interstitium, termed side population cells, can adopt alternative
fates in permissive environments, including the capacity for myogenic regeneration
(Bittner et al., 1999; Gussoni et al., 1999; Jackson et al., 1999; Seale et al., 2001;
Asakura and Rudnicki, 2002; Poleskaya et al., 2003; Tavian et al., 2005; Peault et al.,
2007). Others have suggested that a different class of stem cells (muscle-derived stem
cells, MDSCs) is present in adult skeletal muscle with the ability to give rise to different
cell types, including MPCs (Royer et al., 2002; Tamaki et al., 2002; Wada et al., 2002).
Further studies need to be undertaken to determine whether these cells truly are satellite
cell progenitors, a subpopulation of satellite cells or an independent progenitor cell
population that is resident in the extracellular niche of skeletal muscle (McKinney-
Freeman et al., 2002). Significantly, the potential to produce different tissues from
muscle-derived cells opens up another dimension for the tissue engineer (Qu-Petersen et
al., 2002).Chapter 1: Literature Review
29
Figure 1 – The Role of the Satellite Cell in Skeletal Muscle Regeneration
Muscle repair and regeneration is undertaken by quiescent satellite cells (A), which are activated
in response to mitogens/trauma (B). The cells undergo proliferation (C) and some of the cells will
cycle to replenish the satellite cell pool (D). Other daughter cells will either fuse together to
produce new muscle fibres, or fuse with damaged muscle fibres to effect repair (E). As the muscle
fibres mature, the nuclei become more aligned and the satellite cells assume a state of quiescence
at the periphery of the muscle fibre (F).
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2.2.2. The Temporal Expression of Muscle Markers
A number of skeletal muscle-related markers have been identified (Figure 2), including
M-cadherin (Irintchev et al., 1994; Cornelison and Wold, 1997), c-met (Cornelison and
Wold, 1997) and myocyte nuclear factor (Garry et al., 1997; Deasy et al., 2001). M-
cadherin is a calcium-dependent homophilic cell adhesion molecule expressed during
foetal myogenesis. Its role appears to be in the alignment and fusion of MPCs to form
and expand developing myotubes. It is also detected in activated satellite cells during
injury-related regeneration (Irintchev et al., 1994). In intact muscle, the enhanced
amounts of M-cadherin present at sites of contact between these cells and the parent
fibre suggest a crucial role as a molecular link between mitotically quiescent satellite
cells and muscle fibres (Irintchev et al., 1994). c-met expression continues even after
the regeneration program has been activated and cell proliferation has begun
(Cornelison and Wold, 1997).
Quiescent satellite cells express no detectable levels of MRFs (Smith et al., 1994;
Cornelison and Wold, 1997), however, it has been demonstrated that the majority of
satellite cells express CD34 (Deasy et al., 2001), myf5 and M-cadherin and represent
quiescent, committed precursor cells (Beauchamp et al., 2000). As yet, an undefined
minority are negative for both markers and M-cadherin, which could represent the more
stem cell-like population responsible for replenishing the primed population (Zammit et
al., 2006). The expression of myf5 is required to prevent muscle cells from adopting
alternative fates and may act to restrict quiescent cells to myogenesis. Activated satellite
cells express MyoD or myf5 and desmin (Kaufman and Foster, 1988; Yablonka-
Reuveni and Nameroff, 1990) in the early stages following injury (Megeny et al., 1996;
Cornelison and Wold, 1997). This is followed soon after by co-expression of Myf5 and
MyoD. Desmin is one of the earliest known myogenic markers in both skeletal and
cardiac muscle (Van der Ven et al., 1992; Capetanaki et al., 1997). In mature skeletal
muscle, desmin intermediate filaments surround the Z disks, interlink them together and
integrate the contractile apparatus with the sarcolemma and nucleus. The cytoskeletal
filament has been demonstrated to have an important role in the maintenance of the
myofibril, the myofibre and the whole muscle tissue structural and functional integrity.Chapter 1: Literature Review
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Figure 2 – Skeletal Muscle-Associated Markers
This diagram highlights many of the markers associated with skeletal muscle. In particular, some
(e.g. M-cadherin) are expressed in quiescent satellite cells and MPCs, and not muscle fibres. Other
markers are not exclusive to skeletal muscle and thus are of limited value for isolation or
confirmation of the nature of the tissue/cells.
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As abovementioned, myogenin and MRF4 are expressed last during the time associated
with fusion and differentiation (Smith et al., 1994; Cornelison and Wold, 1997; Lee et
al., 2000). Upon the formation of multinucleated myofibres, there is the expression of
muscle creatine phosphokinase (CPK) and the structural protein myosin heavy chains
(MyHCs) (Andrés and Walsh, 1996; Chargé and Rudnicki, 2004). Furthermore, a small
population of satellite cells remain undifferentiated and retain expression of Pax7
(Zammit et al., 2004), and it has been suggested that at least some Pax7
+ satellite cells
are true stem cells resident in postnatal skeletal muscle (Collins et al., 2005).
2.3. Skeletal Muscle Structure and Function
Skeletal muscle is a classic example of form determining function. The high cell density
and high degree of cellular orientation and differentiation are essential for the
generation of power in a certain vector. Adult fibres have an elaborate system for force
transmission, mainly via specialised endpoints creating attachments to bone
(myotendinous junctions). The mechanical function is carried out by syncytial
myofibres  of  variable  diameter  (5-100μm)  and  length  (1mm  to  several  centimetres) 
(Fawcett et al., 1994) with each containing a highly specialised contractile apparatus
maintained by large numbers of postmitotic myonuclei. The myofibres are individually
surrounded by the endomysium and groups of myofibres form fascicles encased by the
perimysium. The entire muscle is enclosed by the epimysium (Figure 3). The extensive
capillary networks present in skeletal muscle facilitate rapid metabolism. The flexibility
enabling the same muscle to undertake various tasks is dependent on accurate nervous
control and the availability of different fibre types with specific functions, such as
resistance to fatigue. To engineer a skeletal muscle tissue with the ideal functional
properties, knowledge of the ultrastructure and inner workings of the native tissue is
also key.
Individual myofibres are made up of myofibrils, which occupy most of the intracellular
space and are ultimately responsible for the conversion of chemical to mechanical
energy leading to the production of a vectoral force. Muscle sarcomeres, the basic
contractile unit of skeletal muscle, are composed of myofilaments and a serial
arrangement of the sarcomeres makes up the myofibrils. A number of different proteinsChapter 1: Literature Review
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Figure 3 – Skeletal Muscle Architecture
Schematic view of skeletal muscle architecture. The multinucleated muscle fibres, covered by the
endomysium, are arranged in parallel bundles encased within the perimysium. The whole muscle
is contained within the epimysium and attached to bone via tendons. The parallel orientation
enables contraction in one direction to effect movement.
(Adapted from http://www.tarleton.edu/~anatomy/musclepix2.html)Chapter 1: Literature Review
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make up the contractile processes, including tropomyosin, C protein, M protein, titin, α-
actinin and nebulin (Schiaffino and Reggiani, 1996). Actin and myosin, composed of
thin and thick filaments respectively, are the major structural components of sarcomeres
leading to the characteristic banding observed in skeletal muscle: The Z line or disk is a
dense region from which the actin filaments extend creating a lighter region (I band),
and where they interdigitate with the myosin filaments, there is a darker region known
as the A band. The H zone, created within the A band, is composed of myosin filaments
only.
2.3.1. The Myosin Heavy Chains and Relationship to Fibre Type
The actin-myosin relationship is key to skeletal muscle contraction (Bárány, 1967;
Bárány et al., 1967). The sarcomeric myosin filament is one of the most important
elements of the contractile mechanism, consisting of two MyHC subunits and four
myosin light chain (MyLC) subunits, which may be further subdivided into essential
(alkali) light chains and regulatory (phosphorylatable) light chains (Lowey and Risby,
1971). The role of the MyLCs in human skeletal muscle has yet to be clarified, but it is
the MyHCs that are responsible for force-velocity characteristics of myofibres, although
other factors may influence (e.g. neural input and architecture). Various isoforms of the
MyHCs exist within myofibres enabling investigation and classification of the
physiological properties (Bárány, 1967; Bárány et al., 1967; Brooke and Kaiser, 1970;
Weiss and Leinwand, 1996).
Nine MyHC isoforms have been identified in mammalian skeletal muscle with β/I, IIA, 
IIB and IID/X as the main isoforms in adult skeletal muscle. MyHC-β/I represent the 
same slow contracting MyHC, with MyHC-β designated to cardiac muscle (Weiss and 
Leinwand, 1996) and MyHC-I referring to skeletal muscle. The group of MyHC-II are
fast contracting MyHCs with a shortening speed relative to one another: IIB > IIX/D >
IIA. It has been demonstrated in knockout mice that MyHC-IIB and IIX/D are
necessary for the normal function of adult skeletal muscle, and the absence of these
MyHCs leads to the presentation of distinctive phenotypes (Acakpo-Satchivi et al.,
1997). With respect to human skeletal muscle, the presence or absence of MyHC-IIB is
still unanswered. Histochemical studies have identified type IIB fibres as a major
constituent of fast muscle, but Pereira et al. (1997) and others (Ennion et al., 1995) haveChapter 1: Literature Review
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shown that the isoform is a homologue of MyHC-IIX found in rat and rabbit, and thus
absolute clarification is still required. Slow fibres are better adapted for isometric
contractions, developing the same force as fast fibres, but with less ATP consumption.
Thus, developing the maximum power with the most efficiency at low velocity, slow
fibres are found mainly in the postural muscles that are essentially fatigue-resistant. On
the contrary, fast fibres (MyHC-II) develop maximum power with the greatest
efficiency at high velocity, and thus are best suited to short-lasting, faster and more
powerful movements, such as those effected by sprinters (Yoshioka et al., 2007) and
during mastication.
Embryonic and neonatal MyHCs (MyHC-emb and MyHC-neo) are typically expressed
during embryonic myogenesis (Periasamy et al., 1984; Schiaffino et al., 1986a;
Bouvagnet et al., 1987), within regenerating (Schiaffino et al., 1986a; Sartore et al.,
1982; Matsuda et al., 1983) or denervated (Schiaffino et al., 1988) adult muscle, and the
extraocular muscles (Wieczorek et al., 1985; Sartore et al., 1987). Additionally,
extraocular MyHC (MyHC-II-L) has been found in the extraocular (Sartore et al., 1987)
and laryngeal muscles (DelGaudio et al., 1995). The fast contracting MyHC-α is
expressed in cardiac muscle, however, it has been found occasionally in skeletal muscle
and labelled as α-cardiac myosin. Fibre differences are not detectable until the 20
th
week in utero and by one year postnatal, all the fibres are fully differentiated (Bottinelli
and Reggiani, 2000). Studies utilising chick MPCs have demonstrated that the adult
phenotype is already expressed during the latter stages of embryonic myogenesis
(Hartley et al., 1991, 1992).
2.3.1.1. The Craniofacial Jaw Muscles and Fibre Type
The main jaw-opening muscles, the anterior and posterior digastric, have been studied
extensively in humans (Vignon et al., 1980) and other mammalian species (Rowlerson
et al., 1983). The jaw-opening mechanism is not particularly different amongst the
species, hence the predominant fibres are fast, with moderately fewer type I fibres.
Eriksson et al. (1982) have reported human digastric muscles to contain approximately
29% type I fibres, with the remainder as type II. Conversely, there are appreciable
differences in the kinetics of jaw-closing and hence the expression of fibre types withinChapter 1: Literature Review
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individual muscle compartments, and between the different jaw-closing muscles.
Human jaw-closing muscles contain 10-90% type I fibres and no type IIM (masticatory)
fibres, which are found in primates (Rowlerson et al., 1983). The different insertions of
these jaw-closing muscles (Figure 4) will produce different functionality: for example,
the insertion of the temporalis muscle nearer to the occlusal plane in carnivores enables
rapid jaw closure (Sciote and Morris, 2000).
Moreover, differences are evident between human jaw-closing and limb muscles such
that healthy limb skeletal muscle comprises of a mosaic of type I and II fibres, with the
type II fibres displaying a relatively larger diameter. The myofibres tend to be
homogeneous for a specific MyHC, however, combinations may co-exist within the
same myofibre (Sciote and Morris, 2000). Human jaw-closing muscles tend to have
equal proportions of type I and II fibres, but the type II fibres tend to be of a smaller
diameter (Ringqvist, 1973a, b). Equally, the human masseter muscle has been shown to
have a number of phenotypes specific to individual factors, including the presenting
dental occlusion (Sciote et al., 1994). As previously mentioned, the different muscle
compartments may house different fibre types and it has been suggested that the
anterior superficial aspect of the masseter muscle contains the largest variability in fibre
type (Serratice et al., 1976).Chapter 1: Literature Review
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Figure 4 – Craniofacial Muscles Involved in Mastication
The masseter muscle originates from the zygomatic arch and inserts into the external surface of the
mandible. The masseter, temporalis and medial pterygoid muscles are responsible for jaw closure,
whereas the lateral pterygoid is associated with jaw opening and facilitates lateral and protrusive
mandibular movements.
(Adapted from http://www.tpub.com/content/medical/14274/css/14274_49.htm)
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Interestingly, the craniofacial muscles express other isoforms, with MyHC-IIM present
in the jaw-closing muscles of primates and carnivores (Rowlerson et al., 1981, 1983).
Studies into the jaw-closing muscles of humans and rabbits have also shown the
expression of α-cardiac myosin, and it has been confirmed that rabbit α-cardiac fibres 
have slower shortening velocities than MyHC-IIA (Sciote and Kentish, 1996). The
persistent expression of the developmental MyHC isoforms within the adult human
masseter muscle is in varying amounts (Sciote et al., 1994; Stål et al., 1994; Butler-
Browne et al., 1988). The differences observed in the jaw closing muscles, including
the masseter, compared to the limb muscles have been attributed to a number of factors:
(a) The jaw closing muscles are branchial arch derivatives developing from
embryonic tissue separate to the limb muscles.
(b) Innervation is by the cranial nerves as opposed to the spinal nerves for the limb
muscles.
(c) It has been suggested that the development of the jaw closing muscles is later
and prolonged, hence accounting for the persistence of the neonatal and
embryonic MyHC isoforms in postnatal muscle (Soussi-Yanicostas et al., 1990).
2.3.2. The Extracellular Matrix
Cell-cell and cell-extracellular matrix (ECM) interactions lead to the upregulation of
specific transcription factors and genes essential in the normal development and
maintenance of skeletal muscle (Maley et al., 1995; Melo et al.,1996; Grounds et al.,
1998). The three-dimensional ECM consists of the interstitial connective tissue and the
basement membrane in intimate contact with satellite cells and myofibres (Figure 3).
The basement membrane, regulating cell polarity and separating tissue types, is
composed of mainly collagen IV, laminin, entactin and heparan sulphate proteoglycans
(HSPGs) (Sanes et al., 1986), whereas the interstitial ECM between myofibres is
composed of mainly collagen I, fibronectin and HSPGs (Cornelison, 2008). Collagen
provides tensile strength and the proteoglycans (PGs) create space for the tissue and
allow for diffusion; additionally, the ECM behaves as a storage depot for cytokines and
growth factors. The main ECM components form four groups – collagenousChapter 1: Literature Review
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glycoproteins, non-collagenous glycoproteins, proteoglycans and elastin (Lewis et al.,
2001). The ECM differs between muscle groups and all members play an essential, co-
ordinated, often synergistic role in functionality with the binding of growth factors and
their proteolytic fragments demonstrating a number of important influences, such as
direct mitogenic effects (Foster et al., 1987). Importantly, the majority of biologically
active ECM molecules exhibit multiple active binding sites with the capacity to bind
different ligands and effect different activities.
Structural integrity of the muscle tissue is crucial to normal function and thus the ECM,
with its vast array of molecules, lends itself well to this role. The adhesion molecules
present on MPCs consist of five groups, of which three, the ADAMs (a disintegrin and
metalloproteinase domain), cadherins (M-, N- and R-Cadherin) and immunoglobulin
superfamily (e.g. neural cell adhesion molecule 1 (NCAM-1) and vascular cell adhesion
molecule 1 (VCAM-1)), are involved in direct cell-cell adhesion (Lewis et al., 2001).
The dystrophin-dystroglycan complex and integrins, on the other hand, play an
important role in cell-ECM adhesion.
For the tissue engineer, manipulation of the ECM can modulate cell behaviour and
effect ultimate success of the engineering process. Table 1 outlines the main ECM
components and their role in myogenesis.Chapter 1: Literature Review
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Table 1 – A Synopsis of the Main ECM Components with a Role in Myogenesis
ECM component Role in myogenesis
The Proteoglycans
Four groups:
hyaluronic acid,
chondroitin/dermatan
sulphate, keratan
sulphate and
heparin/heparan
sulphate
 MPCs and newly formed myotubes initially synthesise hyaluronic acid
and chondroitin sulphate PGs, which then decrease as HSPG synthesis
increases (Carrino and Caplan, 1982).
 HSPGs, such as syndecan and perlecan, play a role in signal transduction
of growth factors: for example, binding of fibroblast growth factor with
HSPG enables differentiation (Schlessinger et al., 1995).
 Perlecan, present in the basal lamina of mature myofibres (Murdoch et al.,
1994), is thought to be synthesised by connective tissue fibroblasts
bordering myofibres (Kuhl et al., 1984).
The Integrins
24 receptors
classified formed
from combinations of
18 α and 8 β 
glycoproteinous
subunits
 Facilitated by integrins, focal adhesion complexes (FACs) are sites of
contact formed between the ECM and the cytoskeletal actin filaments of
cells (Geiger et al., 2009) – can lead to the activation of signalling
pathways and changes in gene expression.
 α7β1  integrin,  a  major  laminin-binding  integrin  in  both  cardiac  and 
skeletal muscle, is considered to facilitate migration, differentiation and
maintain skeletal myofibre adhesion to the ECM, thus ensuring muscle
integrity.
 Suggested α7β1 integrin also functions in neuromuscular connectivity and 
force transduction (Miosge et al., 1999), due to its localisation at the
myotendinous and neuromuscular junctions (NMJs) in adult muscle.
The Dystrophin-
Glycoprotein
Complex: The
Costameres
 Dystrophin is concentrated in discrete rib-like configurations, known as
costameres (similar to FACs), at regular intervals within myofibres.
 Responsible for anchoring the Z disks of peripheral myofibrils, through
the sarcolemma, to the ECM ensuring uniform contractile force to the
skeleton (Bloch and Gonzales-Serratos, 2003).
 Demonstrated in humans and mice that the lack of dystrophin creates an
indiscriminate costameric lattice and a very fragile sarcolemma
susceptible to damage upon physical exercise (Bloch et al., 2004).
The Glycoproteins
Laminins (-211, -221, -411, -421 and –521
 Maintenance of tissue integrity: laminin-211, within myofibre basement
membrane,  binds  to  both  α-dystroglycan  and  the  α7β1  integrin,  thus 
connecting with the ECM (Oliveira et al., 2008).
 Isoforms in developing and mature skeletal muscle also form ligands for
the α3β1 and α6β1 integrins (Kikkawa et al., 2000).
 Primary  absence  of  laminin  α2  chain  found  in  laminin-211  prevents 
dystroglycan binding to basement membrane accounting for 40% of
congenital muscular dystrophy (Hayashi et al., 1998).
Fibronectin
 Responsible for intracellular signalling leading to cytoskeletal
organisation, cell cycle progession and cell survival (Frisch and
Ruoslahti, 1997).
 α5β1 integrin on proliferating MPCs (Ruoslahti, 1991) and α5β3 (Wu et
al., 1996) key in the process of binding and/or fibronectin matrix
formation.
 Proposed proangiogenic function of α5β1 integrin establishes important 
role of fibronectin in scaffold vascularisation.
 Proteolytic fragments of fibronectin and laminin are chemotactic for both
inflammatory cells and MPCs (Foster et al., 1987; Gullberg et al., 1999)
and mitogenic for MPCs (Foster et al., 1987).Chapter 1: Literature Review
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2.3.2.1. Regulation of the Extracellular Matrix
The matrix metalloproteinases (MMPs), secreted into the ECM as latent proenzymes,
are essential to ECM maintenance – for example, the gelatinases (MMP-2 and –9)
degrade the major components of the ECM, namely collagen IV and laminin (Lewis et
al., 2001). Activation occurs by proteolysis and is inhibited in a 1:1 manner by the
tissue inhibitors of the metalloproteinases (TIMPs) (Birkedal-Hansen, 1995) with any
disturbances in the MMP:TIMP ratio manifesting clinically as disturbances in wound
healing (Carmeli et al., 2004; Guillen-Marti et al., 2009).
Studies suggest MMP-2 is secreted by MPCs and the interstital fibroblasts (Kherif et
al., 1999) and in healthy skeletal muscle is localised to the perivascular regions, nerves
and neuromuscular junctions (NMJs) (Lewis et al., 2001). MMP-9, a product of
inflammatory cells (Lewis et al., 2000; Schoser et al., 2002), is similarly located to the
blood vessels, nerves and NMJs at almost non-existent levels (Kherif et al., 1999), and
also within myofibres in healthy human craniofacial muscle (Singh et al., 2000): the
differences in location between the craniofacial and somatic muscles could be the
consequence of their different origins. Specifically within the human masseter muscle,
TIMP-1 appears to be consistently expressed and the very low levels of TIMP-2, MMP-
2 and MMP-9 emphasise the low level of ECM turnover in the craniofacial musculature
(Tippett et al., 2008). The gelatinases facilitate MPC migration during development
(Chin and Werb, 1997) and regeneration, and their important role has been clarified by
both in vitro (Allen et al., 2003) and in vivo (El Fahime et al., 2000) studies whereby
over-expression has faciliated substantially greater migration, and blocking activity has
been enough to prevent MPC migration. MMP-9 expression within the craniofacial
muscles increases just prior to MPC fusion. In contrast, MMP-2 mRNA and protein
expression occur during all stages of MPC differentiation (Kherif et al., 1999; Lewis et
al., 2000; Carmeli et al., 2004). Studies have also suggested a synergistic role of growth
factors on MMP expression (Allen et al., 2003).Chapter 1: Literature Review
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2.3.2.2. The Function of Growth Factors and Hormones
Although the in vivo permissive and repressive factors cannot be taken into account, in
vitro studies have provided valuable insight into the role of growth factors in
myogenesis and their potential use in muscle engineering. Table 2 highlights the roles
of some of the key growth factors in skeletal muscle.
2.3.2.2.1. Insulin-Like Growth Factors
The important role of the insulin-like growth factors I and II (IGF-I and -II) in the
general growth and development of different tissues has been established. The effects of
IGFs, which are under negative feedback, are initiated upon binding to cell surface
receptors, which are abundant in skeletal muscle (Livingston et al., 1988), and
modulated through interactions with secreted IGF binding proteins (IGFBPs), of which
there are six members (Stewart and Rotwein, 1996). IGFBPs are secreted from cells,
which also secrete IGFs (Ernst et al., 1992) and it has been speculated that IGFBP-4
may be necessary for in vivo enhancement of human skeletal muscle (Brimah et al.,
2004). IGF-I appears to be essential for correct embryonic development in animal
models, as demonstrated by the perinatal death of mice homozygous for either a
mutation of the IGF-I gene or IGF-I receptors (IGF-1Rs) resulting in underdeveloped
muscle tissue (Liu et al., 1993; Powell-Braxton et al., 1993).
It is likely that the growth hormone (GH)-IGF axis plays a major part in mediating the
growth and differentiation of skeletal muscle. The direct action of GH is unclear
(Halevy et al., 1996), despite establishing the presence of the GH receptor mRNA in
skeletal muscle. Data from more recent studies in GH receptor knock-out mice and
established cell cultures have suggested that GH is not necessary for the control of
skeletal muscle during the embryonic and perinatal stages, but more so for postnatal
myofibre growth involving the fusion of MPCs to nascent myotubes, and the positive
specification of type I fibres (Sotiropoulos et al., 2006). It has been determined that the
growth-enhancing actions of GH are facilitated by circulating or autocrine-paracrine
production of IGF-1 (Le Roith et al., 2001). Indeed, numerous studies have shown
increased IGF-1 mRNA within skeletal muscle tissue and MPC cell lines in response toChapter 1: Literature Review
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Growth factor Role
Hepatocyte
growth factor
(HGF)
HGF and receptor (c-met) localised to satellite cells and adjacent myofibres
(Cornelison and Wold, 1997).
Highly expressed in regenerating muscle – requires HSPGs for optimal ligand
presentation to c-met. Autocrine HGF-c-met loop exists.
 MPC migration during embryonic development (Bladt et al., 1995).
 Potent mitogen and chemotactic agent for satellite cells both in vitro and in vivo
(Johnson and Allen, 1993; Allen et al., 1995; Sheehan and Allen, 1999; Tatsumi
and Allen, 2004).
 Inhibits muscle differentiation in vitro and in vivo (Miller et al., 2000; Barbero et
al., 2001).
Down-regulation of the signalling pathway enabling differentiation achieved by c-
met down-regulation (Sheehan and Allen, 1999), HGF reaching saturation levels
and effects of HGF on non-myogenic cells (Miller et al., 2000).
Fibroblast
growth factor
family (FGF)
Nine different isoforms.
Stored in ECM and bound to HSPGs until needed for local action (Flaumenhaft et
al., 1989).
Activity of the FGFs is transmitted to the cell by high affinity tyrosine kinase
receptors or by binding to low affinity receptors associated with HSPGs located on
the cell surface and in the ECM (Larrain et al., 1997).
 FGF-1,2,4,6,9 stimulate MPC proliferation (Sheehan and Allen, 1999).
 FGF-2,4,6,9 act synergistically with HGF to stimulate satellite cell proliferation
above that of optimal concentrations of HGF alone (Barbero et al., 2001).
 FGF-2 acts synergistically with IGF-I to stimulate adult rat MPC proliferation
(Allen and Boxhorn, 1989).
 FGF-2 inhibits differentiation (Allen and Boxhorn, 1989; Rando and Blau, 1994)
and has weak chemotactic activity. In vivo effects include fibrosis and thus
interference with myogenesis (Barbero et al., 2001; Grounds, 1991).
There may be the ability of family members to compensate for one another.
Transforming
growth factor
family (TGF)
Inactive forms bound to decorin in ECM.
TGFβ released by damaged muscle, platelets and inflammatory cells. 
 TGFβ chemotactic to macrophages and leukocytes, initiates reconstruction of the 
basement membrane and ECM around damaged fibres (Ignotz and Massague,
1986), and induces angiogenesis (Roberts et al., 1986). Inhibits muscle cell
differentiation (Allen and Boxhorn, 1987).
The ECM in turn regulates expression of the TGFβ gene. 
Leukaemia
inhibitory
factor (LIF)
and
interleukin-6
(IL-6)
LIF action mediated by specific receptors on MPC membrane.
 IL-6 and LIF stimulate proliferation of MPCs in vitro (Austin and Burgess,
1991, Austin et al., 1992).
 LIF and TGFα or TGFβ may act synergistically to stimulate primary murine and 
human MPCs (Austin et al., 1992).
Platelet-
derived
growth factor
family (-AA, -
AB, -BB)
Released by platelets and macrophages.
 Chemotactic for MPCs (Ross et al., 1986).
 PDGF-BB has been shown to promote proliferation and inhibit differentiation in
animal models (Yablonka-Reuveni et al., 1990).
Table 2 - Key Growth Factors Involved in the Processes of Myogenesis, Regeneration and
MaintenanceChapter 1: Literature Review
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GH exposure (Florini et al., 1996). IGF-I and –II and its splice variant, mechano growth
factor (Yang et al., 1996), are produced by MPCs within regenerating muscles (Hawke
and Garry, 2001) and are unusual in that they promote MPC cell survival (Stewart and
Rotwein, 1996; Napier et al., 1999), proliferation (Florini et al., 1996; Yang and
Goldspink, 2002), differentiation (Galvin et al., 2003) and hypertrophy (Baker et al.,
1993; Florini et al., 1996; Matsumoto et al., 2006; Quinn et al., 2007): responses that
are temporally separate in MPCs (Allen and Boxhorn, 1989; Florini et al., 1991). Allen
and Boxhorn (1989) have shown that maximal stimulation of proliferation and the
highest percentage of fusion of rat satellite cells in vitro, is produced by a combination
of FGF and IGF-I, however, differentiation with minimal proliferation was achieved
with IGF-I alone. Proliferation is effected by the activation of MAP kinases (Coolican
et al., 1997), whilst differentiation is achieved by increasing levels of mRNA for
myogenin, the MRF most directly associated with terminal myogenesis (Florini et al.,
1991), and activation of the phosphoinositol 3-kinase/Akt/70-kDa S6 protein kinase
pathway (Coolican et al., 1997). In exercised muscle/compensatory hypertrophy, IGF-I
exerts its effects by increasing protein (sarcomere) formation (Adams and Haddad,
1996; Adams and McCue, 1998). Notably, the age-related changes of sarcopenia and
muscular dystrophy were negated in mice expressing muscle-specific IGF-1 (Musaro et
al., 2001; Barton et al., 2002).
2.3.3. The Non-Myogenic Cellular Component
The micro-environmental cues provided by tissue-specific ECM components are
essential in determining the fate of stem cells and their progeny, and this has been
discussed previously. The ‘stem cell niche’ itself protects the quiescent cells from these
influences, however, upon escaping the niche, cells are not only directed by the ECM
components, but also by non-myogenic cells. The non-myogenic cells playing an
important role in skeletal muscle development, maintenance, regeneration and often
chronic pathological conditions, include platelets, polymorphonuclear leukocytes
(PMLs), macrophages and fibroblasts.
Inflammatory cells, in particular macrophages, play a role in tissue homeostasis
whereby upon injury they can undertake phagocytosis (Robertson et al., 1993), antigen
presentation, and provide support through the delivery of mitogens and cell contact-Chapter 1: Literature Review
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mediated survival signals (Nathan, 1987; Cantini et al., 2002). PMLs accumulate
rapidly within minutes at the injury site and by cytokine release can promote attraction
and activation of other inflammatory cells. The role for leukocytes is based on the
observation that quiescent satellite cells express vascular cell adhesion molecule-1
(VCAM-1) and infiltrating leukocytes express the specific co-receptor VLA-4 (integrin
α4β1).  Thus  cell-cell  interactions  may  initiate  genetic  responses  to  promote 
regeneration.
Skeletal muscle injury leads to the influx of newly recruited macrophages by 24 hours,
which are responsible for the active removal of necrotic tissue and successful muscle
regeneration (Grounds, 1987, 1991; Robertson et al., 1993; Bischoff, 1997). It has been
demonstrated that human MPCs, released after micro- and macro-injury, can selectively
and specifically attract monocytes through the release of a variety of chemokines (e.g.
vascular endothelial growth factor (VEGF) (Rissanen et al., 2002)). Incidently, the
chemotactic influence was highest in newly activated MPCs, aided by close proximity
to muscle capillaries (Schmalbruch and Hellhammer, 1977) and declined towards the
time of late differentiation and the formation of multinucleated myotubes (Chazaud et
al., 2003). Others have also shown greater in vitro MPC proliferation in the presence of
primary rat monocytes (Cantini et al., 1995), and superior primary rat and human MPC
proliferation and myotube formation in the presence of macrophage-conditioned
medium, as compared to a negative control (Cantini et al., 2002). Additionally, in vivo
adminstration of the macrophage-conditioned medium substantially improved
regeneration with respect to speed and amount within rat muscles subjected to tissue
ablation (Cantini et al., 2002).
As the monocytes differentiate into macrophages, reciprocal interaction with MPCs
amplify the release of macrophage chemoattractants for additional monocytes and
MPCs (Chazaud et al., 2003). It has been implied that the growth factors released by
macrophages (IGF-I and -II, HGF, FGFs, PDGFBB, epidermal growth factor (EGF),
IL-6 (Robertson et al., 1993; Hawke and Garry, 2001)) and involvement with cell
adhesion molecules may not only rescue MPCs from apoptosis, but also erythroblasts
and neuronal cells (Meucci et al., 2000; Chazaud et al., 2003).Chapter 1: Literature Review
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Within skeletal muscle, fibroblasts are surrounded by the peri- and endomysium and are
attached to the ECM via integrins (Mackey et al., 2008) enabling the cells to register
and respond to any mechanical stimuli transmitted through the ECM: this ability has
been suggested to be essential for correct fibroblast functioning (Sarasa-Renedo and
Chiquet, 2005). The endomysial collagen is primarily produced by fibroblasts and it has
been demonstrated in vitro that fibroblasts produce factors that may modify MPC
response (Sinanan et al., 2008).
3. Tissue Engineering
3.1. The Concept of Tissue Engineering
The loss of tissues and organ failure, whether congenital or acquired, can lead to
considerable distress for the individual with respect to poor function and aesthetics.
With the increase in life expectancy in the developed world, the number of cases is on
the rise. This has been paralleled by improvements in medical techniques to find better
solutions and reduce costs, both financially and psychologically, for all those involved
(Langer and Vacanti, 1993). There have been varying degrees of success dependent on
the type of tissue to be replaced: for example, bone and skin have both been replaced
successfully (Meijer et al., 2007; Langer and Rogowski, 2009; Huss et al., 2010)
whereas the replacement of skeletal muscle still remains a challenge.
Autografts involve the transfer of the patient’s tissue, often with its associated blood
supply, from a donor site to the host site (Lalan et al., 2001). This technique has become
the gold standard for many procedures, such as for the correction of soft tissue defects
following the surgical resection of cancer. The advantages of autografts include
negligible immunological and ethical issues, however, there are a number of key
limitations, such as paucity of donor tissue, donor site morbidity and unpredictable
remodelling resulting in compromised function and aesthetics (Katsantonis, 1988;
Urken et al., 1994; Hench, 1998). Allografts (i.e. from human donors) may overcome
the issues of the adequate restoration of function and aesthetics. Tissue may be from
living donors or from human cadavers, however, demand still outstrips supply
(http://www.unos.org). Furthermore, there is the real risk of the transmission ofChapter 1: Literature Review
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bacterial and viral diseases, including HIV and CJD (Simonds et al., 1992; Christie,
1997). Matters of ethics, religion and cost remain of concern, and lifelong
immunosuppression, with its associated side effects, is necessary to reduce the
possibility of rejection (Agich, 2003; Pomahac et al., 2008; Schiano and Rhodes, 2010).
Xenografts, obtained from other species, have also been utilised, but the clinical
outcomes have been less than ideal (Yang and Sykes, 2007; Millard and Mueller, 2010).
The ability to replace or restore deficient or defective host skeletal muscle tissue with
living tissue tailor-made for the individual could circumvent the disadvantages of the
techniques outlined above (Langer and Vacanti, 1993; Vacanti and Langer, 1999), and
this vision has led to the emergence of the relatively new field of tissue engineering.
The term ‘tissue engineering’ was first used in relation to the identification of
endothelial structures on the surface of polymethylmethacrylate (PMMA) prostheses
(Wolter and Meyer, 1985), however, prior to this in the late 1970s, sheets of epithelium
derived from dermal keratinocytes were successfully grafted into wounds in athymic
murine models (Green et al., 1979) paving the way for use in burns patients (Gallico et
al., 1984). At a similar time, encased cells within polymer membranes were
successfully implanted to release the desired factors (Chick et al., 1975). Tissue
engineering has been described as “an interdisciplinary field that applies principles and
methods of engineering and the life sciences toward the development of biological
substitutes that restore, maintain and improve the function of damaged tissues and
organs” (Langer and Vacanti, 1993). Expertise has been drawn from various fields,
including the disciplines of materials science, cell biology, engineering and surgery,
with the aim to produce biological substitutes with the capacity to provide a permanent,
cost-effective solution. Various methods have been employed to repair and regenerate
defective or deficient tissues and may be divided into three broad approaches (Alsberg
et al., 2001) (Figure 5).Chapter 1: Literature Review
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Figure 5 – Tissue Engineering Approaches
The three approaches utilised in the engineering of various tissues. Figure 6A depicts the use of
biomaterials to exclude cells not required in the repair and regenerative process, such the use of
GORE-TEX
 membrane in the management of periodontal defects (inductive approach). Figure
6B demonstrates the use of growth factors (blue squares) to encourage the required cells within
the host site to repair and regenerate (conductive approach), whereas Figure 6C involves the
implantation of new cells, ideally from the same patient, to effect repair and regeneration (cell
transplantation).Chapter 1: Literature Review
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The third approach is the most-widely investigated and involves cell extraction from a
biopsy obtained from a healthy donor site, and expansion in vitro. Pre-selected cells
may also be genetically modified to replace a defective gene or to secrete certain
factors. The expanded cells, whether they are modified or not, can be implanted back
into the same patient host site to effect repair and regeneration. For effective and
efficient cell delivery these cells may be seeded onto a suitably shaped scaffold.
Alternatively, the expanded cells are seeded onto a three-dimensional (3-D) biomimetic
scaffold for in vitro maturation, often within a bioreactor, prior to implantation of the
resultant functional ‘organoid’ for correction of the defect and further growth (Figure 6)
(Vacanti and Langer, 1999). The availability of modern technology can ensure that
surgical procedures are minimally invasive, thus ensuring reduced morbidity (Rattner,
1999), and ultimate success relies on the correct combination of progenitor cells,
biomaterial scaffold and environmental cues. The timing of transplantation, whether
early on to allow the cells to be exposed to the natural milieu or later after the tissue has
matured in vitro, is key.
3.1.1. Biomaterials Used in Tissue Engineering
As mentioned above, natural and synthetic biomaterials have been increasingly used in
the engineering of numerous tissues (Hubbell, 1995; Barrère et al., 2008). Specifically,
they can provide the appropriate cues temporally, spatially and mechanically, maintain
space for de novo tissue formation, behave as a cell delivery vehicle, or act as a drug or
protein carrier to stimulate precise cellular activity at a discrete host site (Langer, 1998;
Murphy and Mooney, 1999; Salvay and Shea, 2006). There are a number of generic
requirements for biomaterial scaffolds employed in tissue engineering approaches,
which are highlighted in Figure 7.Chapter 1: Literature Review
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Figure 6 – The Technique of Cell Transplantation
This illustration demonstrates the cell transplantation approach (Figure 6C) in more detail. Cells
are extracted and expanded (B, C) from a small biopsy taken from a healthy donor site (A). These
cells may be implanted back into the host site for repair and regeneration (C), or alternatively
seeded onto a scaffold (D) and allowed to mature in vitro (E), often within a bioreactor, prior to
implantation (F).Chapter 1: Literature Review
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Figure 7 – Desirable Scaffold Characteristics
This illustration highlights many of the ideal scaffold characteristics required in order to aid the
tissue engineering process. The order of priority will depend on the tissue of interest.
Biocompatible; long shelf
life; easy to use
(Persidis, 1999)
Highly porous for cell
infiltration and waste and
nutrient efflux and influx
respectively
(Brauer et al., 2007)
Protein and gene delivery
through a combination of
diffusion and scaffold
degradation
(De Laporte and Shea, 2007)
A ‘smart’ scaffold design to
support multiple cell types –
e.g. vascular and neural
(Langer and Vacanti, 1999;
Sheridan et al., 2000)
Appropriate mechanical
properties to withstand in
vivo forces (Kim and
Mooney, 1998; Hutmacher,
2001; Georges and Janmey,
2005; Engler et al., 2006)
Controllable and complete
degradation
(Langer and Vacanti, 1999)
Ability to manipulate into the
desired shape, size and
organisation for particular
tissue (Hutmacher, 2001;
Hutmacher and Cool, 2007)
Only support attachment,
migration, proliferation,
differentiation and maturation
of cells of interest
Ideal scaffold
characteristicsChapter 1: Literature Review
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3.1.1.1. Natural Biomaterial Scaffolds
Naturally occurring biomaterials are those found in vivo. They have the advantage of
biological recognition, which can guide specific cell attachment, migration and
orientation (Silver and Pins, 1992; Thomson et al., 1995) and upon degradation, are
ultimately replaced by the ECM produced by the ingrowing cells. Nonetheless, as these
materials are isolated from humans or animals, quantities obtained may be small, batch
variations may occur and there is the possibility of inducing an immune reaction or
transmitting disease (Thomson et al., 1995; Kim and Mooney, 1998). The degradation
of natural biomaterials depends on enzymatic processes, therefore, this rate may differ
between patients making it difficult to be specific with respect to matching the rate of
tissue formation.
Collagen is the main constituent protein of all mammalian tissues, offering strength and
flexibility (Hubbell, 1995), with type I the most abundant (Hulmes, 2002). It is
biodegradable, can be successfully purified from mammalian sources utilising an
enzymatic process and salt/acid extraction (Gross et al., 1955; Rubin et al., 1965) and is
processed into various forms, such as fibres, gels and sponges (Doukas et al., 2002;
Cohen-Sacks et al., 2004). Collagen proteins are identified by a triple-helix formation
that extends over a large part of the molecule.
These individual molecules can polymerise in vitro to form fibres, which may be
organised into larger structures. Further modification by the formation of intra- and
intermolecular crosslinking aids in the formation of fibres, fibrils, and then
macroscopically discernable bundles used to form tissue. Various chemical and physical
techniques have been exploited to augment the crosslinking for tissue engineering uses:
physical crosslinking utilises exposure to heat, ultraviolet (Zeugolis et al., 2009) or
gamma irradiation (Gouk et al., 2008), whereas chemical crosslinking uses bi-
functional products, such as gluteraldehyde (Zeugolis et al., 2009). The density and
extent of crosslinking determines the degradation rate of the resultant scaffold. More
recently, collagen has also been electrospun into nanofibres (Matthews et al., 2002).
Collagen gels are visco-elastic (Rosenblatt et al., 1993) and can make suitable delivery
matrices releasing proteins and growth factors by the processes of diffusion andChapter 1: Literature Review
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degradation (Tabata, 2003), as well as scaffolds for tissue engineering purposes.
Collagen scaffolds have been used with degrees of success in tissue engineering, such
as the commercially available artificial dermis (Apligraf
®) for the management of burns
injuries (Burke et al., 1981; Fang et al., 1996; Guerret et al., 2003; Hudon et al., 2003).
Nonetheless, the issues of low tensile and compressive strength suggest the sole use of
collagen may not be ideal in all cases.
Polysaccharides have also been used as scaffolds in tissue engineering and include
hyaluronic acid (Caplan, 2000), alginates (Shapiro and Cohen, 1997) and chitosan
(Chenite et al., 2000). Alginate can form a minimally invasive injectable delivery
system or a good cell immobilisation matrix in vivo due to its gentle gelling properties
in the presence of divalent ions (Smidsrød and Skjåk-Bræk, 1990; Kim and Mooney,
1998). There may be batch variation and the gelling action is dependent on the presence
of ions, which may be lost with transplantation (Kim and Mooney, 1998). Recent
research involving partial oxidation of alginate has resulted in a scaffold material that
may be degraded within a relatively short time and hence of benefit in tissue
engineering (Bouhadir et al., 2001). Indeed, due to its relative biocompatibility, it has
been approved as a wound dressing material by the Food and Drug Adminstration
(FDA).
3.1.1.2. Synthetic Biomaterial Scaffolds
Synthetic biomaterials have a number of advantages, including greater control over
production to provide flexibility in terms of required strength, degradation properties
and macro- and microstructure for different tissue types. Growth factors and adhesion
molecules may also be added to the biomaterial. Although enzymatic processes can
feature in the degradation of these materials, simple hydrolysis commonly takes place,
therefore, factors such as hydrophilicity, access to unstable bonds, structure and
crystallinity  will  determine  the  rate  (Pişkin,  1995;  Nair  and  Laurencin,  2007). 
Environmental pH changes can affect this degradation, but more importantly, there is
less demand on the efficiency of the individual’s metabolism. Additionally, availability
is supposedly limitless and production is much more reproducible. SyntheticChapter 1: Literature Review
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biomaterials  include  organosilanes,  α-hydroxy  acids,  metals  and  calcium  phosphate 
glasses.
3.1.1.2.1. Organic Synthetic Biomaterials
Organosilanes, including alkylsiloxanes and alkanethiolates, have been used as
chemisorbed monolayers on solid supporting materials. Variations in the charge density
and reactivity can guide tissue regeneration for a wide variety of cells (Acarturk et al.,
1999). The drawback is the lack of degradation of the base material, for example, silica.
Polyesters of the naturally occurring α-hydroxy acids have been widely investigated 
over the years and have gained FDA approval for different applications, including use
as suture materials (Vicryl (polyglactin 910), manufactured by Ethicon Inc.) and tissue
engineering scaffolds (Thomson et al., 1995; Freed and Vunjak-Novakovic, 1998;
Agrawal and Ray, 2001; Hutmacher, 2001). The polyesters commonly used in medical
applications comprise of polyglycolic acid (PGA), poly-L-lactic acid (PLLA) and co-
polymers of polylactic-co-glycolic acid (Agrawal et al., 1997). The ester bonds are
hydrolytically labile and thus the polymers are susceptible to hydrolysis, whereby the
degradation products are natural metabolites (glycolic and lactic acids). Interestingly,
PLA is relatively hydrophobic and less liable to aqueous hydrolysis, whereas PGA is
highly crystalline, much more hydrophilic and thus prone to rapid resorption and loss of
structural integrity within a matter of weeks (Middleton and Tipton, 2000). Varying the
ratio of PGA to PLLA, in the form of co-polymers, altering crystallinity and the initial
molecular weight can enable the tissue engineer to control the degradation rate reliably
over a large range (Sarazin et al., 2004). However, the relationship between this ratio
and the associated physico-mechanical properties is not always linear due to the
degradation mechanism. These polymers undergo bulk degradation, which may
compromise the support of the newly engineered tissue, and contain an amorphous and
crystalline phase, such that upon favoured hydrolysis of the amorphous phase, small
crystalline particles are released with potential to support sterile inflammation (Bergsma
et al., 1995; Middleton and Tipton, 2000). Furthermore, the build-up of acidic
degradation products, due to bulk breakdown, may be acceptable in the repair of
surgical wounds, but unacceptable in tissue engineering where the precise organisationChapter 1: Literature Review
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of the final tissues is fundamental to success (Bos et al., 1989; Suganuma and
Alexander, 1993). The change in local environmental pH can secondly affect the
degradation kinetics of the polyester. Improvements in processing have reduced the
previously described problems of degradation product accumulation and associated pH
changes by measured breakdown.
The polymers may be formed into the preferred macro- and microstructure and size
utilising techniques, such as extrusion, electrospinning, solvent casting and gas-
foaming. Highly porous mesh scaffolds still remain relatively mechanically weak and
thus may not be suited for the engineering of certain tissues, such as bone (Thomson et
al., 1995). As mentioned, production processes are improving all the time (Chapman et
al., 1997; Hutmacher and Cool, 2007). Other organic polyesters used in tissue
engineering include poly(anhydrides) (Burkoth et al., 2000), poly(orthoesters) (Joo et
al., 2009) and poly(-caprolactone) (PCL) (Cao et al., 2010).
3.1.1.2.2. Inorganic Synthetic Biomaterials
Inorganic synthetic biomaterials include metals, ceramics and glasses, which can be
bioinert or bioactive. Bioactivity is often desirable to educe or moderate certain
biological responses, particularly in tissue engineering applications (Hench and Polak,
2002); for instance, titanium implants coated with hydroxyapatite modulate the bone
response (Daugaard et al., 2010; Rebollal et al., 2010), and ceramics have the capacity
to form a calcium-phosphate layer to encourage bone formation and integration
(Kokubo, 1990; Kokubo et al., 1990). A successful outcome relies not only on good
integration, but also matching the mechanical behaviour of the implant with the tissue to
be replaced.
The first known successful clinical repair of a bony defect utilising calcium phosphate
compounds was in 1920 (Albee, 1920) and over time, silica-based glasses have been
used (Hench et al., 1971a; Saravanapanan et al., 2003; Gough et al., 2004). It has been
suggested that the presence of a calcium phosphate and silica-rich layer at the surface of
these glasses, formed when in physiological solution in vitro or in vivo, provides
bioactivity encouraging bone formation (Hench et al., 1971b; Ducheyne and Qiu,Chapter 1: Literature Review
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1999). Due to the in vivo success, these silica-based glasses were approved for clinical
applications, with Bioglass
 45S5 being the ‘gold standard’ (Xynos et al., 2001; Day et
al., 2005). The silica content determines the degree of bioactivity, however, the glasses
are relatively insoluble, as demonstrated in vivo (Tadjoedin et al., 2002), and the long-
term response needs to be determined. Nagase et al. (1992) demonstrated that
suspensions of silica-containing calcium phosphate glasses injected into murine models
indicated toxicity compared to controls of calcium phosphate only.
temporary scaffolds and as devices that release
or active factors effectively and efficiently. The products released are those found in
vivo (Knowles, 2003) and the local ionic environment can impact favourably on the
cellular response. The ability to melt phosphate-based glasses at low temperatures
provides the opportunity to combine useful agents, such as therapeutic organic factors.
The degradation rate is highly dependent on composition (Bunker et al., 1984), which
can be matched to suit the application, and furthermore, the glasses are amorphous if
processed correctly (Knowles et al., 2001). The mechanism of glass dissolution in
aqueous media involves two co-dependent processes (Hench, 1977; Isard et al., 1982).
A hydrated surface layer is formed, which occurs with the exchange of Na
+ions with H
+
ions in the media, followed by eventual network degradation of the P-O-P bonds within
the hydrated layer by H
+ and H2O molecules and the release of phosphate chains. The
significance of such a process is important for tissue engineering purposes whereby a
relatively slow rate of breakdown of the surface layer and maintenance of the body of
the glass can still provide good initial support for de novo tissue formation.
Oxides of various elements play a different role in the glass structure – SiO2, P2O5 and
B2O3are considered to be the main network formers, with the ability to form glasses by
Figure 8 – Illustration of the Basic
Silicate and Phosphate Tetrahedra
Phosphate-based glasses differ from silica-
based glasses, as demonstrated by Figure 8
(Knowles, 2003), and have raised considerable
interest due to the ability to degrade completely
and predictably in aqueous media (Franks et al.,
2002; Navarro et al., 2003). The glasses can be
used in tissue engineering applications as drugsChapter 1: Literature Review
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themselves. Although silicate glasses have been widely used, glasses produced from the
other oxides were of initial attraction in the optoelectronics industry. Intermediate
oxides include Al
3+, Ga
3+ and Ti
4+, whereas network-modifying oxides are classified as
those not behaving as a ‘former’ or ‘intermediate’ oxide.
There are three main units in condensed phosphates: Q1, which serves as the end unit,
Q2, the middle unit and Q3, known as the branching unit (Figure 9). It is important to
note that the role of the oxides of some elements is dependent on the other constituent
oxides. Pure P2O5 glasses are hygrophobic in nature and hence are very soluble in
aqueous media. The crystallised form may exist as hexagonal, orthorhombic and/or
tetragonal polymorphs. These pure glasses consist of phosphate tetrahedra, which form
rings containing different numbers dependent on the polymorph (Brow, 2000). Each
tetrahedron can attach to 3 other tetrahedra or other network modifiers/intermediates
(Bunker et al., 1984). Interestingly, the duration of the melting time will determine the
persistence of the polymorphs, which highlights the necessity for consistent processing
and use of source materials in order to achieve reproducible glass properties (Knowles
et al., 2001). In contrast to SiO2, whereby other oxides (e.g. Na2O and CaO) are added
to reduce the relatively high processing temperature, the addition of oxides to P2O5 can
significantly increase its durability (Abrahams et al., 1997).
Although binary glasses have been investigated, whereby monovalent ions may be
added to stabilise the P2O5 structure (Figure 10), many of these glasses are limited by
their stoichiometry and hence the majority of research has focussed on ternary glasses.
Figure 9 – The Effect of Monovalent Ion Addition to the P2O5 Network
Q0 Q3 Q2 Q1Chapter 1: Literature Review
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Specifically, the ternary composition has mainly consisted of the P2O5-CaO-Na2O
system (Clément et al., 1999; Franks et al., 2000; Salih et al., 2000), with the P2O5
concentration usually fixed at 45-50mol%. Glasses containing at least 50mol% P2O5 are
formed of long chains or rings similar to organic polymers, and although other oxides
may be added to control the properties, the polymeric nature of the glasses enables the
formation of fibres (Ahmed et al., 2004a, b).
Linear rates of degradation have been demonstrated, which can be reduced by
substitution of Na2O with CaO (Franks et al., 2000, 2001, 2002). This is due to the
relatively stronger field strength possessed by Ca
2+ compared to Na
+ creating a
chelating structure by ionic bonding between two adjacent PO4
3- tetrahedra thus
improving the phosphate network strength (Gao et al., 2004). Interestingly, at higher
concentrations of CaO (32 and 40mol%) there seem to be two rates of degradation: an
initial rapid rate of degradation, followed 10-20 hours later by a slower rate (Knowles,
2003). Further, studies have demonstrated that ion release, related to the original
composition and in turn the rate of degradation, can give insight into the degradation
mechanism. Higher degrading glasses release greater amounts of Na
+, therefore
demonstrating preferential release early on in the process (Knowles, 2003). The knock-
on effect on the pH is due to the influx of H
+ into the glass to leave OH
- excess creating
a rise in pH. In contrast, faster degrading glasses containing smaller amounts of CaO,
release more Ca
+ compared to slower degrading glasses. The medium of choice to
investigate the degradation kinetics has varied from distilled water to simulated body
fluid (Uo et al., 1998). Although it is difficult to directly compare ternary glasses due to
the vast permutations and combinations possible with respect to composition, those
investigated have demonstrated good biocompatibility both in vitro (Uo et al., 1998;
Salih et al., 2000) and in vivo (Araujo et al., 2010).
Ternary glasses can still be too soluble for certain applications, therefore, the addition
of metallic oxides at the expense of Na2O, whilst keeping the CaO and P2O5 content
constant, may further increase durability. To this end, numerous oxides with greater
field strength, including Fe2O3 (Yu et al., 1997; Ahmed et al., 2004c; Abou Neel et al.,
2005a), CuO (Abou Neel et al., 2005b) and TiO2 (Abou Neel et al., 2007), have been
investigated for their capacity to stabilise the glass structure. Certain ions, such as Cu
2+,Chapter 1: Literature Review
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Ag
+, Zn
2+ and Ga
3+, have antibacterial properties, and thus glasses containing the
metallic oxides have been investigated for use as local antibacterial release devices
(Abou Neel et al., 2005b; Mulligan et al., 2003; Valappil et al., 2007, 2008a, 2008b,
2009) and as means of reducing biomaterial-associated infection (Gristina, 1987).
Importantly, it has been demonstrated that there are a number of parameters that will
influence the rate of antibacterial ion release, including surface area and its close
relationship to the degradation rate. Quinary glasses have also been investigated briefly,
such as the P2O5-CaO-MgO-Na2O-TiO2 system, which degrades predictably and is
biocompatible in vitro (Brauer et al., 2006).
4. Skeletal Muscle Engineering
The engineering of certain tissues (e.g. skin) has progressed rapidly and consequently
these tissues are now available as commercially viable alternatives (Meijer et al., 2007;
Langer and Rogowski, 2009; Huss et al., 2010;). On the contrary, skeletal muscle
engineering has been relatively slow to evolve. The potential to engineer a skeletal
muscle tissue has wide-reaching applications: the ability to use such a tissue as a test-
bed would aid understanding of the fundamental cellular mechanisms of proliferation,
differentiation, morphogenesis and regeneration. Additionally, the model could be
subjected to novel treatments used to manage skeletal muscle defects to assess response
and eventual success. The ultimate goal would be to provide the ideal implantable tissue
for the restoration of defects. The limited study into the engineering of the craniofacial
skeletal muscles, and in particular the jaw-closing muscles, opens up an area where
urgent study is essential. Finally, the principles of skeletal muscle engineering may be
applied to the regeneration of other tissues whereby previous studies have had
limitations. Investigations into skeletal muscle engineering have utilised a range of
biomaterials in various configurations and combinations, all with the aim to produce a
tissue with a similar architecture, and thus assumed function, as native skeletal muscle
tissue.Chapter 1: Literature Review
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4.1. Passive Scaffolds
3-D gels of naturally occurring biomaterials have had varying degrees of success.
Cylindrical collagen gels seeded with a murine muscle cell line (C2C12), maintained
within a bioreactor, demonstrated the formation of metabolically active myofibres
(Okano et al., 1997; Okano and Matsuda, 1998a). C2C12 seeded collagen sponges,
containing orientated pores of 20-50µm, showed good host infiltration suggesting
favourable biocompatibility (Okano and Matsuda, 1998b). However, primary rat limb
MPCs seeded within dermal sheep collagen scaffolds have demonstrated limited
regeneration in vivo (van Wachem et al., 1999) despite positive results in vitro utilising
C2C12 cells (van Wachem et al., 1996). With respect to the craniofacial region, in vivo
studies involving the implantation of primary neonatal rat limb MPCs suspended within
a collagen/Matrigel
TM gel into a hemiglossectomy defect model demonstrated the
formation of neo-muscle (Kim et al., 2003). Further work compared the implantation of
undifferentiated and differentiated constructs and although there was improved muscle
formation interdigitated amongst scar tissue within the surgical site, as compared to
implanted acellular collagen gels, there were no apparent differences between the stages
of cellular maturation prior to implantation (Bunaprasert et al., 2003).
Alginate gels have been utilised in both the native form and modified with the addition
of peptide molecules (e.g. the arginine-glycine-aspartic acid (RGD) sequence of
fibronectin (Alsberg et al., 2002)), and gels seeded with C2C12 cells and primary
human MPCs have confirmed the presence of myogenic differentiation in vitro
(Boontheekul et al., 2007; Rowley et al., 1999). Furthermore, modified alginate gels
seeded with primary mouse limb MPCs also demonstrated evidence of differentiation in
vivo (Hill et al., 2006). The density and distribution of cell adhesion peptides and their
affinity for cell receptors are important variables influencing cell behaviour, as
exemplified by the requirement of proliferating C2C12 cells and primary human limb
MPCs for a minimum RGD density (Boontheekul et al., 2008). Moreover, it has been
suggested that the degree of gel stiffness is an important determining factor in MPC
proliferation and differentiation (Boontheekul et al., 2007). Hyaluronic acid has also
been used as a hydrogel and although the interconnecting pores of 80µm facilitated the
differentiation of primary rat MPCs (Wang et al., 2009), the production of aChapter 1: Literature Review
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unidirectional force due to the lack of alignment is doubtful. Additionally, larger
scaffolds have demonstrated central cell necrosis, due to reduced permeability for
nutrients and waste products (Okano et al., 1997; Fuchs et al., 2003). More recently, in
vivo implantation of male primary MPCs, initially cultivated in vitro for 7 days within a
3-dimensional fibrin matrix, have survived and integrated with the female host
myofibres albeit only at the site of implantation (Beier et al., 2004, 2006). The use of
seeded cross-linked collagen sponge scaffolds have demonstrated myofibre formation in
rabbits compared to control sponge-only scaffolds (Kin et al., 2007). Crucially, studies
utilising passive gels have been mainly limited by the lack of unidirectional myofibre
alignment.
4.2. Topographical Approaches
Scaffolds provide the means for supporting seeded cells, however, the arrangement of
the new tissue is dependent on scaffold morphology and numerous techniques,
originally used in the textiles industry, have been utilised to produce the ideal
architecture. In particular, micropatterning and fibre arrangements lend themselves well
to recapitulation of native skeletal muscle structure.
4.2.1. Micropatterning
Micropatterning of biomaterials, i.e. controlling areas of adhesion and topology, can be
used to control cellular morphology, spatial assembly and function by providing
essential guidance cues. Thus, scaffold design has evolved to incorporate features that
encourage the end-to-end fusion of MPCs required for successful myofibre formation
(Wakelam, 1985). Self-assembled monolayers coated onto solid surfaces can produce
‘peaks and troughs’ to encourage cells to assume a certain orientation (Mrksich, 2000).
This technique has been used whereby self-assembled monolayers of alkylsiloxanes
adsorbed onto silica encouraged C2C12 cell adhesion, dependent on the charge of the
alkylsiloxane used, proliferation and differentiation into aligned myofibres (Acurturk et
al., 1999). Protein ‘tracks’ may also be used whereby sites for MPC adhesion are
provided in a certain orientation (Clark et al., 1997; Molnar et al., 2007; Yan et al.,
2007), however, myotubes can be separated by areas devoid of protein.Chapter 1: Literature Review
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Conversely, solid surfaces can be patterned with grooves to essentially effect the same
cell behaviour – microchannels created in polymeric films created by UV-embossing
(Shen et al., 2006) and 60-400m channels produced by laser micro-machining in 2%
agarose and filled with Matrigel
TM (Patz et al., 2005) have all supported C2C12 cell
alignment. Further, grooves within glass slides coated with collagen and laminin have
promoted primary foetal and neonatal murine limb myofibre alignment – interestingly,
the neonatal myofibre formation and alignment was limited by the dimensions of the
grooves more so suggesting that the two populations are separate entities (Evans et al.,
1999).
The processes of plasma oxidation (Lam et al., 2006), modified replica moulding
processes (Zhao et al., 2009) and deep reactive ion etching (Das et al., 2006) have been
used to introduce grooves into the surfaces of polymers, such as polydimethylsiloxane
(PDMS) and diethylenetriamine (DETA), and have also been successful in the
alignment of C2C12 cells and myofibres (Lam et al., 2006; Zhao et al., 2009) and the
myogenic differentiation of embryonic rat limb MPCs (Das et al., 2006).
Modifications to these processes have included the use of customised PDMS slabs for
myofibre alignment followed the transfer of these fibres into degradable, flexible gels
(Lam et al., 2009; Huang and Lee, 2010). PDMS grooved moulds packed with primary
rat limb MPC seeded fibrin gel promoted the formation of porous skeletal muscle
networks in vitro, which were readily transferable (Bian and Bursac, 2009). Indeed,
Lam et al. (2009) noted that aligned myofibres produced twice the peak force of
controls. Alternatively, PDMS stamps have been used to create laminin ‘lanes’ on
smooth hydrogel surfaces to achieve C2C12 myofibre alignment (Cimetta et al., 2009).
More recent studies utilising the C2C12 murine cell line have focussed on the ability to
imprint polystyrene with PDMS moulds, previously created from a grooved silicone
‘master’ wafer (Wang et al., 2010). Cell differentiation was enhanced on the grooved
surfaces and the authors concluded the potential of such surface topography for the
engineering of skeletal muscle.
Finally, soft lithography techniques utilising PDMS moulds have been used to produce
solvent casted micro-patterned poly(lactic-co-glycolic) acid membranes; interestingly,Chapter 1: Literature Review
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the scaffolds were formulated by stacking Matrigel
TM-coated membranes to achieve a
final thickness of 150-200μm, and both in vitro and in vivo investigations demonstrated
successful myogenic differentiation of primary murine MPCs (Boldrin et al., 2007). It is
important to note that a wide range of spacing between grooves (6 to 400 µm) exists for
supporting optimal alignment. Moreover, nanoscale rectangular-shaped grooves may
limit myotube formation (Clark et al., 2002), therefore, modifications by Lam et al.
(2006) centred on the production of continuous, wavy features resembling the
topography created by the primary myotubes, which form a foundation for the
secondary myotubes during embryonic myogenesis (Wilson et al., 1992). C2C12 cells
seeded onto laminin-coated PDMS substrates with a wavy topography aligned and
formed a dense myotube monolayer. Although myofibre alignment is achieved with
many of these techniques, the size of the generated construct remains limited.
4.2.2. Fibre Scaffolds
Fibre scaffolds also have the potential to support the desired alignment of myofibres
(Cronin et al., 2004), and whilst numerous biomaterials have been investigated, PGA
remains the most popular material of choice, due to its commercial use in vivo (van’t
Riet et al., 2002; Sortino et al., 2008). PGA meshes, utilising fibres of 12µm diameter,
seeded with primary rat MPCs were implanted into non-muscular sites in vivo for 4-6
weeks: histology at the time of sacrifice confirmed the presence of multinucleated
structures suggestive of myofibres (Saxena et al., 1999, 2001). Significantly, Kamelger
et al. (2004) compared non-woven PGA fibre meshes, alginate and hyaluronic acid
hydrogels as primary neonatal rat limb MPC delivery agents in an attempt to engineer
skeletal muscle tissue within an ectopic, vascularised site. A subcutaneous silicone
‘capsule’ was used to protect the implanted scaffold from the host defences and prevent
cell migration. Although multinucleated myotubes were detected in all the scaffolds
suggesting that the technique may be suitable for producing tissue of certain volume,
the unidirectional nature of the myotubes was not ascertained (Kamelger et al., 2004).
Furthermore, there was the suggestion of a host reaction to PGA with the creation of a
fibrovascular growth.Chapter 1: Literature Review
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PCL, another popular biomaterial, arranged into a random arrangement of gravity-spun
fibres of 80-150µm diameter, has sustained the attachment and proliferation of C2C12
cells (Williamson et al., 2006). Progressing from the preliminary work involving PGA
meshes, Fuchs et al. (2003) coated non-woven PGA fibre meshes with either PLLA or
poly-4-hydroxybutyrate (P4HB) in order to increase durability. Regardless of the
secondary treatment, thinner meshes seeded with a ‘moderate’ density of foetal lamb
muscle-derived cells fared better with the appearance of myotube-like structures. Most
importantly, cellular responses in all the investigations outlined were only elicted when
coatings of ECM components, such as laminin, fibronectin, collagen (or its denatured
product, gelatin) and Matrigel
TM (a reconstituted basement membrane), were used.
As elucidated previously, scaffold stiffness can affect cell behaviour in terms of
attachment, proliferation, differentiation and maturation. Thus, the use of co-polymers
in different ratios to control the degradation rate can be detrimental, in that a very
compliant scaffold may not be able to withstand cellular forces, whereas an excessively
stiff scaffold may not allow cellular alignment (Georges and Janmey, 2005; Engler et
al., 2006; Levy-Mishali et al., 2009). Therefore, newer biomaterials with elastomeric
properties better suited to skeletal muscle engineering have emerged and various ECM-
coated (10% collagen, Matrigel
TM, and fibronectin) electro-spun DegraPol® (a
degradable elastomeric polyesterurethane) fibre meshes (10µm diameter) have
demonstrated the ability to support the attachment, proliferation and differentiation of
myogenic cell lines (C2C12 and L6) and human MPCs (Riboldi et al., 2005). Similarly,
the G8 myogenic cell line demonstrated a positive response on a spun-cast elastomeric,
albeit non-degradable, polyurethane (Mulder et al., 1998). These newer polymers seem
to have desirable physical properties, however, the necessity for surface coatings is still
a potential disadvantage.
Fibres have a number of advantages over solid structures, including a high surface area
to volume ratio for greater cell adherence and the potential to align MPCs
unidirectionally. Significantly, fibre diameter can also influence cellular attachment and
behaviour and thus there is a suggested optimal range of 10-100µm for successful
myofibre formation (Kamelger et al., 2004). It has been suggested that the optimal
spacing of 30 to 55µm is necessary for the production of a sheet of aligned C2C12Chapter 1: Literature Review
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myofibres (Neumann et al., 2003). As stated above, fibre meshes have been used
frequently, but to recreate the structure of native muscle requires the presentation of
parallel arrays. To attain unidirectional alignment of myofibres, collagen fibrils have
been organised into a parallel fashion (Beier et al., 2009), nonetheless, it has been
suggested that composite scaffolds of collagen/fibrin or collagen/electrospun PCL could
lend better support for the differentiation of primary human muscle-derived cells, with
the advantages of both biomaterials being exploited. PLLA, another member of the α-
hydroxy acid family, subjected to the separate techniques of tension alignment (Huang
et al., 2006) or bundling (Cronin et al., 2004) resulted in parallel fibre arrays supporting
the formation and maturation of C2C12 and primary human myofibres.
Progressing from previous studies investigating electro-spun DegraPol® for skeletal
muscle engineering purposes, Riboldi et al. (2008) created parallel fibre arrays of the
material. It was concluded that the correct architecture and mechanical cues had been
provided to support proliferation and differentiation of the C2C12 and L6 myogenic cell
lines, as confirmed by the presence of the myosin heavy chains.
Also, for successful support, it follows that the degradative process is iterative to the
biological response and for a number of biomaterials, such as the α-hydroxy acids, this 
is not the case. Degradable phosphate-based glasses may be able to provide the ideal
scaffold properties for muscle engineering. The polymeric nature of the glasses enables
production of fibres, which may be shaped to fit a defect. Of note is the ability of
random glass fibre meshes of 10µm diameter to support the attachment, proliferation
and myogenic differentiation of C2C12 cells (Ahmed et al., 2004c).
4.2.3. Acellular Scaffolds
Another attempt at recapitulating the skeletal muscle architecture and function is
through the use of acellular scaffolds with the ideal size and shape of ECM capable of
supporting MPCs and also the neural and vascular cellular components. Borschel et al.
(2004) successfully seeded C2C12 cells on an acellularised mouse limb muscle scaffold
to produce a tissue with an output contractile force upon electrical stimulation.
Unfortunately, there are immunological implications with the use of acellular scaffolds.Chapter 1: Literature Review
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4.3. Mechanical Approaches
During normal growth and function, complex forces are transmitted to the skeletal
muscles, which influence the expression of fibre type and the capability for adaptation
(Lewis et al., 2001). Further, not only must an engineered muscle tissue replace
aesthetics adequately, but it must also be able to withstand in vivo mechanical forces.
Therefore, to this end, engineering techniques have also focussed on the utilisation of
mechanical stimulation to produce such a mature tissue, and indeed stimulation of
muscle cultures have affected the following parameters:
(a) Gene regulation (Carson and Booth, 1998).
(b) Endogenous protein expression (Perrone et al., 1995).
(c) Cellular proliferation (Hatfaludy et al., 1989; Vandenburgh et al., 1989).
(d) Myofibre organisation (Vandenburgh, 1982; Collinsworth et al., 2000) and
hypertrophy (Vandenburgh et al., 1989).
(e) ECM turnover (Vandenburgh et al., 1991; Auluck et al., 2005; Mackey et al.,
2008).
The first reported 3-dimensional model of skeletal muscle used a combination of
collagen and Matrigel
TM to provide a 3-dimensional support (referred to as ‘bioartificial
muscles’ (BAMS)) and the endogenous mechanical strain produced assisted the
production of two- to fourfold longer myofibres (Vandenburgh and Karlisch, 1989;
Vandenburgh et al., 1991). The use of modified primary murine (Vandenburgh et al.,
1996, 1998) and human MPCs (Powell et al., 1999), as delivery vehicles for
recombinant growth factors in muscle disorders, revealed a parallel array of fused
postmitotic myofibres expressing MyHCs. The engineered muscle constructs were far
from identical to native skeletal muscle, however, the primary aim was the delivery of
proteins even in non-muscle sites as opposed to the formation of skeletal muscle for the
correction of defects. Consequently, this platform technology has been modified further
in an attempt to produce a more ideal tissue, as demonstrated by investigations into
applying tension in different planes of space (Powell et al., 2002; Cheema et al., 2005).Chapter 1: Literature Review
67
Cyclical mechanical strain has also been employed in an attempt to produce
unidirectionally orientated multinucleated myofibres: the application of strain to type I
collagen gels seeded with C2C12 cells resulted in reciprocal alignment of both
myofibres and collagen fibres (Okano et al., 1997; Okano and Matsuda, 1998a).
Subcutaneous implantation into the dorsum of mice of the gels revealed the formation
of dense capilliarisation at four weeks (Okano and Matsuda, 1998b). When skeletal
muscle constructs previously subjected to cyclical strain resulting in myofibre
alignment, were implanted into athymic mice, they demonstrated an encouraging 10%
of the force of the latissimus dorsi muscles.
Powell et al. (2002) introduced the combination of repetitive unidirectional loading of
human BAMs during their formation and long-term maturation, via the attachment to
artificial tendons and a stepper motor, and simultaneous recording of real-time forces,
via a force transducer. The dimensions of the experimental set-up enabled up to a 25%
change in length. The endogenous longitudinal tension, in part related to the cell
cytoskeletal elements, was enough to align MPCs such that they fused into parallel
arrays of multinucleated myofibres comprising only 2-10% of the total cross-sectional
area. The application of repetitive stimulation for 8 days resulted in augmentation of the
mean diameter and area of myofibres by 12% and 40% respectively, compared to
controls (Powell et al., 2002). Adult skeletal myofibre diameter ranges from 10μm to 
100μm (Burkitt  et al., 1995). The myofibre dimensions within static human BAMs
were, on average, 5μm, whereas mechanical loading of human BAMs led to an increase 
in diameter analogous to the hypertrophy observed during development and resistance
training (McCall et al., 1996). The mechanism for myofibre hypertrophy within
mechanically stimulated constructs seems to be the upregulation of IGF-I gene splicing
and production (Cheema et al., 2005). It has been implied that BAMs may not generate
the active force of native adult muscle, mainly due to the low myofibre content (2-5%)
and excess non-contractile matrix (Payumo et al., 2002), and later studies have focussed
on collagen compression to increase the cell:matrix ratio (Abou Neel et al., 2006;
Kayhanian et al., 2009). Importantly, the stretch protocol employed can prohibit in vitro
2-D and 3-D myogenesis (Boonen et al., 2010).Chapter 1: Literature Review
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Other investigations have focussed on myofibre
and collagen fibre alignment employing a
passive collagen gel, incubated initially to
allow gel contraction as a resultant of the
cellular component, which is then attached via
Velcro and metal bars to provide mechanical
strain (Figure 10, Eschenhagen et al., 1997).
The initial reduction in gel dimension
increases the collagen concentration, and the
cellular and collagen fibre alignment is
assumed to produce superior mechanical
properties, as compared to poorly aligned
constructs.
As suggested above, the passive tension within the constructs is partly due to the
cellular component. There is a relation between the stiffness and degradability of a
biomaterial scaffold and the propensity for MPCs to proliferate and differentiate
successfully – in other terms, the material properties can determine the transmission of
mechanical forces effected by the cellular component. This was highlighted in studies
investigating the response of C2C12 cells and primary mouse MPCs in 2- and 3-
dimensional alginate gels: within the 2-dimensional model, stiffer gels (13-45kPa)
resulted in improved adhesion, proliferation and differentiation (Boontheekul et al.,
2007). However, within the 3-dimensional degradable gels, as the mechanical stiffness
decreased, there was greater differentiation of C2C12 cells compared to non-degradable
gels. Although the primary MPCs demonstrated greater cell proliferation within the
degradable gels, there was no evidence of differentiation in either type of gel. There is a
critical balance between the degradation of a 2- and 3-dimensional scaffold and the
mechanical properties for skeletal muscle engineering, but more apparent are the
differences between cell lines and primary cell cultures.
Recently, magnetic force-based strategies have been employed to assist cell alignment:
Colleti et al. (2007) used a static magnetic field to promote alignment and
differentiation of the L6 myogenic cell line. Progressing from this, Yamamoto et al.
Figure 10 – A 3-D Collagen Scaffold
This figure demonstrates the contraction
(arrows) of secured collagen gels with
myofibre formation over time. (Adapted
from Eschenhagen et al., 1997).Chapter 1: Literature Review
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(2009) have produced C2C12 alignment with magnetic forces with the eventual
detachment of the cell sheet resulting in the formation of cylindrical constructs. Stern-
Straeter et al. (2005) have advocated electrical stimuli to encourage cell alignment, and
Liao et al. (2008) utilising electromechanical forces have demonstrated MPC alignment
on aligned electrospun polyurethane scaffolds to produce striated myotubes with
upregulation of the contractile proteins. There will always be problems with the use of
cell lines not responding in a realistic fashion to primary cells, nonetheless, it is clear
that a combination of techniques may be exploited for the purposes of skeletal muscle
engineering.
4.4. ‘Self-Organisation’ of Muscle Constructs
‘Self-organisation’ or cell-sheet engineering is another approach to tissue engineering
relying on the ability of cells to deposit and organise their own ECM scaffold, thereby
producing intact, tissue-like sheets. These sheets can be rolled or layered to form larger
tissues. Strohman et al. (1990) undertook the first known investigations indicating the
capacity for primary MPCs to self-organise under tension and express adult MyHCs, as
compared to monolayer cultures. Further research focussed on the use of Sylgard
®- and
laminin-treated plates seeded with primary rat MPCs. The presence of artificial tendons,
constructed from laminin-coated silk sutures or acellularised muscle structures, enabled
fused myofibres to assume a parallel orientation, as they contracted and rolled to form a
cylindrical ‘myooid’ over 3-4 weeks (Dennis and Kosnik, 2000). Although the myooids
demonstrated consistent and repeatable excitability and isometric contractile profiles
over a number of months in culture, the specific peak isometric force (P0) was only
approximately 1% of the adult phenotype (Dennis and Kosnik, 2000). As P0 is a
function of the total myofibre cross-sectional area composed of sarcomeres containing
adult MyHCs, it was concluded that the lower P0 was probably related to large amounts
of non-contractile material, lack of structural organisation of the myofibres and the
presence of embryonic and neonatal MyHCs. Whilst the use of cell lines and other
primary cultures have proved successful (Dennis et al., 2001; Kosnik et al., 2001; Baker
et al., 2003), the length of the technique poses a limitation, therefore, modifications
utilising a fibrin-thrombin gel have produced primary rat myooids within 7-10 days
(Huang et al., 2005). Fibrin is able to bind to FGF-2 (Sahni et al., 1998) and VEGFChapter 1: Literature Review
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(Sahni and Francis, 2000), growth factors that participate in skeletal myogenesis, and
incorporation of IGF-I at optimal levels resulted in an increase in force production
(Huang et al., 2005). The successful production of skeletal muscle tissue without the
constraints of a scaffold is attractive, equally these myooids have yet to produce forces
comparable to those generated by in vivo adult skeletal muscle.
Advances in the area of cell-sheet engineering have included the use of
thermoresponsive substrates, for example, the polymer poly(N-isopropylacrylamide)
(PIPAAm), which can support cell adhesion and proliferation at 37ºC, and enable cell-
ECM delamination at 32ºC due to increased hydrophilicity (Okano et al., 1995). Whilst
this technology is promising, the lack of structural organization of the detached cell
sheets limit their use. Hence, adaptations have included the use of micropatterning in
conjunction with thermoresponsive substrates to control the spatial distribution of
multiple cell types and define the structural organisation of the actual cells and ECM
(Tsuda et al., 2007; Isenberg et al., 2008).
4.5. Cell Transplantation
Gene therapy is a powerful tool that may be used for the management of diseases.
MPCs may be transduced in vivo by the direct injection of viral vectors or plasmid
DNA, however, the efficiency of transduction remains low and the implantation of
MPCs could prove to be more effective (Morgan, 1994; Skuk and Tremblay, 2000). The
first indication of the potential therapeutic use of MPCs was noted when implantation of
minced muscle from one animal to another led to the formation of hybrid myofibres
(Partridge et al., 1978). The rationale behind cell transplantation, alternatively referred
to as ‘myoblast transfer therapy’ (MTrT), is to implant large numbers of healthy MPCs
with the capacity to fuse with diseased or damaged host muscle to form mosaic fibres
(Partridge et al., 1989; Rando and Blau, 1994; Rando et al., 1995; Partridge, 2002).
Thus, in the case of hereditary skeletal muscle diseases (e.g. muscular dystrophy), the
implanted cells could contribute the normal gene product absent in the host (Karpati,
1989; Morgan et al., 1990; Huard et al., 1992, 1994; Rando et al., 1995). Additionally,
the implantation of autologous MPCs could be useful for augmenting muscle mass and
functional capacity in smaller muscles, including the craniofacial muscles, subjected toChapter 1: Literature Review
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atrophy secondary to long-term denervation and areas of congenital malformation
(Atala, 2007). Genetically-modified MPCs have been used as vehicles for the systemic
delivery of recombinant proteins in the management of hormone deficiencies,
neurodegenerative diseases and coagulation disorders in animal models (Barr and
Leiden, 1991; Dai et al., 1992; Bohl et al., 1997). Furthermore, autologous skeletal
MPCs have been implanted in an attempt to repair in vivo cryo-damaged cardiac muscle
with mixed success (Reinecke et al., 2000; Pouzet et al., 2001; Murtuza et al., 2004;
Sherman et al., 2009).
Unfortunately, animal investigations have identified the main limitation of MTrT as
poor donor cell migration and survival (Rando and Blau, 1994; Rando et al. 1995; Fan
et al., 1996; Hodgetts et al., 2000; Skuk and Tremblay, 2000). Donor cell migration and
survival in hybrid myofibres has only been effective under specific experimental
conditions in animal models, such as irradiation (Alameddine et al., 1994; Wernig et al.,
2000; Morgan et al., 2002), cryodamage (Morgan et al., 1987; Irintchev et al., 1997),
immunosuppression (Huard et al., 1994; Smythe et al., 2000), or treatment with matrix
metalloproteinases (Torrente et al., 2000). It has been suggested that the implantation of
myoblasts with an appropriate combination of basement membrane components and
growth factors may enhance MPC survival, proliferation and differentiation (Barbero et
al., 2001; Neuhaus et al., 2003). More recent developments have focussed on the
transplantation of satellite cells in association with their intact single myofibres to effect
muscle regeneration, albeit into injured muscles (Collins et al., 2005), and the systemic
delivery of muscle-derived stem cells (Torrente et al., 2003).
Nevertheless, human MTrT trials have been undertaken in the attempt to deliver
dystrophin within immunosuppressed hosts. Although, immunocytochemistry of the
same muscles six years later revealed over 95% of biopsied fibres as dystrophin-
positive, the fibres were irregular in shape and size with relatively little ECM compared
to the close-packed, polygonal, regular-sized normal control myofibres (Law et al.,
1997a, b). The partial success of other MTrT clinical trails (Huard et al., 1992; Gussoni
et al., 1992; Law et al., 1993; Tremblay et al., 1993; Gussoni et al., 1997) has been
attributed to similar limitations discovered in animal studies: namely, low spread and
survival rate (Huard et al., 1994; Fan et al., 1996; Tremblay and Guerette, 1997),Chapter 1: Literature Review
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immune rejection (Huard et al., 1992; Tremblay et al., 1993; Skuk et al., 2002) and the
lack of host muscle regeneration and presence of connective tissue barriers, as a
consequence of recipient age (Miller et al., 1997). Significantly, in a direct in vivo
comparison of cell injection with scaffold-based engineering techniques, it was
demonstrated that single fibre-derived satellite cells seeded onto Matrigel
TM-coated
PGA meshes produced greater myofibre formation than direct injection in combination
with Matrigel
TMinto regenerating muscles (Boldrin et al., 2007). This study highlighted
the important temporary role of scaffolds in tissue engineering processes.Chapter 1: Literature Review
73
5. Summary
Craniofacial skeletal muscle defects, whether genetic or environmental, can cause the
loss of function and aesthetics. The current gold standard to manage such defects is the
autologous transfer of tissue, however, limitations include the paucity of available
tissue, donor site morbidity and failure of the transferred tissue to remodel adequately.
Tissue engineering offers the ability to create a tissue substitute ideally suited to the
area to be repaired and circumvent the disadvantages posed by current techniques, and
has become a viable alternative for tissues, such as skin. Skeletal muscle engineering
remains in its infancy, and with respect to the craniofacial skeletal muscles, there is a
huge gap in the knowledge base. The potential to engineer a tissue is important for
implantation purposes, but also for the provision of a test-bed to ensure that emerging
therapies are refined for optimal outcome.
Skeletal muscle is a classic example of form governing function. MPCs extracted from
muscle explants in vitro can recapitulate those myogenic processes occurring in vivo.
Animal and human studies of skeletal muscle engineering have highlighted poor cell
migration and survival as the major problem of direct transplantation, whereas both in
vitro and in vivo investigations utilising different cell seeded biomaterial scaffolds have
demonstrated degrees of success. Passive gels and fibre meshes have supported the
myogenic differentiation of cell lines and primary murine and rat cells, but the main
constraint of such scaffolds is the inability to promote myofibre alignment necessary for
correct function. Micropatterning of solid surfaces and the arrangement of fibres into
parallel arrays can encourage such alignment, however, the use of certain biomaterials
can also hinder success. For example, it is difficult to transfer myofibres from solid
surfaces, and degradable scaffolds may not have linear, predictable rates of dissolution
matched to that of tissue formation. The importance of complete and timely scaffold
degradation is to ensure continued tissue maturation and function. Mechanical strain has
also been employed to encourage myofibre alignment analogous to the architecture of
native skeletal muscle, nonetheless, these are often ‘open’ systems prone to infection.
Finally, self-organisation techniques have been considered and still need to be further
developed to increase the bulk and strength of the engineered tissue.Chapter 1: Literature Review
74
From previous studies, it is clear that fibre scaffolds have the potential to provide the
correct arrangement conducive to skeletal muscle engineering, and for ultimate success,
combinations of natural and synthetic materials may be used. Furthermore, in order to
provide a suitable tissue substitute, investigations must be undertaken using primary
human cell cultures. Phosphate-based glasses have many desirable properties in that the
rate of degradation is highly linear and predictable and may be tailored to the rate of
tissue formation by altering the composition. Additionally, the products released are
those found in vivo, and different compositions of the glasses have been shown to be
compatible with many tissues. Other parameters that may be altered include fibre
diameter and spacing between parallel arrays of fibres. Further, the local in vitro
environment may be manipulated with adjuncts, such as growth factors. Phosphate-
based glass fibres have promoted the differentiation of C2C12 cells. This research,
based on these preliminary findings, has focussed on the use of phosphate-based glass
scaffolds in combination with ECM components to engineer an in vitro 3-D human
craniofacial skeletal muscle substitute.
6. Aims and Objectives
6.1. Aims
To produce a human craniofacial skeletal muscle tissue for use as a potential test-bed
for novel therapies involving the craniofacial region.
6.2. Objectives
(a) To confirm the myogenicity of human masseter muscle-derived cell cultures.
(b) To investigate the characteristics and biocompatibility of phosphate-glass
scaffolds with human masseter muscle-derived cell cultures.
(c) To produce a biomimetic scaffold capable of supporting human masseter
muscle-derived cell attachment, proliferation, differentiation and maturation.Chapter 2: Materials and Methods
75
Chapter 2:
Materials and MethodsChapter 2: Materials and Methods
76
Chapter 2: Materials and Methods
1. Primary Cell Culture
1.1. The Explant Technique
Numerous studies have successfully extracted cells from muscle biopsies (Blau and
Webster, 1981; Rando and Blau, 1994). The explant technique was used to establish
muscle-derived cell cultures based on previous success with this method in BTE.
(a) Cells were extracted from human masseter muscle biopsies obtained from
healthy consented adult patients undergoing the removal of impacted lower third
molars or mandibular osteotomy under general anaesthesia at Eastman Dental
and University London College Hospitals. Prior approval had been awarded
(Ref. 00/E014) and the research was part of ongoing work. The biopsies were
taken from the deep surface of the anterior border of the superficial belly of the
masseter muscle (Figure 4) via an intra-oral incision at the time of the surgery.
Care was taken not to use any local anaesthesia in the vicinity of the biopsy area.
The biopsies were transported in Dulbecco’s modified Eagle’s Medium
(DMEM) supplemented with 1% penicillin (100 gml
-1)/streptomycin (5000
gml
-1) (P/S).
(b) MPCs adhere and proliferate effectively in the presence of a net positive charge
and thus, tissue culture flasks were coated with gelatin (Blau and Webster,
1981). 0.2% gelatin had been previously prepared from a stock 2% gelatin
solution diluted with phosphate-buffered saline (PBS). All tissue culture
procedures were carried out under aseptic conditions within a class II flowhood.
The tissue flasks were coated with the appropriate amount of substrate: 5ml per
80cm
2 flask and 10ml per 175cm
2 flask, and left for thirty minutes to allow for
substrate attachment, after which any excess was siphoned off.
(c) The biopsies were finely minced and placed into the flasks and bathed in a
minimal amount of standard growth medium (SGM) (79% DMEM, 20% foetal
calf serum (FCS), 1% P/S) and maintained at 37C in a humidified atmosphereChapter 2: Materials and Methods
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of 5% CO2 in air (Lewis et al., 2000). All unused sterile solutions were placed at
4ºC until the next time of use when they were heated in a water-bath to 37ºC.
(d) The explants were left
undisturbed for 5 days and the
SGM was then changed every 3
days. After approximately 7-14
days, cells were observed
migrating from the explant
(Figure  11)  and  termed  the  α 
wave. Subsequent waves were
termed β and γ respectively. 
1.2. Expansion of Primary Cell Cultures
The formation of myotubes is influenced by the proximity of neighbouring cells, and
hence cultures were passaged at a relatively low level of confluency to ensure minimal
cellular fusion had taken place. The process of passaging allows for expansion of cell
numbers and the opportunity for cloning and characterisation, however, this process is
also associated with the loss of any differentiated cells.
(a) The SGM was changed every 3 days until there was 75% confluency at which
point the cells were passaged.
(b) The SGM was siphoned off and discarded. The cell monolayer was washed
twice with 5mlcm
-2 of Ca
2+ and Mg
2+ ion-free PBS and the solution discarded.
The Ca
2+ and Mg
2+ cations promote cell attachment via glycoproteins, therefore,
the absence of these ions decreases the affinity of the cells to the substrate.
Furthermore, the washing stage assisted with the removal of serum proteins,
which can inhibit the action of trypsin. The cells were released from the
monolayer by incubation in 1ml per 25cm
2 of 0.05% trypsin/0.02% EDTA for 2-
5 minutes during which time the cells became rounded and detached. Trypsin
digests the ECM links and EDTA is a chelating agent, which sequesters Ca
2+
Figure 11 – The Explant Technique
Cells (green arrows) can be seen migrating
from the explant (red arrow) at 10 days. This
was the first wave of cells migrating from the
explant and was termed the α wave. Chapter 2: Materials and Methods
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and Mg
2+ ions. The action of the protease was terminated by the addition of
SGM at a ratio of 3:1 to the trypsin/EDTA.
(c) The solution was gently triturated before being transferred to a sterile centrifuge
tube. A further aliquot of SGM was added to the tissue culture flask in order to
rinse the remaining cells and also transferred to the centrifuge tube. The cell
suspension was centrifuged at 350g for 5 minutes at 4ºC and the supernatant was
decanted off and discarded. The pellet was then resuspended in 2ml of SGM by
firmly tapping the tube and gently triturating to form a single cell suspension
and the cell number was determined with a haematocytometer.
(d) Subsequent plating was carried out at a density of 1.5 x 10
3cm
-2 and flasks were
coded accordingly to ensure anonymity of the patient. Cells used in the
experiments were extracted from healthy adult (22-29 year old) female masseter
muscle biopsies (n=8) and were from the  wave, passages 3-12.
1.3. Cryopreservation of Primary Cell Cultures
The ability to store small aliquots of frozen cells in liquid nitrogen (-196ºC) without the
loss of proliferative or differentiative ability is of a great advantage, in that experiments
may be replicated and comparative studies may be undertaken. Importantly, it has been
demonstrated that MPCs frozen from previous cultures retain the capacity to proliferate
and form normal myofibres (Law et al., 1993). The viability of cells can be reduced by
the potential mechanical damage from ice crystal formation and thus,
dimethylsulphoxide (DMSO), a cryopreservative, may be used to reduce crystal
formation.
(a) After quantification utilising a haemocytometer, the cells was centrifuged at
350g for 5 minutes at 4ºC, and following removal of the supernatant,
resuspended in freezing medium (90% FCS and 10% DMSO) at 1.0 x 10
6
cellsml
-1.Chapter 2: Materials and Methods
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(b) 1ml aliquots were placed in labelled cryovials and transferred to a cooled
styrofoam insulated container, which was stored in a mechanical freezer to allow
a cooling rate of –1ºC/min down to -70ºC.
(c) The cryovials were relocated to the liquid nitrogen store the following day and
the storage record files updated accordingly for accurate retrieval.
1.4. Retrieval and Resuspension of Cryopreserved Primary Cell Cultures
(a) The selected cryovial was retrieved and thawed in a 37ºC water bath with
constant agitation.
(b) The outside of the vial was wiped with a tissue soaked with 70% ethanol to
remove any contaminants and a sterile pipette was used to transfer the contents
to a 10ml graduated centrifuge tube, which contained 10ml of warmed SGM.
(c) After centrifuging the contents at 350g for five minutes at 4ºC and discarding
the supernatant, the pellet was resuspended in more SGM. The cells were plated
at a density of 1.5x10
3 cellscm
-2 in gelatin-coated flasks and allowed to adhere
for one day.
(d) Fresh SGM was added the following day and changed every third day.
2. Phosphate-Based Glasses
2.1. Glass Production
The ternary alumimium-zinc-phosphate (Al-Zn-P) glasses used in the preliminary
studies were provided by colleagues in the Division of Biomaterials and Tissue
Engineering (BTE) at UCL Eastman Dental Institute, whereas a series of quaternary
iron-phosphate glasses (Table 3) were produced for subsequent studies. The glass
compositions were such that the P2O5 and CaO content were kept fixed at 50mol% and
40mol% respectively, and the Fe2O3:Na2O ratio was varied. The calculations
determining the required amounts of chemicals are in Appendix A. The chemicals used
for the production of the iron-phosphate glasses were sodium dihydrogenChapter 2: Materials and Methods
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orthophosphate (NaH2PO4), calcium carbonate (CaCO3), phosphorus pentoxide (P2O5)
and iron oxide (Fe2O3) (BDH, Poole, U.K.).
Glass code P mol% Ca mol% Na mol% Fe mol%
Fe0mol% 50 40 10 0
Fe1mol% 50 40 9 1
Fe2mol% 50 40 8 2
Fe3mol% 50 40 7 3
Fe4mol% 50 40 6 4
Fe5mol% 50 40 5 5
Table 3 – The Composition of a Series of Iron-Containing Glasses and Corresponding Codes
(a) All chemicals were weighed into a 200ml volume Pt/10%Rh crucible type
71040 (Johnson Matthey, Royston, U.K.), which was placed in a carbolite
furnace (Carbolite, RHF 1500, Sheffield, U.K.) preheated to 350ºC. A clean
crucible was used for the production of new batch of glass.
(b) The temperature was increased incrementally to allow for the gradual removal
of H2O and CO2,and then maintained at 1100ºC for 60 minutes.
(c) The molten glass was quench cast on a steel plate at room temperature to form
cullet for the initial studies to investigate the thermal properties.
(d) For the degradation, microbial and biocompatibility investigations, the glass was
poured into cylindrical graphite moulds (15mm diameter) preheated to 420ºC in
a Dicor furnace (Dentsply, U.K.), maintained at that temperature for one hour
and then left to cool to room temperature in the furnace to ensure the release of
any residual internal stresses. Disks with a thickness of 1mm were cut using a
rotary diamond saw (Testbourne Ltd, Basingstoke, U.K.) and methanol, as a
coolant and lubricant. Glass disks from each composition were abraded and
polished using silicon carbide paper (P#500, Struers, U.K.).Chapter 2: Materials and Methods
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(e) Glass fibres were produced utilising a dedicated fibre rig consisting of a top
loading furnace (Lenton, U.K.) with internal Pt/10%Rh crucible; the crucible tip
(15mm length), with an outlet of approximately 1mm, protruded through a
bushing. After heating the crucible to 1400ºC, the glass was placed inside and
allowed to melt and homogenise for 15 minutes. The temperature of the furnace
was then reduced in order to produce a viscosity suitable for fibre-pulling (1235-
1246ºC). As the glass dropped onto the revolving drum, fibres of various
diameters were produced according to the revolutions per minute (RPM), which
equated to metres per second due to the drum circumference of 1m.
Furthermore, to produce fibres with a certain spacing, a stepper motor was used
at a specific hertz calculated by taking the RPM of the drum into account (see
Appendix B for details of the stepper motor speed). Finally, glass fibres were
transferred from the drum using adhesive tape.
2.2. Investigation into Glass Thermal Properties
A differential thermal analyser (SETARAM, U.K.) with an atmosphere of air and a
heating rate of 20ºCmin
-1, up to a maximum of 1200ºC, and the CALISTO
ACQUISITION and PROCESSING thermal analysis software was utilised to measure
the thermal parameters of glass transition (Tg), glass crystallisation (Tc) and glass
melting (Tm) temperatures.
(a) Glasses of all compositions were ground for 5 minutes using a Retsch
® mixer
mill MM 301.
(b) The ground glass was placed into a miniature Pt/10%Rh crucible, weighed and
placed into the differential thermal analyser.
(c) The data were baseline corrected by undertaking a blank run simultaneously and
subtracting this from the plot obtained. Three batches of each composition were
analysed for thermal properties.Chapter 2: Materials and Methods
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2.3. Degradation and pH Effects
(a) The disks were weighed and the surface area was calculated by measurement of
the diameter and thickness using a pair of Mitutoyo digimatic vernier callipers.
(b) High purity water (18.2MΩcm resistivity) at pH 6.0 +/- 2 was obtained from a 
PURELAB UHQ-PS (Elga Labwater, U.K.) system for use as the incubation
medium. After the pH of the water had been adjusted to 7.0 by the dropwise
addition of 1M NH4OH, the disks were placed in polyethylene bottles containing
a volume of 5mlcm
-2 to account for any variation in surface area between the
disks, and incubated at 37ºC.
(c) At 2, 4, 8, 10, 24, 48, 72, 168, 240 and 336 hours, the disks were removed from
the medium, air-dried, weighed and replaced in fresh medium. All compositions
were investigated in triplicate and the entire experiment was repeated to confirm
reproducibility. The cumulative weight loss per unit of surface area was
calculated according to the following formula below, where W0 was the initial
weight of the sample, Wn the weight at each timepoint and TSA the total surface
area.
(W0 – W1) +(W0 – W2)…..+ (W0 – Wn)
Weight loss/surface area (mgcm
-2) = TSA
(d) The pH of the post-degradation medium was measured using an Orion pH meter
(Orion, U.K.) with a pH glass electrode and temperature sensor (BDH, U.K.).
Prior to use, the meter was calibrated using colourkey standard solutions (BDH,
U.K.).
(e) The degradation properties of fibres (10-30µm diameter) produced from Fe1- to
Fe5mol% were also investigated in deionised water. Fe0mol% fibres were too
soluble and therefore were not included in the investigations. Due to the
difficulty in assessing the surface area of a bundle of fibres, only the reduction
in weight of fibres secured to stainless steel frames (3 x 1cm, n=3) was recorded
at 0, 2, 4, 8, 24, 48, 72, 168 and 240 hours. This enabled calculation of the
percentage of scaffold remaining. The medium was changed at these timepoints.Chapter 2: Materials and Methods
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2.4. Ion Release
Ion release was analysed by ion chromatography following the methodology of Ahmed
et al. (2005). For all the ion release studies described, the post-degradation samples
were in triplicate and obtained from the degradation investigations described above. The
Chromeleon
® software package was used to analyse the data.
2.4.1. Cation Release
A Dionex ICS-1000 ion chromatography system (Dionex, U.K.) was used to quantify
the release of Na
+ and Ca
2+ from the disks with time. The separation was performed
using 30mM methanesulfonic acid (Fluka, U.K.) eluent, a 4x250mm Ion Pac
® CS12A
separator column and a 25µL injection loop.
(a) Prior to running the samples, the ion chromatograph was calibrated utilising
standard solutions prepared with NaCl (Sigma, U.K.) and CaCl2 (BDH, U.K.). A
stock solution of 100ppm was prepared and serial dilutions were performed to
produce solutions of 5, 10, 25 and 50ppm. 600µl were placed into vials with a
special rubber top to allow extraction of the sample for analysis and the software
was used to produce a standard curve (Figure 12).
(b) Once the system had been calibrated, all the samples were pre-processed
through an OnGuard IIA cartridge (Dionex, U.K.) containing an anion exchange
resin in order to remove phosphate species prior to injection onto the column.
600µl were placed into vials for analysis.
2.4.2. Anion Release
A Dionex ICS-2500 ion chromatography system (Dionex, U.K.) consisting of a gradient
pump with a 25µL sample loop was used for the measurement of the phosphate ion
release. The polyphosphates were eluted using a 4x250mm Ion Pac
® AS16 anion-
exchange column packed with anion exchange resin. A Dionex ASRS
® (Anion Self-
Regenerating Suppressor) was used at 242mA in combination with a Dionex EG40
eluent generator equipped with a potassium hydroxide (KOH) cartridge. The EG40Chapter 2: Materials and Methods
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eluent generator system electrolytically produces high-purity KOH eluent using
deionised water as the carrier stream at the point of use, and can result in negligible
baseline shifts during the hydroxide gradients along with greater retention time
reproducibility.
(a) The calibration of the ion chromatograph was achieved by preparing standard
solutions using sodium phosphate tribasic (Na3PO4), trisodium trimetaphosphate
(Na3P3O9), pentasodium tripolyphosphate (Na5P3O10) (Sigma-Aldrich, U.K.) and
tetrasodium pyrophosphate (Na4P2O7) (BDH, U.K.). A 100ppm working
solution containing all of the above four reagents was prepared and serially
diluted to produce solutions containing 5, 10, 25 and 50ppm. The software was
used to produce a standard curve (Figure 13).
(b) 600µl of each sample were placed into vials for analysis. The sample run time
was set at 20 minutes whereby the gradient program initiated at 30mM KOH for
10 minutes, then increased from 30mM to 60mM KOH for 5 minutes and was
held at 60mM KOH for 3 minutes followed by a return to 30mM KOH during
the last 2 minutes.Chapter 2: Materials and Methods
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Figure 12 – Software-Generated Standard Curve for Na
+
Figure 12A depicts the results obtained for ‘standard #4’ whereby the retention times for the peaks
obtained correspond to Na
+ and Ca
2+, and the areas of the peaks enable the actual amounts to be
calculated. Figure 12B demonstrates the standard curve for Na
+ produced by the software.
A
BChapter 2: Materials and Methods
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Figure 13 – Software-Generated Standard Curve for PO4
3-
Figure 13A shows the peaks related to the various phosphate ions released for ‘standard #4’. The
areas of the peaks correlate to the amount of ion present. Figure 13B is the standard curve
generated for PO4
3-.
A
BChapter 2: Materials and Methods
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2.4.3. Iron Release
A Dionex ICS-2500 ion chromatography system (Dionex, U.K.) consisting of a 25µL
sample loop was used to analyse the post-degradation solutions for iron release. The
samples were eluted using an Ion Pac
® CS5A cation-exchange column with attached
CG5A guard column used for the determination of transition and lanthanide metals. Met
Pac pyridine-2,6-dicarboxylic acid (PDCA) (Dionex, U.K.) was used as the eluent: the
PDCA is used as a complexing agent, which separates the metal complexes via anion
exchange. Met Pac 4-(2-pyridylazo) resorcinol (PAR) (Dionex, U.K.) post-column
reagent diluent was used as the diluent for PAR. The post-column reagent has a
controlled pH and low metal concentration, which reacts with a wide range of metals
and has the ability to detect levels as low as 1ppb. The absorbance was detected at
530nm.
(a) A stock solution of 100ppm was prepared using FeCl3 (Sigma-Aldrich, U.K.)
and serially diluted to produce concentrations of 1, 5, 10 and 20ppm in order to
calibrate the ion chromatograph and produce a standard curve.
(b) 600µl of each sample were placed into vials for analysis.Chapter 2: Materials and Methods
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2.5. Investigation into Bacterial Response
The broth used to support bacteria contains a certain amount of free Fe
3+, hence the
growth of Staphalococcus aureus (NCTC 6571) and Streptococcus epidermidis (NCTC
11047) were assessed in serial dilutions of tryptone soya broth (TSB, Oxoid Ltd, U.K.)
prior to embarking on the investigations. It was confirmed that the bacteria grew well in
a 0.25% dilution and this was used throughout. Each investigation for S. aureus and S.
epidermidis was undertaken in triplicate for each glass composition and compared to a
positive control of bacterial growth in 0.25% TSB (Figure 14). The investigations were
repeated three times in total for each strain of bacteria to establish the trends in
response.
(a) The bacteria had been previously grown on blood agar plates and were diluted in
0.25% TSB to an average optical density (OD600) of 0.022 measured using a
spectrophotometer (Ultraspec 2000, Pharmacia Biotech, U.S.A.). The disks,
previously sterilised by dry heat at 180ºC for 2 hours, were then incubated in
23mls of the solution under constant agitation at 37°C for 48 hours.
(b) The OD600, a reflection of bacterial number, was recorded hourly for the first 6
hours and then at 24 and 48 hours using the spectrophotometer. 1ml was
removed from each sample and placed within a plastic cuvette for analysis.
(c) Bacteria were also plated onto blood agar plates at 0, 3, 6, 24 and 48 hours to
establish the number of colony forming units (CFU) with time. 20µl were
removed from each sample and diluted by a factor of 10
-1 in 180µl sterile PBS.
Serial dilutions of 10
-2 to 10
-8 were undertaken in a microplate and 10µl of
solution were pipetted onto agar plates, which were incubated at 37ºC. The
blood agar plates had been produced previously by mixing 50ml defibrinated
horse blood (E&O Lab. Ltd, U.K.) with 1000ml sterilised Bacto
TM Agar (BD,
U.K.) and placing in petri dishes before allowing to cool.Chapter 2: Materials and Methods
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Positive
control
Fe0mol% Fe1mol% Fe2mol% Fe3mol% Fe4mol% Fe5mol%
23mls Tryptone Soya Broth + S.aureus or S.epidermidis
n=3
OPTICAL
DENSITY
Hourly 1-6 hours 24 hours 48 hours
24 hours 48 hours 0, 3 and 6 hours
COLONY
FORMING
UNITS
1ml removed at each timepoint from each sample for measurement of optical density
20µl removed at each timepoint from each sample for CFU data
Figure 14 – The Methods for Investigating Bacterial Response
Each disk was placed into 23mls of TSB (n=3) and the bacterial growth was investigated over 48 hours
and compared to a positive control. 1ml of solution was removed from each sample at 1, 2, 3, 4, 5, 6, 24
and 48 hours and the optical density was measured using a spectrophotometer. Furthermore, 20µl were
removed at 0, 3, 6, 24 and 48 hours from each sample to investigate the growth of colony forming units
over time.Chapter 2: Materials and Methods
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2.5.1. Scanning Electron Microscopy
Disks were also fixed at 6 and 24 hours (n=2) for qualitative assessment under scanning
electron microscopy (SEM).
(a) Samples were fixed in 2% glutaraldehyde in 1.0M sodium cacodylate buffer for
at least 48 hours.
(b) To prepare the specimens for scanning electron microscopy (SEM), sequential
dehydration was undertaken by incubation in 20%, 50%, 70% and 90% alcohol
for 10 minutes and 100% alcohol for 10 minutes, repeated three times.
(c) The specimens were then transferred into hexamethyl disilazane solution
(HMDS) (Sigma, U.K.) for 2 minutes and placed in a dessicator prior to
mounting onto aluminium stubs and gold sputter coating.
(d) After using self-adhesive tabs to mount the samples onto the stubs and
application of a conductive carbon cement (Agar Scientific) to ensure contact
between the sample and aluminium, the samples were placed in a SEM coating
unit (Model E5000, Polaron Equipment Ltd).
(e) A vacuum was created prior to coating the samples for 90 seconds at 1.25kV,
20mA.
(f) All the specimens were viewed with a Cambridge 90B SEM (Leo Electron
Microscopy Ltd, U.K.) operating at 15kV and associated INCA software
(Oxford Instruments, U.K.).
2.6. Scaffold Preparation
2.6.1. Aluminium-Zinc-Phosphate Glass Fibre Scaffolds
Glass fibres used in the preliminary investigations of biocompatibility with human
masseter muscle-derived cell cultures were composed of P2O5 (62.9mol%), Al2O3
(21.9mol%) and ZnO (15.2mol%) (Al-Zn-P), had a diameter of 6.5µm and degradation
rate of 0.16mg/g/24 hours.Chapter 2: Materials and Methods
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Mesh
Spread
Bundle
(a) The fibres were encased in aluminium foil, sterilised by dry heat at 180ºC for
120 minutes and stored in a sealed plastic bag until required.
(b) Under sterile conditions, the fibres were
arranged in 6-well plates, with a surface area
of 10cm
-2, into three different configurations
to create a 3-dimensional scaffold: in order to
achieve this, the fibres were ‘teased’ apart
using tweezers to create a bundle
arrangement, a mesh arrangement and an
arrangement where the fibres were widely
spread and separate (Figure 15). All scaffold
configurations were in triplicate and the
wells contained a sterile 30mm diameter
coverslip to aid with later processing of the
scaffolds. Additionally, some of the mesh scaffolds were secured at either end
with sterile tape to investigate the influence of a stable scaffold on cellular
response, as compared with unsecured scaffolds.
(c) All of the glass scaffolds were coated overnight with either gelatin or Matrigel
TM
dissolved in DMEM at a concentration of 0.2% and 2-10gcm
-2 respectively.
The Matrigel
TM, which had been previously aliquoted and stored at -80ºC, was
allowed to thaw at 4ºC overnight and cooled pipette tips were used to transfer
the solution, due to its rapid gelling properties at temperatures above 4ºC. The
concentration of Matrigel
TM was chosen to produce a ‘thin coating’ in
accordance with previous in vitro studies of myogenesis (Maley et al., 1995).
2.6.2. Iron-Phosphate Glass Scaffolds
Later studies utilised disks of iron-containing glasses for investigations into
biocompatibility and custom-made frames for the production of parallel arrays of glass
fibres.
Figure 15 – The Glass Fibre
Scaffold ArrangementsChapter 2: Materials and Methods
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2.6.2.1. Iron-Phosphate Glass Disks
(a) Iron-phosphate glass disks were produced and sterilised, as described in section
2.1.
(b) The disks were placed into a 24-well plate and coated for 30 minutes in 10% rat
tail collagen (2.10-2.12mgml
-1 in 0.6% acetic acid) diluted in PBS.
(c) The excess collagen was siphoned off and the disks were seeded with the
desired cell density.
2.6.2.2. Iron-Phosphate Glass Fibre Scaffolds
(a) Glass fibres were removed from the fibre rig drum, placed onto handmade 3 x
1cm stainless steel frames and secured with cyanoacrylate.
(b) After cutting the excess fibres away from the frames, the frames with the
secured fibres were transferred into an aluminium foil jacket and sterilised by
dry heat at 180°C for 120 minutes.
(c) The frames were stored until
required: 72 hours prior to cell
seeding, the cyanoacrylate was
covered by silicone (RTV118,
Techsil Ltd., U.K.) in the class II
flow hood and allowed to set for
24 hours. 70% ethanol (EtOH) was
used to further sterilise the frames
and allowed to evaporate for 48
hours after which the frames were
ready for coating with ECM
components and cell seeding
(Figure 16).
Transferred and
secured onto 3 x 1cm
stainless steel frames
with cyanoacrylate.
Coated with a thin
layer of collagen prior
to cell seeding.
Transferred to
a glass slide for
embedding
within collagen
matrix and
seeded cells
utilising a
stainless steel
mould
(3 x 1cm).
Parallel arranged fibres
on drum
Figure 16 – Production of Scaffolds with
Parallel Fibre Arrays
Fibres were either secured onto frames and
coated with a thin layer of collagen prior to cell
seeding or embedded within a collagen matrix
containing cells.Chapter 2: Materials and Methods
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(d) The aligned, secured glass fibres were coated with rat tail collagen for 30
minutes to allow for a thin coating. Any excess collagen was siphoned off prior
to cell seeding.
(e) A number of the glass fibres were also embedded within a collagen gel (Figure
17). Fibres were placed onto a glass slide and secured with tape. The fibres were
subsequently placed in an aluminium foil jacket and sterilised by dry heat, as
described above. A stainless steel frame with dimensions of 3 x 1 x 0.4cm was
placed over the fibres and held in place by stainless steel clips.
(f) A cooled solution of 6ml rat tail collagen (2.10-2.12 mgml
-1 in 0.6% acetic acid)
and 0.7ml 10x minimum essential medium (MEM) was neutralised with 1M
NaOH, such that there was a colour change from yellow to fushcia pink. 7.2 x
10
6 cells, previously resuspended in 500µl of SGM, were added to the
neutralised collagen mixture.
(g) 750µl of the cell-containing collagen solution was then placed into the stainless
steel frame and incubated at 37°C for 30 minutes to allow for gelation.
(h) After the collagen solution had formed a gel, the frame was carefully removed
and the excess glass fibres were cut away with a scalpel blade (11) before the
composite structure was placed into a six-well plate and covered with SGM.
(i) Control collagen gels were constructed utilising the same method, but without
the presence of the glass fibres.
(j) All constructs were maintained at 37C in a humidified atmosphere of 5% CO2
in air and the SGM was changed to differentiation medium (DM) (97% DMEM,
2% FCS, 1% P/S, 10ng/ml IGF-I) on day 3 to encourage MPC fusion into
prototypic multinucleated myofibres. The DM was changed every three days.Chapter 2: Materials and Methods
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Figure 17 – The Process of Composite Scaffold Production
Figure A demonstrates the glass fibres (pink arrow) secured onto a glass slide with autoclave tape and
stainless steel mould (yellow arrow) on top ready for dry sterilisation. Figure B shows the expected
colour change with dropwise addition of NaOH to a solution of rat-tail collagen. A known quantity of
cells was added to the neutralised solution at this point. The neutralised collagen was then added to the
sterilised glass fibre/stainless steel mould and allowed to gel at 37C (Figure C). Thereafter, the seeded
glass fibres encased within the collagen gel were transferred to 6-well plates and incubated in standard
growth medium. Figure D depicts such a composite scaffold on day 1 after seeding (Scale bar 5mm). The
control collagen gels were produced in a similar fashion without the presence of the glass fibres.
A
D
C
B NaOH
Collagen +
MEM
Neutralised
collagen and cellsChapter 2: Materials and Methods
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3. The Cellular Response
3.1. Myogenicity of Masseter Muscle-Derived Cell Cultures
It was essential to establish the myogenicity of the primary cell cultures for all the
studies undertaken. In vitro proliferation is enhanced by high serum levels (10-20%)
whereas low serum levels (0-2%) can promote myotube formation (Ham et al., 1988).
(a) Glass coverslips were soaked overnight in a jar containing 70% ethanol (EtOH)
made up from absolute ethanol diluted with tissue culture grade water. After
soaking, the coverslips were placed into a clean Pyrex petri dish, using forceps
and a needle. The excess EtOH was pipetted off and a small volume of the tissue
culture grade water was added to prevent the coverslips from aggregating. After
wrapping the dish in an aluminium foil jacket, the coverslips were sterilised by
dry heat at 200C for 2 hours. The cooled dry coverslips were then transferred
under sterile conditions to a plastic petri dish, sealed with parafilm and stored
under dry storage conditions until required.
(b) In order to determine myogenicity, coverslips were placed into a 24 well plate
and coated for 30 minutes with 0.2% gelatin.
(c) Masseter muscle-derived cells were plated at a density of 1.5x10
3cm
-2 and
maintained at 37ºC in a humidified atmosphere of 5% CO2 in air for 14 days.
(d) The SGM was changed every three days and as soon as the cells became 80-
90% confluent (day 3), the SGM was changed to DM. The DM was also
changed every three days.
(e) Cells were fixed at 1, 3, 7, 10 and 14 days, and stained with the appropriate
antibodies in order to assess myogenicity – an inverted microscope (Model
DMIRB, Leica Microsystems, U.K.) was used in conjunction with a COHU
CCD camera and Leica FW4000TZ imaging software to capture phase and
immunofluorescence images. Cell fusion consists of two stages: MPC-MPC
fusion in order to form nascent myotubes and then the subsequent fusion of
MPCs with myotubes resulting in an increase in size.Chapter 2: Materials and Methods
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3.1.1. Immunocytochemistry
3.1.1.1. Cell Fixation for Immunocytochemistry
The aim of cell fixation is to preserve cell structure and to make target antigens
available to the appropriate antibodies – a combination of paraformaldehyde and
methanol was used.
(a) A solution of 4% paraformaldehyde and 0.0625% sodium azide (NaN3) was
prepared by dilution of a stock solution of 10% paraformaldehyde with PBS.
(b) Up to 2% paraformaldehyde was added to each specimen-containing well by
pipetting the solution down the side of each well and left for 5-10 mintues in
order to lightly fix the cells.
(c) After removal of the paraformaldehyde and transferring the solution to a waste-
solvent bottle, the cells were washed twice with 2ml of freshly prepared PBS.
Thereafter, 1.5ml of methanol was added dropwise for further fixation for 10
minutes.
(d) The methanol was decanted to the waste-solvent bottle and the cells were
washed twice again with PBS. The cells were covered in 2ml PBS/NaN3and the
wells sealed with parafilm
® and stored at 4ºC ready for antibody staining.
3.1.1.2. Antibody Staining
For all the studies undertaken, the skeletal muscle-specific cytoskeletal structures,
desmin and α-sarcomeric actin, were identified to confirm the presence of MPCs and 
myotube formation. Immunocytochemistry was also utilised to identify MyoD1,
myogenin and the embryonic (MyHC-emb) and neonatal (MyHC-neo) myosin heavy
chains. Importantly, the specificity of the staining was confirmed by elimation of the
primary antibody.Chapter 2: Materials and Methods
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3.1.1.3. Addition of Primary Antibody
(a) Where cells had been grown on coverslips, the coverslips were removed from
the wells and placed on custom-made pedestals. Alteratively, specimens were
left in the wells and solutions were added accordingly.
(b) The cells were washed six times with freshly prepared PBS and permeabilised
by incubation with 0.25% Triton-X-100/0.0625% NaN3 in PBS for 10-15
minutes.
(c) Thereafter, the cells were washed again six times with PBS and incubated
overnight  at  room  temperature  with  skeletal  muscle-specific  primary  (1˚) 
antibodies. The mouse monoclonal anti-human desmin antibody (Clone: D33,
Isotype: IgG1, Dako, U.K.) was diluted 1:2,000-4,000 in antibody diluent (PBS,
10% heat-inactivated FCS, 0.0625% NaN3, 0.1M lysine). The mouse
monoclonal anti-α sarcomeric actin antibody (Clone: 5C5, Isotype: IgM, Sigma, 
U.K.) was diluted 1:12,000 with antibody diluent.
(d) Prior to the addition of the mouse monoclonal anti-human MyoD1 (Clone: 5.8A,
Isotype: IgG1, Abcam, U.K.), myogenin (Clone: F5D, Isotype: IgG1, Abcam,
U.K.), MyHC-emb (Clone: F1:652, Isotype: IgG1, Enzo
® Life Sciences, U.K.)
and MyHC-neo (Clone: WB-MHCn, Isotype: IgG1, Novocastra, U.K.)
antibodies, there was an additional blocking step with incubation of the samples
in 0.5% bovine serum albumin (BSA) in PBS for 30 minutes. Thereafter, the
cells were washed six times with PBS. The antibodies were diluted 1:50 in
antibody diluent and left overnight at room temperature.
3.1.1.4. Addition of Secondary Antibody
(a) After overnight incubation, the cells were washed in freshly prepared PBS and
incubated with the secondary (2º) antibodies for 30 minutes at room
temperature. The anti-mouse IgG1 class specific FITC (Jackson
ImmunoResearch Europe Ltd.) was diluted 1:200 and the anti-mouse IgM
specific Cy3 (Jackson ImmunoResearch Europe Ltd.) was diluted 1:800-1,000Chapter 2: Materials and Methods
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in antibody diluent. Nuclei were identified using the fluorescent DNA probe
DAPI (Invitrogen
TM, U.K.), which was diluted 1:10,000 in the antibody diluent.
(b) The cells were washed for a final six times with PBS and coverslips were then
mounted onto glass slides with antifade media (Citifluor Ltd, U.K.) and the
edges sealed with clear nail varnish. Where glass fibre scaffolds had been
stained in the wells, they were lifted out and placed between a glass slide and
coverglass with antifade media, and once again the edges were sealed with nail
varnish.
(c) The samples were visualized with epifluorescence using the following filters to
determine the degree of cell proliferation and differentiation: FITC (excitation at
485 nm, emission at 520 nm), Cy3 (excitation at 550 nm, emission at 570 nm),
and DAPI (UV excitation at 372 nm, emission at 456 nm).
3.2. Cell Migration
To examine cell migration on the glass fibres, time-lapse imaging of selected samples
was undertaken with the inverted microscope and associated software. The sample was
placed within a microscope incubation chamber at 37C in a humidified atmosphere of
5% CO2 in air. The area to be filmed was carefully selected and images were captured
using the automatic capture sequence software over a time period of 24-48 hours.
3.3. Cell Attachment and Proliferation Assays
There are a number of assays available to assess the rate of cell proliferation, including
direct cell counting, measures of cellular metabolic activity and the replication of DNA.
Each have their own advantages and disadvantages, as exemplified by the accurate, but
laborious process of direct cell counting, and the safety aspects associated with the use
of H-thymidine.Chapter 2: Materials and Methods
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3.3.1. The CyQUANT
® Proliferation Assay
As the DNA and RNA levels within cells are under tight regulation (Frankfurt, 1980), it
is possible to ascertain the cell number by assessing the content of cellular nuclei acids.
Essentially, the levels of DNA and RNA may vary over time in an individual cell.
However, the average nucleic acid content per cell remains constant providing the
culture is non-synchronous (Jones et al., 2001), in that the timing of replication and
transcription in any particular cell is out of phase with that in other cells. There are
numerous dyes utilised in cell quantification assays, such as propidium iodide (Krishan,
1990), that demonstrate fluorescent enhancement on binding with nucleic acids.
Nonetheless, although they offer a fairly accurate measure of cell number, these dyes
have relatively poor sensitivity for the measurement of low cell numbers (Jones et al.,
2001). Further developments based on binding to nucleic acids have included the use of
highly sensitive cyanine dyes, and in particular, the CyQUANT
® GR dye has been
demonstrated to provide the greatest sensitivity combined with the largest linear
dynamic range for cell quantification (Jones et al., 2001): therefore, for the assessment
of muscle-derived cell attachment and survival, the CyQUANT
® assay was used
(Figure 18).
(a) The samples were washed gently with PBS after removal of the growth medium,
and the plates were stored at -70ºC until the completion of the particular study.
(b) All stock solutions were allowed to warm to room temperature before
preparation of the CyQUANT
® GR dye-cell lysis buffer on the day of the
experiment – the cell-lysis buffer stock solution (Component B) was diluted 20-
fold with dH2O  in  a  plastic  container.  Each  assay  required  200μl,  thus,  the 
appropriate volume of CyQUANT
® GR stock solution (Component A) was
diluted 400-fold with the 1X cell lysis buffer, also in a plastic container, and
covered in aluminium foil to prevent photodegradation of the dye.
(c) The plates containing the samples were allowed to thaw at room temperature
and thereafter, 200μl of the CyQUANT
® GR dye-cell lysis buffer was added.
All the samples were incubated for 5 minutes at room temperature, protected
from light. 200μl of the lysis buffer was placed into 3 empty wells in order to Chapter 2: Materials and Methods
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establish background fluorescence, which was deducted from the sample values
obtained.
(d) A reference standard curve was created
from a known quantity of cells translating
the fluorescence reading to actual cell
number. At the start of the study, these cells
had been trypsinised, quantified, centrifuged
and then stored at -70ºC, as a pellet after
removal of the supernatant. The pellet was
thawed at room temperature and
resuspended in 1ml of the CyQUANT
® GR
dye-cell lysis buffer. As each assay was a
200μl volume, a series of dilutions ranging 
from 0 (background control) to 5x10
4 cells
was created and incubated at room
temperature for 5 minutes, also protected
from light.
(e) All samples were transferred to a 96 well
plate. Fluorescence was measured at
excitation 485nm and emission 520nm with a
Fluoroskan Ascent fluorescence reader
(Labsystems, Finland) and associated Ascent
software (version 2.4).
3.3.2. The alamarBlue
® Assay
The measure of long-term cell viability to exposure of biomaterials is extremely
important. A number of assays require a large number of samples and necessitate cell
death in order to make an assessment (Mosmann, 1983). Therefore, the ability to
measure viability in the same sample over time is advantageous over other techniques,
such as the 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide (MTT)
assay. alamarBlue
® (resazurin) is a stable, water-soluble dye that is non-toxic to cells
Figure 18 – Stages Undertaken
for the CyQUANT
® Assay
Remove culture media
Freeze at -70C
Thaw and add lysis buffer
Measure fluorescenceChapter 2: Materials and Methods
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and enables continous monitoring of the same sample (Fields and Lancaster, 1993).
Upon addition to the masseter muscle-derived cell cultures, the oxidised form of
alamarBlue
® enters the cytosol and is transformed to the reduced form by the
mitochondrial enzymes (O’Brien et al., 2000), and possibly cytosolic and microsomal
enzymes (Gonzalez and Tarloff, 2001). The redox reaction is associated by a
measureable change in the colour of the culture medium from non-fluorescent blue to
fluorescent pink (resorufin). alamarBlue
® shows good correlation with other assays
(Back et al., 1999; Hamid et al., 2004), and a linear relationship between cell number
and fluorescence has been demonstrated (Nakayama et al., 1997). Furthermore, it has
been demonstrated to possess a higher sensitivity and reproducibility in the detection of
low cell numbers, as compared with the tetrazolium salts, (e.g. MTT) (Hamid et al.,
2004). Interestingly, a cumulative increase in alamarBlue
® reduction can be seen with
time-courses (Al Nasiry et al., 2006) and therefore, the final concentration and
incubation time was determined and adhered to throughout all of the studies undertaken
to enable accurate comparison.
(a) At each timepoint, the old medium was removed and replaced with 900μl of 
fresh SGM. 100μl of alamarBlue
® was added to give a final concentration of
10% and the samples were incubated for 4 hours at 37ºC in a humidified
atmosphere of 5% CO2 in air. As a negative control, alamarBlue
® was also
added to fresh SGM in a well without cells.
(b) The fluorescence of the sample and control wells was read using the Fluoroskan
Ascent system at an excitation wavelength of 530nm and emission wavelength
of 590nm, and the final readings were calculated by deducting background
fluorescence.
3.4. Cell Differentiation
There are a number of methods to assess skeletal muscle differentiation – in addition to
the immunofluorescent techniques described above, the following methods were also
utilised.Chapter 2: Materials and Methods
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3.4.1. Detection of Creatine Phosphokinase
The extent of differentiation into multinucleated myotubes was assessed quantitatively
by measuring for the enzyme creatine phosphokinase (CPK), a marker of myotube
formation (Blau and Webster, 1981) at 1, 3 and 7 days after the addition of DM. CPK
catalyses the formation of adenosine-5-diphosphate (ADP) and phosphocreatine from
adenosine-5-triphosphate (ATP) and free creatine, and the reaction may be followed by
measuring the formation of one of the end products.
ATP + Creatine ADP + Phosphocreatine
Phosphocreatine Creatine + Inorganic Phosphorus
It has been demonstrated that measurement of the inorganic phosphorus can serve as a
basis of rate monitoring, therefore, the Fiske and SubbaRow method (Fiske and
SubbaRow, 1925) was utilised to measure colorimetrically the amount of inorganic
phosphorus, which was in turn proportional to CPK activity. The amount of phosphorus
(gml
-1) was calculated in terms of the amount of protein (µgml
-1) present in each
sample.
3.4.1.1. Creatine Phosphokinase Assay
A standard CPK assay kit (Sigma, U.K.) intended for use in the qualitative, colorimetric
determination of CPK in serum at 620-700nm was used according to the manufacturer’s
instructions.
(a) Each time the assay was performed, known concentrations of inorganic
phosphorus were used to prepare a calibration curve by plotting the absorbance
values at 620-700nm versus the corresponding phosphorus concentration
(µg/tube). This standard curve (Figure 33B) helped determine the phosphorus
concentration in the various samples and hence the CPK expression.
Hydrolysis
CPKChapter 2: Materials and Methods
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(b) Table 4 states the reagents placed into 1.5ml clean centrifuge tubes. Each ‘test’
corresponded to each sample, and blanks 1 and 2 were prepared in triplicate.
(c) The tubes were placed carefully in the 37°C water bath and allowed to warm for
a few minutes.
(d) To each tube, 10µl ATP-glutathione solution was added and gently mixed, and
to start the reaction, the tubes were incubated at 37°C.
(e) Following the incubation period, 160µl trichloracetic acid was added to stop the
reaction. After thorough mixing and allowing the tubes to stand at room
temperature for 5 minutes, the samples and blanks were centrifuged at 2000
RPM for 5 minutes.
Component (µl) Test Blank 1 Blank 2
TRIZMA
®buffer solution - 100 -
Creatine solution 100 - 100
Sample 30 - -
Glyglycine buffer (0.5mmol) - 30 30
Water 100 100 100
Table 4 – Reagents Used for Assessing the Inorganic Phosphorus Concentration of Various
Samples, and thus CPK Expression
(f) 100µl of the clear supernatant were then transferred carefully into clean labelled
eppendorfs corresponding to the first set.
(g) 400µl water, 100µl acid molybdate solution and 25µl Fiske and SubbaRow
solution were added to the tubes and after thorough mixing, the tubes were
allowed to stand at room temperature for 30 minutes. This step resulted in
hydrolysis of the phosphocreatine and the development of the colour.
(h) 150µl of each solution was transferred to a 96 well plate within 10 minutes of
colour development and the absorbance was read at 620nm.Chapter 2: Materials and Methods
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3.4.1.2. Protein Assay
The concentration of protein in each sample was determined using the Pierce BCA
Protein Assay Reagent Kit. The method used is based upon the Biuret reaction and
combines the well known reduction of Cu
2+ to Cu
+ by protein in an alkaline medium,
with the highly sensitive and selective colorimetric detection of the cuprous ion (Cu
+)
using a reagent containing bicinchoninic acid (BCA) (Smith et al., 1985). The purple
coloured reaction product is formed by the chelation of two molecules of BCA with one
cuprous ion. The complex exhibits a strong absorbance at 562nm that is almost linear
with increasing protein concentrations over a broad working range (20-2000µgml
-1).
(a) The cells in the samples were washed twice with ice-cold PBS on days 1, 3 and
7 after the addition of DM and then stored frozen in 0.05M glyglycine buffer
(pH 6.75). When required for assay, cells and/or myotubes were lysed by rapid
thawing and 25µl of sample collected.
(b) The protein concentrations were determined by reference to a standard curve
produced by establishing the absorbance values of different bovine serum
albumin (BSA) standards (Figure 33A). Final BSA concentrations in 0.5mM
glyglycine buffer were 0, 100, 200, 300, 400, 500, 750, 1000, 1500 and
2000g/ml.
(c) The working reagent (WR) consisted of 50 parts of BCA reagent A mixed with
1 part of BCA reagent B. Three 25µl aliquots of each standard and the samples
were pipetted into a 96 well plate. 200µl of the working reagent was added to
each well to give a sample:WR ratio of 1:8, and the plate was mixed on a shaker
for 30 seconds and incubated at 37ºC for 30 minutes. After allowing the plate to
cool for 10 minutes to room temperature, the absorbance was measured at
562nm.Chapter 2: Materials and Methods
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3.4.2. The Reverse-Transcriptase Polymerase Chain Reaction
3.4.2.1. RNA Extraction
RNA was extracted from the samples according to a modified methodology to that of
Chomczynski and Sacchi (1987). All equipment was kept as RNAse/DNAse-free as
possible.
(a) For monolayer cultures, 1ml of TRIzol
® reagent was added to wells with an
average surface area of 10cm
2, and the cell lysate was passed several times
through a pipette. For smaller surfaces, the amount of reagent was adjusted
accordingly. For glass fibre/collagen constructs, 1ml of TRIzol
® reagent was
added in a 2ml RNAse/Dnase-free microcentrifuge tube and the samples were
manually homogenised. Samples were stored at -80ºC until the time of RNA
extraction.
(b) At the time of RNA extraction, the samples for incubated for 5 minutes at 15-
30ºC to allow the complete dissociation of nucleoprotein complexes. 200μl of 
chloroform was added per 1ml of TRIzol
®reagent and the contents were shaken
vigorously by hand for 15 seconds and incubated at 15-30ºC for another 2-3
minutes, following which they were centrifuged at 12,000 x g for 15 minutes at
2-8ºC.
(c) After centrifugation, three layers were evident: a colourless upper aqueous phase
containing the RNA, an interphase and a lower red, phenol-chloroform phase
containing DNA and protein. The volume of the aqueous phase was
approximately 60% of the volume of TRIzol
®reagent used for homogenisation.
(d) The upper aqueous phase was transferred to a clean microcentrifuge tube and the
organic  phase  was  stored  at  -80ºC.  500μl  of  isopropyl  alcohol  per  1ml  of 
TRIzol
® reagent used for the initial homogenisation was added in order to
precipitate the RNA from the aqueous phase. The samples were incubated at 15-
30ºC for 10 minutes and centrifuged at 12,000 x g for 10 minutes at 2-8ºC. The
RNA precipitate formed a gel-like pellet at the bottom of the tube.Chapter 2: Materials and Methods
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(e) The supernatant was discarded and the RNA pellet was washed once with a
volume of 75% ethanol in a ratio of 1:1 to the TRIzol
® reagent used for the
initial homogenisation. The samples were vortexed and centrifuged at 7,500 x g
for 5 minutes at 2-8ºC.
(f) Again, the supernatant was discarded and the RNA pellet was air-dried for 10
minutes, ensuring that complete dessication did not occur resulting in decreased
solubility. The RNA was dissolved in 20μl of diethylpyrocarbonate (DEPC)-
treated water by gentle trituration and incubated at 55-60ºC for 10 minutes.
(g) 2μl of RNA diluted in  68μl of DEPC-treated water  was placed into a black 
cuvette for spectrophometric analysis. The A260/A280 ratio and quantity of RNA
were recorded. Following calculation of the total RNA in each sample, DEPC-
treated water was added to make up a final concentration of 10ngml
-1. All the
RNA samples were of excellent quality and stored at -80ºC until required.
3.4.2.2. cDNA Conversion
Total RNA was converted into single-stranded cDNA using a specific reverse
transcription (RT) kit in accordance with the manufacturer’s instructions:
(a) Once again, the working area and all equipment was kept as RNAse/Dnase-free
as possible. The components were allowed to thaw on ice and all the
preparations were undertaken on ice.
(b) The amount of cDNA required for the polymerase chain reaction (PCR) was
calculated in order to make up the correct amount of RT mastermix. For a 20μl 
reaction, Table 5 outlines the components for the RT mastermix.Chapter 2: Materials and Methods
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Component Volume (µl)/20µl reaction
10X RT Buffer 2.0
25X dNTP Mix (100mM) 0.8
10X RT Random Primers 2.0
Multiscribe
TM Reverse Transcriptase 1.0
Nuclease-free H2O 4.2
Total 10.0
Table 5 – The Components of the cDNA Mastermix
(c) For a 20μl reaction, 10μl of the RT mastermix was placed into a nuclease-free 
microcentrifuge tube together with 10μl of RNA, and all the tubes were briefly 
centrifuged. Thereafter, the samples were loaded into the thermal cycler (100
TM
PTC, MJ Research, Inc, U.S.A.) and subjected to the thermal profile parameters
outlined in Table 6.
Step 1 Step 2 Step 3 Step 4
Temperature 25 37 85 4
Time 10 min 120 min 5 sec ∞ 
Table 6 – Conditions for cDNA Synthesis
(d) After completion of the reverse transcription, the cDNA samples were aliquoted
and stored at -20˚C until required. 
3.4.2.3. Real-Time Quantitative Polymerase Chain Reaction
The Applied Biosystems 7300 Real Time PCR System and related sequence detection
software (Version 1.4) was used to carry out the real time quantitative polymerase chain
reaction (qPCR). Each sample was examined in quadruplicate for expression of the
target genes and the endogenous control (18s). To ensure accuracy of the singleplex
PCR, preparation was undertaken in a specified nuclease-free zone utilising nuclease-Chapter 2: Materials and Methods
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free equipment on ice. Additionally, highly reliable TaqMan
®
gene expression assays
and PCR mastermixes (Applied Biosystems, U.K.) were employed to reduce pipetting
errors associated with the use of multiple reagents. Figure 19 explains the process of the
TaqMan
®
probe-based chemistry used for the PCR. Each reaction was 25µl, which had
been optimised previously.
(a) All the reagents were thawed on ice and mixed gently.
(b) Table 7 outlines the reagents used, with volumes adjusted to allow for pipetting
loss. The volumes were placed into a nuclease-free eppendorf and gently mixed.
25µl was transferred into each well of a 96 well plate.
(c) After protecting the samples with an adhesive plastic film and brief
centrifugation at 350g, the plate was placed into the PCR system for
commencement of the reaction. Figure 20 outlines the thermal cycling
conditions for the PCR.
3.4.2.3.1. Real-Time Detection
The threshold cycle (CT) value is the cycle number at which a statistically significant
increase  in  ΔR
n is first detected (Figure 21). The threshold cycle occurs when the
Sequence Detection System starts to detect the increase in signal related to the
exponential growth of the PCR product.
The comparative CT method (ΔΔC
T) was used to compare the different samples to the
control after all the target gene levels were normalised to the endogenous gene. This
method eliminates the use of standard curves and is accurate for relative quantitation
providing the PCR efficiencies between the target genes and endogenous control (18s)
are equivalent. Table 8 gives the example of how the data may be compared in a
relative fashion to the calibrator.Chapter 2: Materials and Methods
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Figure 19 – Outline of the TaqMan
® Probe-Based Chemistry
The TaqMan
® reagent-based chemistry uses a fluorogenic probe to enable the detection of a
particular PCR product, as it accumulates during the PCR cycles. The advantages include
increased specificity and the availability of optimised assays.
Component Volume (µl)
TaqMan
®
Universal PCR Master Mix 53.2
TaqMan
®
probes 5.3
cDNA 10.6
Nuclease-free H2O 37.2
Table 7 – Reagents Used in the PCR Reaction
Cleavage Polymerisation completed
Stage 1 – A reporter (R) and quencher (Q)
are attached to the 5’ and 3’ ends of a
TaqMan
® probe.
Stage 1 (cont’d) – Reporter dye emission is
quenched with attachment of both dyes to the
probe.
Stage 2 – With each extension cycle, the
AmpliTaq Gold
® DNA polymerase cleaves
the reporter dye from the probe.
Stage 3 – Cleavage results in fluorescence
emission from the reporter dye.
Strand displacement PolymerisationChapter 2: Materials and Methods
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Figure 20 – The Thermal Cycling Conditions for Real Time PCR
Stage 1 involves holding the samples for 2 minutes at 50ºC to allow activation of the AmpErase
®
uracil N-glycosylase (UNG). Stage 2 corresponds with activation of the AmpliTaq Gold
® DNA
polymerase for 10 minutes at 95ºC. The final stage relates to the PCR, with each of the 40 cycles
incorporating melting for 15 seconds at 95ºC and annealing and extension for 1 minute at 60ºC.Chapter 2: Materials and Methods
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Figure 21 – Illustration of the Increase in PCR Product with Time
The baseline is where there has been little change in the fluorescence signal during the initial
stages of the PCR. The threshold is a level of Rn set above the baseline and sufficiently low to be
within the exponential growth of the amplification curve. CT is when the fluorescence passes the
threshold.
Sample
Gene of
interest
(Average CT)
Endogenous
control
(Average CT)
CT
(Gene of
interest –
endogenous
control)
CT
(CTtreated -
CT
calibrator)
2^-CT
(Fold
difference in
treated relative
to calibrator)
Calibrator 30.490.15 23.630.09 6.860.19 0.000.19 1 (0.9-1.1)
Treatment A 27.030.06 22.660.08 4.370.10 -2.40.10 5.6 (5.3-6.0)
Treatment B 26.250.07 24.600.07 1.650.10 -5.110.10 37 (34.5-39.7)
Treatment C 25.830.07 23.010.07 2.810.10 -3.950.10 16.5 (15.4-17.7)
Table 8 – Relative Quantification of Data Obtained from the qPCR Process
The data is first adjusted for each sample (CT) and then the CT is calculated using the value
obtained from the calibrator. Finally, the fold difference is calculated to indicate differences in
relation to the calibrator (2^- CT) – for example, the gene expression in relation to treatment B
was 37 times greater than that expressed by the calibrator.
Rn
Cycle number
Baseline
Threshold
No template control
Rn-
Rn+
Rn
0 5 10 15 20 25 30 35 40
Sample
Endogenous
controlChapter 3: A Preliminary Study to Investigate Biocompatibility
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Chapter 3: A Preliminary Study to Investigate the
Biocompatibility of Phosphate-Based Glasses with Human
Masseter Muscle-Derived Cell Cultures
1. Introduction
Skeletal muscle engineering, although in its infancy, is progressing at a rapid pace with
investigations being undertaken in vitro (Acarturk et al., 1999; Dennis and Kosnik,
2000; Powell et al., 2002) and in vivo (Okano and Matsuda, 1998b; Boldrin et al.,
2007), and is reliant on the ability of MPCs to recapitulate the exact processes occurring
during muscle development and regeneration. Many of these studies have suggested that
there is indeed potential to engineer skeletal muscle tissue. Nonetheless, these skeletal
muscle analogues are yet to become a reliable entity for clinical applications, such as
use as a test-bed for the investigation of novel treatments and ultimately implantation.
The architecture of many of these constructs is far from that of native skeletal muscle:
essentially, parallel-orientated, multinucleated myofibres for the production of active
force of a certain vector (Vandenburgh, 2002). Furthermore, engineered myofibres are
often of a small diameter and associated with an excessive amount of ECM, also
precluding the production of adequate force (Dennis and Kosnik, 2000; Payumo et al.,
2002).
An important factor to circumvent these problems is the appropriate design of scaffolds
for the support of cell proliferation, differentiation into contiguous myofibres and
maturation. In line with the theory of contact guidance, chemical, structural and/or
mechanical scaffold properties can direct the desired cell proliferation and
differentiation (Hutmacher, 2001; Khademhosseini et al., 2006). Polymeric microfibres
have been utilised frequently and the classic degradable polyesters, PLA, PGA and their
co-polymers, have been investigated with some success in directing myofibre formation
along the length of the fibres (Neumann et al., 2003; Cronin et al., 2004). However, it
has been implied that the relative stiffness and the inability to finely modulate the
mechanical and chemical properties, limits the use of these polyesters in skeletal muscle
engineering (Agrawal and Ray, 2001; Georges and Janmey, 2005; Engler et al., 2006).Chapter 3: A Preliminary Study to Investigate Biocompatibility
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Phosphate glasses have the important advantage of being able to predictably tailor the
constituents and degradation rate to the tissue of interest. Screening assays have clearly
demonstrated that different combinations of cell types and biomaterial scaffolds can
result in both the enhancement and inhibition of proliferation and differentiation (Neuss
et al., 2008). Interestingly, phosphate glasses have been shown to be biocompatible with
numerous cell types (Lin et al., 1994; Salih et al., 1999, 2000; Navarro et al., 2003b;
Abou Neel et al., 2007), but most importantly, studies have demonstrated compatibility
with the C2C12 murine muscle cell line (Ahmed et al., 2004c). Although the glasses are
of a brittle nature, there are numerous advantages including the ability to tailor the
linear degradation rate. The fibres can be placed in various arrangements and coated
with ECM components to aid attachment, proliferation and differentiation, and the
desirable mechanical properties may be achieved by combining with other biomaterials
to produce a composite scaffold. This study investigated the in vitro biocompability of
ternary aluminium/zinc-containing phosphate-based (Al-Zn-P) glass fibres with primary
human masseter muscle-derived cell cultures.
2. Aims
(a) To confirm the myogenicity of human masseter muscle-derived cell cultures.
(b) To investigate the biocompatibility of Al-Zn-P glass fibres with human masseter
muscle-derived cell cultures in terms of the following affecting cell survival,
proliferation, migration and differentiation:
i. Fibre arrangement
ii. Fibre coating
iii. Cell seeding density
3. Hypothesis
Al-Zn-P glass fibres are compatible with human masseter muscle-derived cell cultures.
Moreover, scaffold arrangement, coating and cell seeding density can positively
influence cell attachment, proliferation and differentiation.Chapter 3: A Preliminary Study to Investigate Biocompatibility
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4. Materials and Methods
The materials and methods utilised in this study are highlighted in Table 9.
Materials and Methods Cross-reference with Chapter 2
Cell culture Section 1.
Scaffold preparation Section 2.6.1.
Confirmation of myogenicity Section 3.1.
Cell migration Section 3.2.
CyQUANT
® assay Section 3.3.1.
Creatine phosphokinase assay Section 3.4.1.
Table 9 – Materials and Methods Used to Investigate Biocompatibility are Cross-Referenced
with Chapter 2
After confirming the myogenicity of three patient biopsies (G01U, G02A and G03I),
cells were expanded under standard culture conditions. The preliminary study was
divided into three parts, whereby part 1 investigated masseter muscle-derived cell
response to scaffold architecture, part 2 looked at the role of ECM coatings on cell
response, and part 3 examined the effect of increasing cell density and scaffold fixation.
The masseter muscle-derived cells were seeded at a density of 2 x 10
5 or 4 x 10
5 cells
into wells containing the glass fibre scaffolds and placed in a humidified atmosphere of
5% CO2 in air at 37°C. All the samples containing the various seeded scaffolds were
imaged under modulation contrast with the Leica DMIRB microscope. For all parts of
the study, the SGM was changed to DM following three days of proliferation to
encourage MPC fusion and myotube hypertrophy. The DM was changed every three
days.
4.1. Cell Survival and Proliferation
To study the effects on cell survival and proliferation, secured Matrigel
TM-coated mesh
scaffolds were fixed or stored at -80ºC on days 1, 2 and 3 post-seeding. TheChapter 3: A Preliminary Study to Investigate Biocompatibility
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CyQUANT
® cell proliferation assay was used on the frozen samples, and the fixed
samples were stained for direct counting under immunofluorescent light. Care was
taken to ensure that the scaffolds remained intact during the washing stages, and they
were placed between a glass slide and coverglass with antifade media in an attempt to
transfer only cells that had attached to the glass fibres.
For the proliferation study, twenty random fields in each sample (n=3) were viewed and
the number of stained nuclei counted. Relative numbers of cells on the various scaffold
combinations were compared over the three-day period.
Furthermore, to investigate the direct effect of the glass degradation products on the
masseter muscle-derived cells (Salih et al., 2000; Navarro et al., 2003b), glass fibres
were placed in SGM for seven days at 37ºC. The ‘conditioned’ medium was then
filtered  utilising  a  0.22μm  filter  and  stored  at  -20ºC  until  required  for  use.  Serial 
dilutions of 25%, 6.25% and 1.56% were produced using fresh SGM, and cells were
cultured in these dilutions, as well as the ‘neat’ conditioned medium and a SGM-only
control, for a period of three days (Salih et al., 2000). At each timepoint, the relevant
samples were stored at -80ºC to halt cell proliferation and later analysed with the
CyQUANT
® assay.
4.2. Cell Differentiation
Immunofluorescent  techniques  were  used  to  establish  the  presence  of  α-sarcomeric 
actin, as a sign of differentiation, in addition to the measurement of CPK levels.
4.3. Statistical Analysis
SPSS (Version 14.0, SPSS Inc.) was used for descriptive statistics: multiple groups of
parametric data were compared with the one-way ANOVA, followed by the Bonferroni
and Games-Howell posthoc tests. p<0.05 was considered significant. The Kruskal-
Wallis test was used to compare multiple groups of non-parametric data and where the
p-value was significant, the Mann-Whitney U test was used to compare between groups.Chapter 3: A Preliminary Study to Investigate Biocompatibility
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5. Study Timeline
Figure 22 highlights the experiments undertaken to establish the biocompatibility of
human masseter muscle-derived cells with Al-Zn-P glasses, and the cellular response to
certain glass fibre scaffold variables.
Confirmation of
myogenicity
Toxicity study
Investigation into
scaffold
architecture
Investigation into
scaffold coating
Investigation into
cell seeding
density and
scaffold
immobilisation
Figure 22 – An Overview of the Timelines for the Experiments Undertaken to Investigate
Al-Zn-P Glass Biocompatibility
Cell
seeding
Cell fixation for immunofluorescence
Day 1 Day 7 Day 10 Day 3 Day 14
Processing of
samples and data
analysis
Cell
seeding
Cell storage for
CyQUANT
® assay
Days 1, 2, 3
Processing of
samples and data
analysis
Cell
seeding
Microscopy
Day 7 Day 10 Day 3 Day 14 Day 1
Cell
seeding
Microscopy and cell fixation for immunofluorescence
Day 1 Day 7 Day 10 Day 3 Day 14
Processing of
samples and data
analysis
Cell
seeding
Cell fixation and storage for immunofluorescence and CPK assay respectively
Days 1, 2, 3 Day 7 Day 10 Day 14
Processing of
samples and data
analysis
Timelapse
study (24
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6. Results
6.1. Myogenicity
The cells from three patient biopsies were investigated for myogenicity over a period of
14 days. Single cells were grown to 100% confluence and two of the patient samples
demonstrated desmin immunoreactivity confirming the myogenic nature of these cells.
Following the addition of DM, the confluent cells formed multinucleated myotubes that
co-expressed  α-sarcomeric  actin  and  desmin  (Figure  23A  and  B).  Interestingly,  the 
initial expression of α-sarcomeric actin was at an earlier timepoint of day 7 for patient 
G02A compared to day 10 for patient G01U suggesting greater efficiency for myofibre
formation, and therefore cells from patient G02A were used in subsequent experiments
to investigate biocompatibility.
6.2. Toxicity of Glass Fibre Extracts
Cells grown in increasing concentrations of the glass extracts demonstrated no
difference in proliferative behaviour (p>0.05), as compared with the control grown in
SGM, suggesting minimal toxicity and warranting further investigation into
biocompatibility (Figure 24).
6.3. Scaffold Architecture
The cellular response to the glass fibre arrangement was assessed in a qualitative
manner using light microscopy. On day 1 after seeding, the mesh arrangement had cells
attached mainly at the interstices of glass fibres (Figure 25A and B). Furthermore, in
comparison to the spread and bundle arrangements, there were fewer cells on the base
of the petri dish. Spread and bundles of glass fibres were noted to have minimal cell
attachment. Single glass fibres were also noted to have settled/embedded on the base of
the petri dishes containing all scaffold arrangements and had cells aligning alongside
(Figure 25C).Chapter 3: A Preliminary Study to Investigate Biocompatibility
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Figure 23A – Immunostaining Demonstrating Myogenicity of Cells (Patient G01U)
Cells have been stained with the nucleic stain, DAPI (blue). MPCs were identified by association
with desmin (green) and at the later timepoints, multinucleated myotubes were positive for -
sarcomeric actin (red).
(Magnification 63x, scale bar 25m)
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Figure 23B – Immunostaining Demonstrating Myogenicity of Cells (Patient G02A)
Cells were stained with the nucleic stain, DAPI (blue). MPCs were identified by desmin
immunoreactivity (green) and at the later timepoints, multinucleated myotubes were also
associated with -sarcomeric actin (red).
(Magnification 63x, scale bar 25m)
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Figure 24 – Cell Survival Upon Exposure to Al-Zn-P Glass Extracts (n=3)
Cells were exposed to different dilutions (%) of Al/Zn/P glass extracts and compared to control
cells grown in SGM. There was no difference in cell survival, as assessed by the CyQUANT
®
assay, over a 3 day period (p>0.05).
Time (days)
Figure 25 – Cell Attachment/Alignment on
Meshed/Settled Glass Fibres One Day Post-
Seeding
Figures 25A and B demonstrate cells (yellow
arrows) attached mainly at the intersections of
the glass fibres (blue arrows). Figure 25C
shows settled glass fibres on tissue culture
plastic with cells assuming a parallel
orientation to the fibres.
(Magnification 20x, scale bar 25m)
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By day 7, light microscopy had revealed myotube formation on the base of the petri
dishes, with myotubes aligned alongside settled glass fibres (Figure 26). Generally, cells
on the free floating glass fibre meshes were still located at the intersections of the fibres.
6.4. Scaffold Coating
The qualitative investigation into the influence of fibre arrangement on the cellular
response demonstrated that meshes supported cell attachment mainly at the interstices.
Additionally, settled glass fibres provided a certain topography to allow cell alignment.
Mesh scaffolds were utilised for the remainder of the biocompatibility studies, including
investigation into the use of fibre coating: over a 14-day period, it was observed that
cell growth was excellent on the plastic substrate of wells containing Matrigel
TM-coated
floating fibre scaffolds (Figure 27). After addition of the differentiation medium,
myotubes were present on the substrate and aligned alongside settled glass fibres.
Unfortunately, the floating fibres only had sparse numbers of attached cells.
Importantly, by day 14, where some fibres had amalgamated into a bundle arrangement
due to inevitable movement, there was an absence of cells on the substrate immediately
below. Nonetheless, qualitative examination suggested that Matrigel
TM was overall a
better substrate than gelatin at supporting cell differentiation, as evidenced by the large
number of single cells, and eventually myotubes, present on the petri dish base and
floating glass fibre meshes.
Time lapse microscopy suggested that cells migrated alongside early embedded glass
fibres (Figure 28). Retrieval of the coverslips on the base of the petri dishes and
subsequent phase contrast microscopy and immunocytochemistry implied that the early
settled glass fibres were able to influence cell alignment (Figure 29).Chapter 3: A Preliminary Study to Investigate Biocompatibility
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Figure 26 – Settled Glass Fibre (Day 7)
There were multinucleated, parallel aligned myotubes (yellow arrows) in close relation to the
settled glass fibre (blue arrow).
(Magnification 40x, scale bar 25m)
Figure 27 –Cell Growth on Tissue Culture Plastic (Day 3)
Figure 27A shows cells in relation to gelatin-coated settled fibres (blue arrow) day 3 post-seeding.
In comparison, qualitative examination revealed a greater number of cells at the same timepoint in
relation to Matrigel
TM-coated settled glass fibres (Figure 27B, blue arrow).
(Magnification 10x, scale bar 100m)
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Figure 28 – Time Lapse Sequence Demonstrating Cell Migration
The pink and yellow arrows track the movement of individual cells in relation to Matrigel
TM-
coated glass fibres (blue arrows) settled on the tissue culture plastic. Note how the cells move
alongside the glass fibre using its architecture as a guide analogous to the alignment of MPCs in
the formation of secondary myofibres. (Magnification 20x, scale bar 100m)
Figure 29 – Phase Contrast and Corresponding Immunofluorescence Image (Day 2)
The MPCs (desmin-positive, green staining) were aligned parallel to the settled glass fibres (blue
arrows). Nuclei (blue) not associated with desmin were likely to be fibroblasts.
(Magnification 63x, scale bar 25m)
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6.5. Cell Seeding Density and Scaffold Immobilisation
Doubling the cell seeding density on the Matrigel
TM-coated floating fibre meshes
increased the number of attached cells and those present on the petri dish base, as
determined qualitatively over a 14-day period (Figure 30A). By day 7, there seemed to
be myotube-like structures on the meshes (Figure 30B) and the presence of myotubes in
a parallel orientation to settled glass fibres (Figures 30C, 30D and 31) – late embedded
fibres were distinguished by being in a different focal plane to the cells on the substrate.
Cell proliferation was assessed quantitatively on secured Matrigel
TM-coated floating
meshes utilising the immunofluorescent DNA marker, DAPI (Figure 32B). There was a
statistically significant increase (p<0.001) in cell number over a 3-day period (Figure
32A).
CPK expression was measured indirectly as a function of inorganic phosphorus
formation and, after the formulation of standard curves (Figure 33), presented in
proportion to the amount of protein present. Investigation into myotube formation over
a period of 7 days demonstrated a statistically significant difference between the
floating meshes (secured and unsecured) compared to the Matrigel
TM-coated petri dish
base containing embedded glass fibres on day 1 (p=0.05). Most importantly, CPK
expression increased on the scaffold meshes by day 7, such that by that timepoint there
was no difference (p>0.05) between myotube formation on all combinations (Figure
34).Chapter 3: A Preliminary Study to Investigate Biocompatibility
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Figure 30 – Modulation Contrast Images Demonstrating Cell Response on Matrigel
TM-
Coated Fibres
Figure 30A shows a number of cells (yellow arrows) attached at the interstices of meshed
unsecured floating Matrigel
TM-coated fibres (blue arrows) on day 3 post-seeding. By day 7 (Figure
30B), multinucleated myotube-like structures (pink arrows) were evident on the secured and
unsecured mesh scaffolds (blue arrows).
Images C and D depict settled glass fibres (blue arrows) with numerous multinucleated myotubes
(green arrows) aligned alongside on day 10 post-seeding.
(Magnification 20x, scale bar 25m)
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Figure 31 – Phase Contrast Images and Corresponding Immunofluorescence Images
Depicting Cell Response to Settled Glass Fibres
By day 7, multinucleated myotubes (positive for desmin (green) and -sarcomeric actin (red))
were evident parallel to settled glass fibres (blue arrows). Image C shows a myotube attached to a
late settled fibre. (Magnification 63x, scale bar 25m) (Cell density: 4 x 10
5 cells/well)
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Figure 32 – Cell Proliferation on Secured Matrigel
TM-Coated Mesh Scaffolds (n=3)
Figure 32A demonstrates a statistically significant increase (*** p<0.001) in cell number/field
over 3 days, as determined by direct cell counting on DAPI stained nuclei. Figure 32B shows a
desmin-positive (green staining) MPC attached to the mesh scaffold on day 3.
(Magnification 63x, scale bar 25m)
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Figure 33 – Standard Curves Generated for the Protein and Phosphorus Assays
Figure 33A shows the standard curve for protein whereby the formula used to calculate the protein in
each sample was:
x = y + 0.081
0.000268
Figure 33B depicts the standard curve for phosphorus. The formula used to calculate the amount of
phophosrus was calculated using the following formula:
x = y + 0.009
0.079
gml
-1
gml
-1
A
B
R sq linear = 0.975
R sq linear = 0.977
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Figure 34 – CPK Expression on Glass Fibre Scaffolds (n=3)
CPK expression was calculated as amount of phosphorus in relation to protein concentration over time.
There was a statistically significant difference between the embedded fibres and mesh scaffolds on day
1 (* p=0.05). Thereafter, there was no difference in expression between the various scaffold
arrangements. There was a stark reduction in CPK expression on the embedded fibres between days 1
and 3, which may be accounted for by the loss of contractile myotubes from the relatively stiff glass
coverslips.
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7. Discussion
Biomaterial scaffolds can serve as a temporary substitute for the biological and
mechanical function of the native ECM, thus enabling seeded cells to assume the
appropriate spatial organisation and function (Kim and Mooney, 1998; Langer and
Vacanti, 1999; Hutmacher, 2001). Cell adhesion to a suitable substrate is essential for
regulating cellular function, including the processes of proliferation, migration and
differentiation, and this may be achieved by the use of suitable biomaterials and their
surface modification with specific bioactive molecules to elucidate the desired response
(Hubbell, 1999; West and Hubbell, 1999; Alsberg et al., 2002; Cimetta et al., 2009).
Additionally, other scaffold properties may also affect the success of the tissue
engineering process (Figure 35): for example, degradation products should not cause
any adverse reaction and should be removed via metabolic pathways at a rate that keeps
the concentration within the tissues at a tolerable level (Bergsma et al., 1995).
Figure 35 – Scaffold Changes in Response to the In Vitro and In Vivo Biological Mileau
Phosphate-based glasses have desirable properties enabling them to serve as the ideal
scaffold for the engineering of skeletal muscle. Specifically, these characteristics
include the ability to tailor the degradation kinetics to the rate of tissue formation and,
due to the polymeric nature of the glasses, the production of fibres analogous to the
myofibres of native muscle. This preliminary study explored the biocompatibility of Al-
Zn-P glasses with human masseter muscle-derived cell cultures. Cell cultures from two
patients, previously extracted from masseter muscle explant cultures and cryopreserved,
demonstrated good myogenic capacity and the potential to be used for the in vitro
BIOMATERIAL
Degradation products
BIOLOGICAL FLUIDS,
CELLS, TISSUES
Ionic and molecular exchanges
Changes of surface chemistry and physics
Direct effect on cells
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biocompatibility investigations.
As mentioned, the degradation of any biomaterial will lead to a build-up of breakdown
products, which have the potential to influence cell behaviour in a positive or negative
manner. The proliferation studies demonstrated that glass extracts of varying dilutions
had no significant effect on cell proliferation compared to control cells in SGM, and this
was in concordance with other studies utilising certain glass compositions (Salih et al.,
2000; Ahmed et al., 2004c). Interestingly, the nature of the leached ions is dependent on
the original composition, which is also intimately linked to the degradation rate, and not
all studies have demonstrated a positive effect of faster degrading compositions on the
behaviour of certain cell types (Salih et al., 2000). Nonetheless, minimal toxicity of this
specific composition was established.
The stages of attachment, proliferation, migration, differentiation and maturation are
dependent on chemistry and architecture (contact guidance), with the balance between
tissue growth, including ECM production, and scaffold degradation being of
significance in the latter stages. Further studies involved optimisation of certain scaffold
parameters for successful myofibre formation.
Skeletal muscle engineering studies have confirmed that the macro- and
microtopographical factors play an important role in the interaction of muscle-derived
cells with the biomaterial of interest (Clark et al., 2002; Lenas et al., 2009a, b). For
instance, silica has been micropatterned with alkylsiloxanes to encourage in vitro MPC
attachment, proliferation and differentiation and as a means of producing a degree of
cellular orientation (Acarturk et al., 1999). Significantly, areas of untreated silica also
enabled MPC attachment due to the presence of microporosities, thus implying that
such irregularities are also critical for MPC-biomaterial interaction. Non-woven PGA
meshes seeded with MPCs have demonstrated myotube formation in vivo in rat models,
and there was the suggestion that the mesh arrangement may have enhanced cell
attachment and contributed to the success (Saxena et al., 1999, 2001; Kamelger et al.,
2004). This study has shown that an overlapping mesh arrangement supported cell
attachment, mainly at the interstices of the glass fibres: it is likely that the intersections
provided a greater surface area for cells to attach, in addition to the creation of protectedChapter 3: A Preliminary Study to Investigate Biocompatibility
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niches. Spread fibres provided a lower total surface area for cell attachment and this
was indicated by the greater number of cells observed on the base of the petri dish, as
opposed to on the fibres themselves. Despite difficulties in visualisation, it is possible
that bundles of glass fibres may not have allowed the efficient influx and efflux of
nutrients and oxygen and waste products respectively. Fibres are advantageous in
possessing a high surface area to volume ratio, thus providing for greater cell
attachment. Additionally, meshes have a high degree of porosity to facilitate flow-
through of nutrients and waste products, but the issue of myotube unidirectional
alignment still remains a desirable outcome not readily achieved with such an
arrangement (Kamelger et al., 2004; Riboldi et al., 2005).
Interestingly, single settled glass fibres derived from the floating scaffolds (secured and
unsecured) provided support for cells to migrate alongside, as noted in the time-lapse
footage, and in the latter stages of the investigations, the ability to enable parallel
orientation of myotubes. The migration of MPCs is fundamental to myotube formation,
as evidenced during in vivo myogenesis (Phillips et al., 1990; Grounds, 1991; Watt et
al., 1994). This important finding suggested that glass fibres have the correct properties
to encourage myotube alignment analogous to that of native skeletal muscle. Other
studies employing fibre scaffolds have also demonstrated the guidance of cell growth
offered by such topography (Li et al., 2002, Cronin et al., 2004).
Earlier studies into skeletal muscle engineering utilising fibre scaffolds have identified
the essential use of ECM coatings, such as laminin to aid attachment and differentiation
(Neumann et al., 2003; Cronin et al., 2004) – gelatin and Matrigel
TM were used in this
study. The collagen-based gelatin has many merits, such as its biological derivation
with the presence of functional groups (e.g. RGD), biodegradability and low cost (Choi
et al., 1999), but there are also associated limitations precluding its solitary use in tissue
engineering applications (Zhang et al., 2005). More recent investigations have used
gelatin in combination with synthetic biomaterials, such as poly(-caprolactone) (PCL),
to produce electrospun composite scaffolds with the aim of exploiting the advantages
offered by both (Zhang et al., 2005). Interestingly, it was demonstrated that gelatin
exhibited better wettability as compared with PCL, due to its hydrophilicity. Further,
the gelatin/PCL composite scaffold demonstrated even better wettability, which may beChapter 3: A Preliminary Study to Investigate Biocompatibility
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suitable for supporting certain cell types. Matrigel
TM, on the other hand, consists of a
‘cocktail’ of various ECM proteins and growth factors, albeit in undefined
concentrations, and has been used successfully for in vitro and in vivo investigations of
myogenesis (Melo et al., 1996; Barbero et al., 2001).
Qualitative analysis in this study suggested that Matrigel
TM gave optimal outcomes with
respect to the cellular response, as compared with a gelatin coating. Maley et al. (1995)
has compared the response of primary murine cells on different ECM components and
discovered that Matrigel
TM promoted the formation of larger and more frequent
myotubes rather than gelatin, laminin, fibronectin and collagen IV used in isolation.
Cronin et al. (2004), using the C2C12 murine cell line and a human myogenic cell line,
also showed that cell attachment was far more superior on ECM gel-, fibronectin- and
laminin-coated poly-L-lactic acid (PLLA) films in relation to uncoated and gelatin-
coated PLLA films, and subsequent experiments involved the arbitrarily chosen ECM
gel-coated PLLA fibres. Further quantitative analysis of the Matrigel
TM-coated glass
fibre meshes used in this investigation confirmed good cell proliferation and
differentiation.
Increasing the cell seeding density improves the probability of cell attachment,
however, there will always be a balance between the time and cost involved for cell
expansion and the final viable numbers used in the production of muscle constructs.
Paracrine factors can also influence myogenesis (Yang et al., 1996; Hawke and Garry,
2001) and in theory, increasing the density of the seeded cells should lead to a build-up
of local circulating factors. Paracrine stimulation of MPC proliferation has been
demonstrated whereby conditioned medium obtained from young murine myotube
cultures was mitogenic for MPCs extracted from adult mice (Mezzogiorno et al., 1993).
Additionally, the non-myogenic fibroblast population also produce factors, which
promote MPC proliferation and differentiation (Quinn et al., 1990; Sinanan et al., 2008;
Brady et al., 2008). Qualitative examination suggested that there were greater numbers
of attached cells on the Matrigel
TM-coated meshes upon doubling the cell seeding
density. Direct cell counting confirmed an increase in cell number over 3 days on
Matrigel
TM-coated secured mesh scaffolds. Critically, the important desired endpoint of
myotube formation on the scaffolds was confirmed by immunofluorescence and indirectChapter 3: A Preliminary Study to Investigate Biocompatibility
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measurement of CPK. Myotubes attached to scaffolds may be transferred to different
sites with relative ease (Ahmed et al., 2004c) compared to those adhered to tissue
culture plastic: although early timepoints demonstrated a statistically significant
increase in myotube formation on Matrigel
TM-coated tissue culture plastic/embedded
fibres as compared with the floating glass fibre meshes, crucially there was no
difference by day 7. There was a sharp reduction in CPK expression on the tissue
culture plastic/embedded fibres between days 1 and 3: it is likely that the low
compliance of the 2-D substrate resulted in detachment of formed myotubes by day 3
and is a phenomenon routinely seen in standard muscle cell cultures that have reached
100% confluence. Nonetheless, there was an increase in CPK expression on all scaffold
types by day 7. There was no difference in CPK expression between secured and
unsecured floating scaffolds, but it should be noted that the number of glass fibres, and
hence potential for cell attachment and differentiation, present in each scaffold was an
arbitrary amount due to the method of fibre mesh construction.
Differentiation medium, consisting of a reduced serum content and exogenous IGF-1
(10ngml
-1) in accordance with previous studies (Brimah et al., 2004), was utilised to
maximise the potential for myogenesis (Florini et al., 1991). The scope to expose in
vitro cell cultures to various growth factors and modulate the cell response is of great
advantage.
8. Conclusions
(a) Human masseter muscle-derived cell cultures have the potential to form
myotubes in vitro.
(b) Al-Zn-P glasses are potentially biocompatible with human masseter muscle-
derived cell cultures.
(c) The following parameters have a positive effect on myotube formation:
i. Mesh arrangement of fibres
ii. Matrigel
TM-coated fibres
iii. Increased cell density
iv. The use of exogenous IGF-1Chapter 4: Characterisation of Iron-Containing Phosphate-Based Glasses
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Chapter 4: Characterisation of Iron-Containing Phosphate-
Based Glasses for the Purposes of Skeletal Muscle
Engineering
1. Introduction
The preliminary study (chapter 3) has demonstrated that phosphate-based glasses are
biocompatible with human masseter muscle-derived cell cultures (Shah et al., 2005).
However, the in vitro degradation rate of these original glasses (Al-Zn-P) is in the order
of years
* and not ideally matched to that of long-term de novo craniofacial muscle tissue
formation and function. The challenge remains to produce an ideal glass fibre scaffold
with degradation kinetics matched to the rate of muscle tissue formation, such that there
is adequate support early on and over time, the eventual creation of space for new tissue
growth, as the scaffold degrades (Figure 36). The means to tune the degradation profile
is becoming a reality for the tissue engineer: for example, the introduction of the
relevant modifying ions into the network of phosphate-based glasses to allow alteration
of this process.
Numerous phosphate glass compositions have been investigated for their suitability as a
biomaterial scaffold for the engineering of different tissues. The difficulty has been
establishing the fine balance between many factors, including ion release (Knowles et
al., 2000; Salih et al., 2000), pH change (Patel and Knowles, 2006) and bacterial
response (Abou Neel et al., 2005b), for the application in mind. The degradation rate of
the glass can be a limiting factor, as the cells need a relatively stable surface for initial
attachment, proliferation and differentiation. There have been numerous studies
investigating the relationship between the composition and degradation and
biocompatibility of ternary glasses based on the P2O5-CaO-Na2O system (Franks et al.,
2000; Ahmed et al., 2004a, 2004b). The limited ability to control degradation of ternary
glasses may be overcome by substitution with oxides, such as Fe2O3, which can
increase the cross-linkage in order to make the glass structure less susceptible to
hydrolysis (Ahmed et al., 2004c; Abou Neel et al., 2005a). Indeed, the properties of
* Data supplied by colleagues in BTEChapter 4: Characterisation of Iron-Containing Phosphate-Based Glasses
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Figure 36 – Scaffold Degradation Kinetics in Relation to Tissue Formation
The kinetics of scaffold degragation can affect the successful formation of a fully functioning,
viable tissue. If the scaffold fails early (black line), there will be lack of support for the early
formation and growth of the tissue. If the scaffold remains after there has been tissue formation,
this may preclude the correct function of the new tissue. Ideal degradation kinetics are such that
there is early support for tissue formation, but scaffold breakdown by the time the tissue is
maturing and functioning.
Tissue formation
Scaffold remaining after
tissue formation = scaffold
failure
Ideal scaffold
degradation
Rapid degradation
= scaffold failure
TimeChapter 4: Characterisation of Iron-Containing Phosphate-Based Glasses
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Fe2O3-containing glasses have been studied for decades (Choueka et al., 1995), with
studies demonstrating good in vivo hard and soft tissue biocompatibility of ternary
Fe2O3-containing glass fibre-reinforced composites at 9 weeks (Lin et al., 1994).
Further flexibility of ternary glasses may be achieved with the introduction of a fourth
component, and later studies have investigated compositions based on the P2O5-CaO-
Na2O-Fe2O3 system. Franks et al. (2001) demonstrated that glasses with a fixed
proportion of at least 45mol% P2O5 had favourable characteristics, including the ability
to melt and cast easily, and good in vitro biocompatibility. Other studies have suggested
that only glasses containing 50mol% P2O5or greater were suitable for the production of
fibres, an important topographical factor for skeletal muscle engineering. Quaternary
glasses containing at least 50mol% P2O5 and 4-5mol% Fe2O3 have been shown to
promote MPC attachment and myotube formation, albeit using the C2C12 murine cell
line (Ahmed et al., 2004c). In an attempt to increase the rate of degradation of these
iron-containing glasses, other investigators have substituted Na2O with SiO2 to produce
a quinary system: the greatest mass loss was seen with the replacement of 5mol% Na2O
with SiO2 in both cell culture medium and dH2O (Patel and Knowles, 2006). It was
suggested that although SiO2 is a network former, the bonds formed were more
susceptible to hydrolysis. Significantly, the composition containing 5mol% SiO2
underwent rapid degradation up to day 4 and an increase in mass thereafter, possibly
due to the ion re-precipitation reported by others (Xynos et al., 2001). Furthermore, the
pH decreased with an increase in SiO2. Although these glasses had a higher rate of
degradation, the associated rapid changes in surface structure and related pH changes
may not support cellular growth and development long term - indeed biocompatibility
of the MG63 osteoblast cell line was only investigated for 24 hours (Patel and Knowles,
2006). In addition, the lack of excretion of SiO2 still remains a problem, as previously
highlighted (Nagase et al., 1992).
The proportion of CaO also plays an important role in glass durability (Ahmed et al.,
2004a). It was established, utilising the MG63 osteoblast cell line, that ternary glasses
containing less than 40mol% CaO supported little cell adhesion and survival (Bitar et
al., 2004). This was related to the ability of CaO to stabilise the network and thus
reduce the degradation rate (Franks et al., 2000). Bitar et al. (2004, 2005) determined
that the slowest degrading glass containing P2O5 (50 mol%), CaO (46 mol%), Na2OChapter 4: Characterisation of Iron-Containing Phosphate-Based Glasses
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(1 mol%) and Fe2O3 (3mol%), as assessed by immersion within standard cell culture
medium, was the best at supporting human fibroblast and osteoblast attachment and
differentiation.
Interestingly, Kesisoglou et al. (2002) discovered that extracts of quaternary phosphate
glass containing CoO, ZnO or Fe2O3 were able to activate resting T lymphocytes, with
the highest detected increase in DNA synthesis associated with ZnO and Fe2O3-
containing glasses. Nevertheless, it was suggested that the effects observed were of
limited biological consequence, as the induced DNA synthesis was low compared with
the high levels elicited by the control polyclonal mitogen Con A. In addition, Cartmell
et al. (1998a) demonstrated that controlled release glasses containing Fe2O3 and NaF
did stimulate greater macrophage activation compared to the control and other
compositions. Even so, there was the suggestion that fibres of these compositions could
still be of use in tissue engineering applications.
Added to the propensity for a scaffold to induce an inflammatory response in vivo, there
is also the potential for promoting infection due to the presence of degradation products,
which can affect the success of implanted constructs and patient satisfaction.
Staphylcoccus epidermidis and Staphylococcus aureus have been reported to be the
most important pathogens in biomaterial-related infections (Arrecubieta et al., 2009;
Geipel, 2009). Degradable biomaterials consisting of iron have the likelihood to support
infection due to the requirement of most cells and organisms, including bacteria and
fungi, for iron to facilitate mechanisms, such as DNA synthesis. In order to resist
bacterial infections, iron in the blood and secretions is bound to molecules with a high
affinity for binding free iron, such as protophyrins (heme) or proteins (e.g. transferrin
and lactoferrin). These proteins are the first line of defense known as the ‘iron
blockade’ (Wandersman & Delepelaire, 2004). To assist iron uptake, bacteria and fungi
have adopted sophisticated techniques: the pathogenic bacterium Staphylococcus
aureus produces haemolysins, which liberate heme from red blood cells during the
initial stages of infection (Skaar et al., 2004; Skaar and Schneewind, 2004) (Figure 37).
This porphyrin ring is then internalised and degraded to release free iron. In humans,
sequestration of iron within macrophages limits the availability of iron duringChapter 4: Characterisation of Iron-Containing Phosphate-Based Glasses
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Figure 37 – S. aureus Growth Explained
S. aureus obtain iron in mammalian hosts from the iron-containing porphyrin ring, heme.
Haemolysins produced by the bacteria lyse red blood cells containing heme in the form of
haemoglobin. Enzymatic breakdown of the haemoglobin ensues and the free heme is catabolised
with the liberation of free iron used to fuel further bacterial growth.
(Adapted from http://pubs.acs.org/cen/news/8237/8237notw5.html)
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bacterial infections and inflammation. The capacity of degradable Fe2O3-containing
glasses to support bacterial growth has yet to be investigated.
With respect to in vitro muscle tissue engineering, although conditional on the initial
seeding density, it is possible to form myotubes within days. Nevertheless, the
maturation of these prototypic myofibres takes much longer and is dependent on
mechanical and neuronal influences (DiMario and Stockdale, 1997), amongst others.
Whether tissue maturation is allowed to take place in vitro or in vivo will also play a
role. As highlighted, the original glasses used in the preliminary study had a very low
degradation rate and thus presence of the glass beyond a certain time that may preclude
tissue maturation. It is impossible to establish the exact rate of muscle tissue formation,
as there are many influential factors, however, it would be reasonable to suggest that a
scaffold may be required for up to 12 months. Based on the success of Fe2O3-containing
glass fibres to support murine MPC lines and primary human osteoblasts and
fibroblasts, it was decided to investigate the characteristics of a range of these glasses
for the purposes of in vitro human craniofacial skeletal muscle engineering.Chapter 4: Characterisation of Iron-Containing Phosphate-Based Glasses
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2. Aims
(a) To produce a series of iron-phosphate glasses.
(b) To characterise the glasses in terms of the following properties:
i. Thermal properties
ii. Degradation profile
iii. Ion release
iv. Effect on pH
v. Propensity to support bacterial growth
3. Null Hypotheses
(a) The glass thermal properties do not change with increasing Fe2O3content.
(b) There is no difference in the rate of degradation between different batches of the
same glass composition.
(c) There is no difference in the rate of ion release between different batches of the
same glass composition.
(d) The ion release does not affect pH of the medium.
(e) Iron-containing glasses do not support bacterial growth.Chapter 4: Characterisation of Iron-Containing Phosphate-Based Glasses
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4. Materials and Methods
The materials and methods utilised in this study are highlighted in Table 10.
Materials and Methods Cross-reference with Chapter 2
Production of iron-containing
phosphate glass disks Section 2.1.
Investigation into glass thermal
properties Section 2.2.
Degradation and pH measurement Section 2.3.
Ion release Section 2.4.
Investigation into bacterial
response Section 2.5.
Table 10 – An Outline of the Materials and Methods Utilised in this Study Cross-Referenced
with Chapter 2
4.1. Statistical Analysis
SPSS (Version 14.0, SPSS Inc.) was used for descriptive statistics for all groups of data
and the following tests were used for data analysis:
(a) Measurement repeatability was analysed using the paired two sample t-test,
Pearson correlation coefficient and Bland and Altman plot (Bland and Altman,
1986).
(b) The Pearson correlation coefficient and linear regression were used to establish
the strength of the relationship between the following:
 Fe2O3 content and thermal parameters
 Degradation rate and time
 Rate of ion release and timeChapter 4: Characterisation of Iron-Containing Phosphate-Based Glasses
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(c) The data were log transformed and multiple regression used to compare the
degradation rates obtained from the two experiments, and also to compare the
rate of ion release with degradation.
(d) Hierarchical univariate ANOVA and the Bonferroni and Games-Howell posthoc
tests were used to compare the bacterial response between the three individual
experiments, and also the bacterial response between the compositions
investigated over time. The statistical significance level was set at p<0.05.
Where data were non-parametric, the Kruskal-Wallis and Mann-Whitney U tests
were used.Chapter 4: Characterisation of Iron-Containing Phosphate-Based Glasses
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5. Study Timeline
Figure 38 highlights the experiments undertaken to investigate the characteristics of a
series of iron-containing phosphate-based glasses.
Investigation into
glass thermal
properties
Degradation and
pH studies
Investigation into
ion release
Investigation into
bacterial response
Figure 38 – An Illustration Outlining the Experimental Procedures for Establishing Glass
Characteristics
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6. Results
6.1. Thermal Properties
There was an increase in thermal parameters with an increase in Fe2O3 content
indicating greater thermal stability. With respect to the glass transition temperature (Tg),
the linear regression analysis demonstrated a rise of 10.26°C with every additional
1mol% of Fe2O3(Figure 39).
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Figure 39 – The Relationship Between Tg and Fe Content of Phosphate-Based Glasses
There was an increase in Tgwith increasing iron content (y = 449.7 + 10.26x).
Clear peaks were observed for glass crystallisation (Tc) and melting (Tm) temperatures
(Figure 40) – the traces for Fe0- and Fe1mol% exhibited single sharp peaks for the Tc
indicating the presence of a single crystalline phase. This was in contrast to the other
compositions whereby the Tc was associated with two peaks indicating the existence of
two crystalline phases. Nonetheless, the two peaks associated with Tm for Fe0- and
Fe1mol% suggested the actual presence of two crystalline phases. For Fe2mol%, there
were two peaks for Tm with the later peak almost dividing into two indicating phase
separation. The peak associated with Tm for Fe4- and Fe5mol% had a shoulder related
to the probable presence of a second crystalline phase, albeit in very small quantities.
The DTA traces obtained for Fe1 to Fe5mol% demonstrated close similarity to those
obtained by Ahmed et al. (2004c) for the same compositions indicating the
reproducibility of the glass making process.
R sq linear 0.916Chapter 4: Characterisation of Iron-Containing Phosphate-Based Glasses
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Figure 40 – DTA Traces for a Series of Iron-Containing Phosphate-Based Glasses
Tg denotes the glass transition temperature, Tc indicates the glass crystallisation temperature and
Tmrelates to glass melting temperature.
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6.2. Degradation Profile
The degradation profile of the glass compositions over 14 days was assessed by a
weight loss method in deionised water. The total surface area is one factor, which can
play a role in the rate of degradation, therefore, the dimensions of each disk used was
calculated to ensure complete immersion in a standardised volume of water (5mlcm
-2).
Measurement repeatability of the diameter, thickness and weight of each disk was
analysed using the paired two-sample t-test, the Pearson correlation coefficient and the
Bland and Altman plot. There was no difference detected between the repeated
measures for the diameter (t-value=0.202, df 35, p>0.05), thickness (t-value=0.767, df
35, p>0.05) and weight (t-value=2.002, df 35, p>0.05). The Pearson correlation
coefficient was 0.388 (p<0.05) for the diameter, 0.966 (p<0.001) for the thickness, and
1.000 (p<0.001) for the weight measurements confirming good-excellent repeatability
(Figure 41). The correlation coefficient was low for the diameter, and this was due to
the alignment of the graphite mould during the processing of the glass rods.
Additionally, the Bland and Altman plots demonstrated acceptable coefficients of
repeatability, with 95% of the difference within the limits of agreement (Figure 42). The
difference between the two measurements for diameter was within 0.296mm, for
thickness within 0.042mm, and for weight within 0.520mg.Chapter 4: Characterisation of Iron-Containing Phosphate-Based Glasses
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Figure 41 – Scatter Plots Demonstrating Correlation Between the Two Repeated Measures
for Disk Diameter (A), Thickness (B) and Weight (C)
Plot A demonstrated fair correlation indicating good repeatability, however, plots B and C
demonstrated excellent correlation related to high repeatability.
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Figure 42 – Bland and Altman Plots for Repeatability
Figure A depicts the plot for repeated measures of diameter, whereas figure B depicts the plot for
repeated measures of disk thickness. Figure C is the plot for repeated measures of disk weight. The
coefficient of repeatability was acceptable with 95% of the differences within the limits of
agreement.
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Although there was a good correlation between time and the rate of degradation for all
the compositions from 0 hours, the correlation was excellent from 24 hours for both
experiments (Figure 43). The ternary glass (Fe0mol%) and the composition containing
1mol% Fe2O3 had the highest degradation rates, as compared to the other compositions.
The multiple regression analysis comparing the degradation profiles from both
experiments was statistically insignificant for all the compositions investigated
(p>0.05), therefore, the null hypothesis was accepted and there was no difference
between the rates obtained from both experiments.
Investigation into the degradation profile of fibres (10-30µm diameter) produced from
Fe1- to Fe5mol% demonstrated an interesting difference between the compositions. In
particular, the fibres containing less Fe2O3 had more scaffold remaining at 240 hours
compared to the Fe4- and Fe5mol%, which may be attributed to the reprecipitation
observed as a weight increase during the early timepoints (Figure 44). The Fe1- and
Fe5mol% fibres had a relatively steady rate of degradation during the first 24 hours thus
potentially providing a stable surface for cell adhesion. Over 10 days, approximately
2% of the Fe4- and Fe5mol% glass fibres had degraded.Chapter 4: Characterisation of Iron-Containing Phosphate-Based Glasses
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Figure 43 – Degradation Rates for a Series of Iron-Containing Phosphate Glass Disks (n=3)
The degradation rates from both experiments for all the glass compositions demonstrated a linear
relationship with time. It was evident that the faster degrading glasses were those containing the
least amount of Fe2O3.
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Figure 44 – Degradation Rates for a Series of Iron-Containing Phosphate Glass Fibres (n=3)
The degradation profile of glass fibres produced from Fe1- to Fe5mol% demonstrated that there
was overall greater loss from the Fe4- and Fe5mol% compositions. There was a degree of
reprecipitation, as evidenced by an increase in weight particularly of the Fe2mol% fibres. The Fe1-
and Fe5mol% demonstrated a relatively steady rate of degradation in the early stages, which may
provide a stable surface for cell adhesion.
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6.3. Ion Release
*
6.3.1. Ca
2+ Release
There was good correlation between Ca
2+ ion release and time for all the compositions.
In particular, the faster degrading glasses released the greatest amount of Ca
2+, whereas
glasses containing 4- and 5mol% Fe2O3released a smaller cumulative amount by day 14
(Figure 45). Both experiments demonstrated good correlation between Ca
2+ release and
time from 0 hours, however, the correlation was even stronger from 24 hours. Data
from the linear regression are presented for experiment 2 from 24 hours and are
representative of both experiments.
Comparison of the cumulative Ca
2+ release between the experiments utilising multiple
regression analysis was statistically insignificant for all the compositions, therefore, the
null hypothesis was accepted that there was no difference between the two experiments.
Furthermore, investigation into how the cumulative release compared with the
degradation rate was statistically insignificant for all compositions, with the exception
of Fe3mol% for experiment 2 (p<0.05). Nonetheless, overall the cumulative Ca
2+ ion
release was closely related to the degradation rate.
6.3.2. Na
+Release
The cumulative release of Na
+ was also noted to be greater from the faster degrading
glasses, which in turn had a higher Na
+ content (Figure 46). Following a similar trend to
the cumulative release of Ca
2+, there was excellent correlation between release and time
from 24 hours. The data presented are from experiment 2 and are representative of both
experiments.
Multiple regression analysis demonstrated no difference in cumulative Na
+ release
between the two experiments, with the exception of Fe0mol% (p<0.05). Importantly,
there was statistical insignificance upon using multiple regression to analyse the
relationship between ion release and degradation rate for the individual experiments,
thus confirming a close relationship (p>0.05).
* See compact disc at back of thesis for additional data related to ion release.Chapter 4: Characterisation of Iron-Containing Phosphate-Based Glasses
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Figure 45 – Ca
2+ Release from 24 Hours for a Series of Iron-Containing Phosphate-Based
Glasses (n=3)
The cumulative Ca
2+ release was linear from all the glass compositions with Fe0- and Fe1mol%
exhibiting the greatest release.
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Figure 46 – Cumulative Na
+ Release from 24 Hours for a Series of Iron-Containing
Phosphate-Based Glasses (n=3)
Cumulative Na
+ ion release followed a similar pattern to that of Ca
2+ ion release with the fastest
degrading glass compositions releasing the greatest amounts.
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6.3.3. Release of Phosphate Species
The release of orthophosphate (PO4
3-), pyrophosphate (P2O7
4-), cyclic trimetaphosphate
(P3O9
3-) and linear polyphosphate (P3O10
5-) ions from the compositions investigated
were not identical, however, the general trend was once again for greater release from
the faster degrading glasses in comparison to the slower degrading Fe4- and Fe5mol%.
There was a wide range in cumulative release of the various species over the
experimental period, with more P3O9
3- released as opposed to P2O7
4- (Figure 47). Both
experiments demonstrated similar cumulative release of the phosphate species, and it
was determined that correlation with time was excellent after 24 hours. The data
presented are from experiment 2 from 24 hours, however, the data also reflect the
findings from experiment 1.
6.3.3.1. Release of PO4
3-Ions
Multiple regression analysis demonstrated that there was no difference between the
rates of cumulative ion release for Fe0- and Fe5mol% between the two experiments
(p>0.05); this was in contrast to the PO4
3- release rate between the two experiments for
the other compositions (Fe1-, Fe3-, Fe4mol% p<0.01, Fe2mol% p<0.05). There was a
close relationship between the rate of cumulative PO4
3- ion release and degradation rate
(p>0.05), with the exception of Fe3mol% (p<0.05).
6.3.3.2. Release of P3O9
3- Ions
Multiple regression analysis demonstrated that the rate of cumulative P3O9
3- ion release
was comparable between both experiments (p>0.05). Furthermore, the release rate was
closely related to the degradation rate, with the exception of Fe0- and Fe3mol% for
experiment 1, and Fe2- and Fe4mol% for experiment 2.Chapter 4: Characterisation of Iron-Containing Phosphate-Based Glasses
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6.3.3.3. Release of P2O7
4-Ions
Multiple regression analysis revealed that the rate of cumulative P2O7
4- ion release
between the two experiments was reproducible for Fe2- and Fe5mol% (p>0.05).
Significantly, the multiple regression analysis demonstrated that the null hypothesis
could be accepted for Fe0-, Fe2-, Fe4- and Fe5mol%, such that the degradation rate was
closely related to the rate of cumulative P2O7
4-ion release (p>0.05).
6.3.3.4. Release of P3O10
5-Ions
The multiple regression analysis demonstrated the rates of cumulative ion release were
comparable between the two experiments for Fe2-, Fe3- and Fe5mol% (p>0.05).
Furthermore, the rate of cumulative ion release was closely related to the degradation
rate for Fe2-, Fe3-, Fe4- and Fe5mol% (p>0.05).Chapter 4: Characterisation of Iron-Containing Phosphate-Based Glasses
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Figure 47A-B – The Cumulative Release of Phosphate Species (P3O9
3-, PO4
3-, P3O10
5- and
P2O7
4-) for a Series of Iron-Containing Phosphate-Based Glasses (n=3)
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Figure 47C-D – The Cumulative Release of Phosphate Species (P3O9
3-, PO4
3-, P3O10
5- and
P2O7
4-) for a Series of Iron-Containing Phosphate-Based Glasses (n=3)
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6.3.4. Fe
3+ Release
The cumulative release of Fe
3+ was also noted to be greater from the faster degrading
glasses, despite having a lower Fe
3+content (Figure 48). Following a similar trend to the
cumulative release of other ions, there was excellent correlation between ion release and
time from 24 hours. The data presented are from experiment 2 and are representative of
both experiments.
The multiple regression analysis was statistically insignificant for all compositions
studied, such that the null hypothesis was accepted that the rate of Fe
3+ release between
the two experiments was comparable. The release of Fe
3+ ions was also closely related
to the degradation rate (p>0.05), with the exception of Fe4mol% for experiment 2
(p<0.05).
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Figure 48 – Cumulative Release of Fe
3+ Ions for a Series of Iron-Containing Phosphate-
Based Glasses (n=3)
Fe
3+ release was linear for all the compositions investigated and related to the degradation rate – in
particular, the glasses with the least amount of Fe2O3 released greater amounts of Fe
3+ due to faster
degradation profiles.
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6.4. pH Changes
There was a sharp drop in pH from 0 to 2 hours, and thereafter the faster degrading
glass compositions maintained a reduced pH throughout the course of the study
compared to the Fe3-, Fe4- and Fe5mol% glasses (Figure 49). Of interest was the
increase in pH of all the compositions between 48 and 72 hours, which may have been
due to a reduction in the phosphate species released during this time and relatively
greater amounts of Na
+ and Ca
2+ ion release. This rise was noted for all the
compositions investigated.Chapter 4: Characterisation of Iron-Containing Phosphate-Based Glasses
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Figure 49 – pH Effects Over Time in Relation to Degradation of Iron-Containing Phosphate-
Based Glasses in dH2O (n=3)
The sharpest decrease, which was then maintained throughout the experimental period was with the
fastest degrading glass compositions (Fe0- and Fe1mol%).
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6.5. Bacterial Response
*
6.5.1. Staphylococcus aureus
6.5.1.1. Qualitative Assessment
Scanning electron microscopy demonstrated grooves created during the polishing
process on all the glass surfaces investigated (Figure 50, red arrows). It was evident that
the samples underwent a superficial degradation process, whereby the faster degrading
glasses (Fe0mol% to Fe3mol%) presented with considerable breakdown and loosening
of the surface by 24 hours (Figure 50B, pink arrows).
Qualitative assessment of the attachment of S.aureus suggested that by 6 hours there
were greater numbers on the Fe0- and Fe1mol% glass samples (Figure 50A, green
arrows). By 24 hours, the difference in numbers of attached bacteria was even more
apparent: specifically, Fe0-, Fe1- and Fe2mol% had more bacterial colonies located in
niches created by breakdown of the glass surface (Figure 50B, green arrows). There did
not seem to be any qualitative difference in the numbers of attached bacteria between 6
and 24 hours for the slowest degrading glasses (Fe4 and Fe5mol%).
* See compact disc at back of thesis for additional data on bacterial response.Chapter 4: Characterisation of Iron-Containing Phosphate-Based Glasses
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Figure 50A – SEM Images of Iron-Containing Phosphate-Based Disks Exposed to S. aureus
at 6 Hours (Qualitative assessment)
The red arrows refer to grooving created during the polishing process of the disks prior to
exposure to the S. aureus bacteria. The Fe0- and Fe1mol% glass disks had evidence of bacterial
adherence at 6 hours (green arrows).
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Figure 50B – SEM Images of Iron-Containing Phosphate-Based Disks Exposed to S. aureus
at 24 Hours (Qualitative assessment)
The pink arrows refer to surface cracking and breakdown evident with the Fe0-, 1- and 2mol%
compositions at 24 hours. Grooving created during the polishing stage of the disks was seen on the
Fe4- and 5mol% compositions (red arrows). S. aureus bacteria were present on all the disks,
however, by 24 hours the faster degrading compositions had greater numbers of adherent bacteria
mainly in areas of surface breakdown (green arrows).
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6.5.1.2. Optical Density
The hierarchical ANOVA demonstrated that there was a statistically significant
difference between the experiments for all the glass compositions investigated (p<0.05,
f=639.68, df 2,12), nonetheless, there was a definite trend in the bacterial response, as
demonstrated graphically (Figure 51). The data from experiment 2 (Figure 51B) are
described and are representative of experiments 1 and 3 (Figures 51A and C). There
was an interaction with the glass composition and time (p<0.001, f=19.620, df 48,126).
Although there were differences in the bacterial count between the compositions at all
timepoints investigated, the most apparent differences were at 24 and 48 hours. The
post-hoc tests demonstrated that the faster degrading glasses (Fe0- and Fe1mol%)
promoted greater S.aureus growth at 24 hours compared with the positive control and
the other glass compositions (p<0.05). Additionally, Fe2mol% supported greater
bacterial growth than the positive control and Fe4- and Fe5mol% (p<0.05). There was
also a statistically significant difference between Fe3mol% and the positive control
(p<0.05), with the glass sample sustaining greater bacterial growth.
The Fe0- and Fe1mol% glasses demonstrated the same differences at 48 hours (p<0.05)
relative to the positive control and the other glass compositions. Further, by 48 hours,
the Fe2- and Fe3mol% had significantly greater bacterial numbers than the positive
control (p<0.05).Chapter 4: Characterisation of Iron-Containing Phosphate-Based Glasses
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Figure 51A and B – Optical Density Demonstrating S. aureus Growth Upon Exposure to a
Series of Iron-Containing Phosphate-Based Glasses (n=3)
Experiment A was stopped at 24 hours due to the rapid decrease in OD600 at this time.
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Figure 51C – Optical Density Demonstrating S. aureus Growth Upon Exposure to a Series of
Iron-Containing Phosphate-Based Glasses (n=3)
Figures A-C refer to the three experiments and follow a definite trend. There was a difference in
bacterial numbers between the compositions investigated at all timepoints. However, these
differences were more apparent at 24 and 48 hours, such that the faster degrading glasses (Fe0-,
Fe1- and Fe2mol%) demonstrated greater numbers of S.aureus than the positive control +/- the
slower degrading glasses.
(See compact disc at back of thesis for additional data)
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6.5.1.3. Colony Forming Units
Although a statistically significant difference between the three experiments for all
compositions investigated was noted (p<0.05, f=6.027, df 2,12) (Figure 52), there was a
general trend. The results for experiment 2 (Figure 52B) are described, which are
representative of experiments 1 and 3 (Figure 52A and C). The main difference in
viable bacterial counts between the compositions was at 24 and 48 hours. The post-hoc
tests demonstrated that Fe1 to Fe5mol% all supported greater CFUs than the positive
control at 24 hours (p<0.05). In addition, Fe2mol% was associated with more CFUs
than Fe4- and Fe5mol% (p<0.05), whereas Fe3mol% demonstrated more CFUs than
Fe4mol% (p<0.01). Interestingly, at 24 hours, Fe4mol% had less CFUs than Fe5mol%
(p<0.05).
By 48 hours, there was a statistically significant difference between Fe0mol% and the
positive control and Fe3-, Fe4- and Fe5mol% compositions (p<0.05). Fe1mol%
demonstrated a difference between the positive control and Fe2- to Fe5mol%
compositions (p<0.01). Lastly, Fe2mol% was associated with greater numbers of CFUs
at 48 hours than the positive control and Fe5mol% (p<0.05).Chapter 4: Characterisation of Iron-Containing Phosphate-Based Glasses
171
24 6 3 0
Time (hours)
7.5
7.0
6.5
6.0
5.5
5.0
C
F
U
(
L
o
g
d
a
t
a
)
48 24 6 3 0
7.5
7.0
6.5
6.0
5.5
5.0
C
F
U
(
L
o
g
d
a
t
a
)
Figure 52A and B – S. aureus Colony Forming Units (n=3)
Experiment A was stopped at 24 hours due to the rapid decrease in OD600 by this time.
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Figure 52C – S. aureus Colony Forming Units (n=3)
Figures 52A-C for the CFU data also relate to the optical density data (Figure 51A-C). There was a
general trend with the main differences in CFU counts evident from 24 hours. In particular, the
positive control had reduced counts compared to the faster degrading compositions.
(The graphs highlight some key differences, however refer to the disc at the back of thesis for the
additional data)
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6.5.2. Staphylococcus epidermidis
6.5.2.1. Qualitative Assessment
Scanning electron microscopy confirmed the presence of the grooves created during the
polishing process and the superficial degradation process observed with the samples
from the S.aureus studies (Figure 53). On the contrary, there were many more adherent
bacteria on the Fe0-, Fe1- and Fe2mol% glasses at 6 hours. The Fe3-, Fe4- and
Fe5mol% glass samples had fewer attached bacteria.
By 24 hours, the faster degrading glasses demonstrated further fragmentation of the
surface, such that there were less numbers of attached S.epidermidis: the Fe3- and
Fe4mol% glass samples, on the other hand, had greater numbers of adherent bacteria
(Figure 53B). It seemed that S.epidermidis were more dependent on the surface
integrity than S.aureus.
6.5.2.2. Optical Density
The hierarchical ANOVA indicated that there was no difference between the
experiments for all the glass compositions investigated and positive control (p>0.05)
with the exception of Fe4mol% (p<0.05, f=4.52, df 2,16). The bacterial response over
48 hours for all three experiments is presented in Figure 54.
The data from experiment 2 (Figure 54B) are discussed and are a good representation of
the findings from the other experiments: there was a statistically significant difference
between the compositions at all times except for 24 hours. The main difference was
between the positive control and the glass compositions investigated, with the glasses
promoting greater growth up to 6 hours. However, by 48 hours, only the Fe0mol%
sample had greater optical density compared with the positive control and the other
glass compositions (p<0.01).Chapter 4: Characterisation of Iron-Containing Phosphate-Based Glasses
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Figure 53A – SEM Images of Iron-Containing Phosphate-Based Disks Exposed to S.
epidermidis at 6 Hours (Qualitative assessment)
The red arrows refer to grooving created during the polishing process of the disks prior to
exposure to the bacteria. The Fe0-, Fe1- and Fe2mol% glass disks had evidence of large numbers
of adherent bacteria (green arrows) often located in areas of surface irregularity.
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Figure 53B – SEM Images of Iron-Containing Phosphate-Based Disks Exposed to S.
epidermidis at 24 Hours (Qualitative assessment)
The pink arrows refer to surface cracking and breakdown evident with the faster degrading
compositions at 24 hours. S. epidermidis bacteria were present on all the disks, however, by 24
hours surface breakdown resulted in relatively fewer numbers on the Fe0-, Fe1- and Fe2mol%
glasses than at 6 hours. In contrast, the Fe3- and Fe4mol% compositions had more adherent
bacteria than at 6 hours (green arrows).
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Figure 54A and B – Optical Density Demonstrating S. epidermidis Growth Upon Exposure to
a Series of Iron-Containing Phosphate-Based Glasses (n=3)
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Figure 54C – Optical Density Demonstrating S. epidermidis Growth Upon Exposure to a
Series of Iron-Containing Phosphate-Based Glasses (n=3)
Figures A-C refer to the three experiments and follow a definite trend. Generally, the glass
samples supported greater bacterial growth compared to the positive from the outset. This trend
continued throughout the course of the experimental period and was statistically significant.
(For additional data on the differences between the glass compositions, see disc at back of thesis)
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6.5.2.3. Colony Forming Units
There was no statistically significant difference in CFUs between the three experiments
for all compositions investigated and the positive control (p>0.05, f=1.502, df 2,12)
(Figure 55). The results from the ANOVA are presented for experiment 3 (Figure 55C)
and are an indication of the results from experiments 1 and 2. There was a difference
between the compositions at 24 (p<0.01) and 48 hours (p<0.001). At 24 hours,
Fe2mol% had a greater number of CFUs compared with the positive control and the
Fe0-, Fe1-, Fe4- and Fe5mol% glasses (p<0.05). However, by 48 hours, Fe0mol% had a
higher number of associated CFUs relative to the positive control (p<0.05), and Fe0-,
Fe1- and Fe2mol% supported the growth of more CFUs than Fe5mol% (p<0.05).Chapter 4: Characterisation of Iron-Containing Phosphate-Based Glasses
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Figure 55A and B – S. epidermidis Colony Forming Units (n=3)
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Figure 55C – S. epidermidis Colony Forming Units (n=3)
Figures 55A-C for the CFU data also relate to the optical density data (Figure 54A-C). There was a
difference in CFU counts mainly at 3 hours and the later timepoints of 24 and 48 hours.
Comparison of the various compositions in their ability to support viable bacteria suggested that
the positive control and Fe4- and Fe5mol% glasses had lower counts towards the latter part of the
experimental period. The salient differences are highlighted in the graphs.
(For additional data, see disc at back of thesis)
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7. Discussion
Phosphate glasses have the potential to serve as an appropriate scaffold for skeletal
muscle engineering, however, as alluded to earlier, it is important that the degradation
rate is concomitant with that of tissue formation. The Al-Zn-P glasses in the preliminary
study had a degradation rate in the order of years necessitating the identification of a
faster degrading glass composition better suited to that of skeletal muscle formation. It
is important to note that muscle formation is influenced by numerous intrinsic and
extrinsic factors, and the assumed ideal rate of scaffold degradation is theoretical to
some extent: for instance, Saxena et al. (2001) chose to leave non-woven PGA meshes
in vivo six weeks prior to sacrifice, but did not specify the rate of degradation of the
scaffold.
Quaternary glasses can add further flexibility in terms of degradation kinetics and the
ions released (Knowles, 2003). Iron-containing glasses have been shown to support
murine muscle cell line attachment, proliferation and differentiation (Ahmed et al.,
2004c). Therefore, this study was undertaken to investigate the characteristics of
various iron-containing glasses with a view to identifying the most suitable composition
in terms of degradation profile, ion release, effect on pH and bacterial response for
further use as a skeletal muscle engineering scaffold. The P2O5 content was kept
constant at 50mol%, as previous studies have demonstrated that at least 50mol% is
necessary to enable the production of fibres desired for skeletal muscle engineering
applications (Ahmed et al., 2004a, 2004b), and to ensure minimal toxicity (Uo et al.,
1998). The CaO content was fixed at 40mol% to maintain glass durability (Uo et al.,
1998; Franks et al., 2000).
The degradation rate of phosphate glasses is influenced by in vitro and in vivo factors,
including the nature of the medium and any degree of supersaturation of the least
soluble species that can leach from the glass (Bunker et al., 1984; Uo et al., 1998). The
ideal medium for in vitro investigations is debatable (Franks et al., 2000). Mulligan et
al. (2003) found no difference between deionised water and artificial saliva, and others
have found a similar degradation profile between water and simulated body fluid (SBF),
albeit slower in SBF (Uo et al., 1998). It was decided to use deionised water in thisChapter 4: Characterisation of Iron-Containing Phosphate-Based Glasses
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study to establish the degradation rate, but also to enable investigation into the rate of
ion release and pH changes from the same samples.
In keeping with the theory of glass dissolution (Hench, 1977; Isard et al., 1982),
phosphate glasses degrade in aqueous media via two co-dependent processes (Figure
56). The hydration reaction involves the exchange of Na
+ with H
+ ions present in water
leading to the formation of a hydrated surface layer. The thickness of the hydrated layer
will determine the rate of exchange of Na
+-H
+ ions, and eventually the degradation of
the glass will depend on the network breakage of the P-O-P bonds within the hydrated
layer by H
+ and H2O molecules and the associated release of phosphate chains.
Figure 56 – Glass Dissolution Processes
It is assumed that phosphate glasses degrade via two co-dependent processes: the hydration
reaction leads to the formation of a hydrated surface layer and there is also an associated breakage
of the P-O-P bonds.
Modifying oxides depolymerise the network resulting in cleavage of the P-O-P bonds
and the creation of non-bridging oxygens. Glass compositions incorporating CaO have
greater chemical durability, due to the higher polarisation capability of Ca
2+ forming a
more stable bond than Na
+ with non-bridging oxygens of two different chains (Clément
et al., 1999) – in essence, the Ca
2+-H
+ ion exchange reaction or Ca
2+ dissociation from
the phosphate network within the hydrated layer does not take place.
Moisture adsorption onto the glass surface is inevitable during the preparation
procedure, and thus P-O-P breakage takes place inside the hydrated layer formed. Once
in contact with the aqueous media, short-chain polyphosphates or orthophosphates leach
P-O-P breakage
Ion exchange
Hydration
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into the solution immediately resulting in a rapid increase in phosphate concentration
and a initial higher rate of degradation. With time, the rate decreases until there is a
balance between the velocities of the glass-media interface and the water-diffusion
front, leading to a steady rate of degradation (Gao et al., 2004).
It has been proposed that the predominant process is that of ion exchange; nonetheless,
the glasses degrade congruently throughout the whole process, such that the degradation
products have an identical composition with that of the bulk glass. On the contrary, it
may be that the role of the hydration reaction is to ‘soften’ the glass surface, with the
main degradation occurring as a process of network breakage. It is likely that other
factors also play a role in further degradation of the bulk glasses, such as changes in
glass surface geometry after a prolonged length of time of leaching and pH (Gao et al.,
2004a, b). It has been demonstrated that an increase in pH can decrease the degradation
rate suggesting the important role of H
+ ions in the aqueous media (Gao et al., 2004a, b;
Prabhakar et al., 2005). Moreover, the concentration of ions in solution can influence
the process: the chelating ability of increasing concentrations of polyphosphates in
solution towards divalent cations in the hydrated layer can enhance the degradation rate.
Importantly, if the concentration of the polyphosphate is high within the solution, Ca
2+
can be attracted out of the glass network, thus accelerating the breakdown of the P-O-P
bonds and dissolution of the hydrated layer and a high rate of degradation. Therefore, it
is of great importance to match the degradation to the rate of blood flow through a
tissue to avoid a build-up of waste products and the secondary effects of premature
scaffold breakdown, changes in pH, cell cytotoxicity and inflammation (Cartmell et al.,
1998b; Uo et al., 1998).
It is evident that glass degradation is a complex process and from the experiments
undertaken, there was an initial fast rate of degradation followed by a steady, highly
linear rate from 24 hours for all the compositions investigated. This was in accordance
with other studies (Abou Neel et al., 2005a, 2008). The degradation rate decreased with
increasing Fe2O3 content, such that the control ternary glasses, Fe1mol% and Fe2mol%
glasses had a relatively high rate of degradation and there was no discernable difference
in degradation rate between Fe4mol% and Fe5mol% glasses. Fe
3+ can exist as a
tetrahedron or octahedron and its presence within the P-O-P backbone creates strong
Fe-O-P bonds that are relatively resistant to hydration (Yu et al., 1997). Importantly,Chapter 4: Characterisation of Iron-Containing Phosphate-Based Glasses
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there was no difference in the rates obtained from both experiments indicating the
consistent degradation profiles of the compositions investigated and the ability to
predict the rate of build-up of the constituent ions, as they are released. The greater
durability of glasses with increasing Fe2O3 content has been established in earlier
studies (Marasinghe et al., 1997; Ahmed et al., 2004c; Abou Neel et al., 2005a).
This durability was also seen as an increase in glass transition (Tg), crystallisation (Tc)
and melting (Tm) temperatures with increasing Fe2O3content indicating the formation of
stronger bonds – for every unit increase in Femol%, it was calculated that the Tg would
increase by 10.26ºC. Investigation into the thermal properties of phosphate glasses can
provide an overview of the glass transformation and morphological structure at different
temperatures. The exothermic peaks on the DTA trace are associated with the
crystallisation temperature, whereas the endothermic peaks define the melting
temperature. The glass transition temperature can give an indication of the cross-linking
density between the phosphate chains and is also useful in establishing the temperature
below which the glass may be manipulated whilst maintaining its amorphous state
(Knowles, 2003). Significantly, the production of stress-free glasses is key to a
controlled and predictable breakdown of the glass network, related only to composition
(Franks et al., 2001).
Degradation may be investigated in a static or dynamic system, however, the build-up
of constituent ions in a static environment can affect the degradation rate (Delahaye et
al., 1998; Franks et al., 2000). In this study, the media was changed regularly, which
limited saturation. The decrease in cumulative Na
+ release, as the Fe2O3 content
increased, can be attributed to a reduction in the amount available as the Na2O content
was replaced by Fe2O3 and a decrease in the actual degradation rate with increasing
Fe2O3content. There was excellent correlation with time, particularly after 24 hours and
there was no difference between the release rates for both experiments with the
exception of the control ternary glass. Importantly, there was a strong relationship
between the rate of release and degradation. The NaO content was relatively small for
all the compositions investigated and possibly did not contribute greatly to the
degradation process.Chapter 4: Characterisation of Iron-Containing Phosphate-Based Glasses
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The CaO content was fixed for all the compositions and hence the rate of release was
strongly linked to the degradation rate, with the faster dissolving glasses releasing more
Ca
2+ ions. There was excellent correlation with time, especially after 24 hours and the
rates of cumulative release were also similar between both experiments, indicating the
reproducibility of cumulative Ca
2+ ion release. On the contrary, a number of phosphate
species were released, but the rates were not always comparable between the two
experiments and also in relation to the degradation rates. In particular, this was the case
for phosphate species released from the ternary glass and Fe1mol%, Fe3mol% and
Fe4mol% glasses. Nonetheless, greater amounts were released from the faster degrading
glasses indicating network breakdown. P3O9
3- ions were in the greatest abundance
suggesting the presence of a significant proportion in the original glass structure, and
this corroborates the findings of previous studies investigating phosphate species release
from various glass compositions (Franks et al., 2000; Ahmed et al., 2004a, 2004c).
Ahmed et al. (2004c), using an equation based on the theory of network connectivity,
predicted the Qn species in glasses containing 50mol% P2O5 to be primarily
metaphosphates (Q2), thus confirming the greater presence of P3O9
3-. Despite the
differences between the experiments, there was excellent correlation of cumulative
release of the individual phosphate species with time, principally after 24 hours.
Fundamentally, the rapid release of the phosphate species from the faster degrading
glasses could have led to saturation of the media, despite regular changes, and a
chelating effect on the Ca
2+ ions within the glass generating further breakdown.
It has been demonstrated that iron can be found in both Fe
2+ and Fe
3+ oxidative states
within iron-containing phosphate glasses nonetheless, Fe
2+ release was not detected by
Abou Neel et al. (2005a), as was the finding in this study. It is highly likely that
oxidation of Fe
2+ to Fe
3+ occurs upon contact with water. There was more cumulative
Fe
3+ release from the faster degrading glasses, despite the Fe2O3 content being less than
the slower degrading glasses (Fe4- and Fe5mol%). The rates between both experiments
and in relation to the degradation rate were comparable indicating the consistent nature
of these glass compositions.
Interestingly, investigation into the degradation kinetics of fibres produced from the
Fe1- to Fe5mol% compositions revealed that the glasses with greater amounts of Fe2O3
had more cumulative loss. There was an element of reprecipitation of the fibresChapter 4: Characterisation of Iron-Containing Phosphate-Based Glasses
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containing lower amounts of Fe2O3 as exhibited by an increase in weight, which may
account for this observation. On average, the Fe4- and Fe5mol% fibres showed a
cumulative loss of 2% of the original scaffold over 10 days, thus suggesting that
complete degradation would take 16.44 months providing the rate was consistent. In
reality, the choice of scaffold degradation rate for the production of a skeletal muscle
test-bed would depend on the testing strategy to be employed – for example, the
response to stretch would require the complete dissolution of the scaffold to elicit the
correct output. The relatively steady rate of degradation of the Fe1- and Fe5mol% fibres
during the first 24 hours could provide a stable surface for cell adhesion.
The pH of the aqueous media in vitro or that of the surrounding tissues in vivo is
dependent on the type and rate of ion released (Franks et al., 2000). Previous studies
investigating phosphate-based glasses for tissue engineering purposes have excluded
certain compositions due to the rapid rate of degradation and corresponding decrease in
pH with potentially harmful effects on cells (Salih et al., 1999, 2000; Ahmed et al.,
2004a). The pH change in this study is likely to be related to the phosphate species
present in the media and the creation of phosphoric acid (Prabhakar et al., 2005;
Abouneel et al., 2008). Also, with P-O-P breakdown, H
+ ions are released with a further
reduction in the pH. The faster degrading compositions had a profound effect on the pH,
whereby the ternary and Fe1mol% glass reduced pH below 5 by 24 hours and
consistently created a more acidic environment, perhaps unfavourable for cell survival.
The Fe3mol%, Fe4mol% and Fe5mol% glasses did not reduce the pH below 5.5
throughout the whole of the experimental period.
Phosphate glasses have been used previously to deliver ions with antibacterial
properties, such as Ag
+ (Valappil et al., 2007, 2008a), Cu
2+ (Mulligan et al., 2005;
Abou Neel et al., 2005b) and Ga
3+ (Valappil et al., 2008b, 2009). Nevertheless, it is
prudent to realise that these ions can be cytotoxic to the cells of importance in higher
concentrations (Vik et al., 1985). Additionally, other leached products may promote the
growth of pathogens, thus jeopardising the success of implanted constructs. Therefore,
this study also investigated the predilection for iron-containing glasses to support
S.epidermidis and S.aureus growth. Interestingly, qualitative examination revealed the
presence of large numbers of S.aureus colonies on the ternary control glass (Fe0mol%)
and Fe1-, Fe2- and Fe3mol% glasses by 24 hours. With respect to the optical densityChapter 4: Characterisation of Iron-Containing Phosphate-Based Glasses
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measurements, although the results between the three experiments were not identical
(p<0.05), there was a definite trend. The faster degrading compositions (Fe0- and
Fe1mol%) promoted bacterial growth at 48 hours, as opposed to the slower degrading
glasses, which followed the pattern of the positive control of considerably reduced
growth by this time. Examination of the CFUs demonstrated similarity between the
experiments (p>0.05) and propensity of the faster degrading glasses (Fe0-2mol%) to
support growth at 48 hours compared with the slower degrading glasses and the positive
control.
Qualitative examination of disks immersed in media containing S.epidermidis
demonstrated a discernable difference at 6 hours with the ternary glass and Fe1mol%
and Fe2mol% presenting with greater numbers of adherent bacteria. By 24 hours, the
ternary glass and Fe3- and Fe4mol% had greater numbers of adherent bacteria. There
was no difference between the optical density and CFU measurements between all three
experiments and all compositions investigated. Nonetheless, it was unpredictable as to
which compositions promoted S.epidermidis growth the best in relation to the positive
control. Rather than the presence of free iron promoting bacterial growth, it is highly
likely that the release of phosphates provided the necessary energy source for the
bacteria investigated (Chou and Pogell, 1981a, 1981b).
It has been shown that media contaminated with certain bacteria can result in a change
in pH, which may have a secondary effect on the degradation of biomaterials. For
example, S.epidermidis decreased the pH of TSB to 5.4 in the presence and absence of a
degrading PLA implant (Hofmann et al., 1990). Moreover, it has been implied that
surface roughness may influence bacterial adhesion (Morgan and Wilson, 2001), and
during the qualitative analysis of bacterial adhesion to the disks, cracking of the
surfaces was noted in conjunction with the presence of debris. It is possible that these
cracks may be the hydrated layer that was disrupted during the SEM preparation. There
was an apparent difference between the compositions, with the faster degrading glasses
exhibiting greater cracks and the presence of debris, thus perhaps exposing bacteria to a
more favourable topography for adhesion. It is possible that the rapidly changing
surface of the faster degrading glasses did not support S.epidermidis adherence at the
later timepoints.Chapter 4: Characterisation of Iron-Containing Phosphate-Based Glasses
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It is evident that a number of interrelated factors determine the success of a scaffold for
tissue engineering applications. The degradation rate is important in that the biomaterial
needs to breakdown at a rate conducive to tissue formation and maturation, however,
the surface needs to be stable enough to enable the desired cellular response (Navarro et
al., 2003; Bitar et al., 2004). Intimately connected to degradation is the release of ions
and the effect on local pH, inflammation and potential to support the growth of
pathogens (Blom, 2007). The faster degrading glasses (Fe0-, Fe1-, Fe2mol%)
demonstrated relatively higher degradation rates and associated cumulative ion release
with a sharp, maintained reduction of pH. Additionally, the change in surface geometry
of these compositions may provide protected niches for the adhesion of pathogens.
Interestingly, the Fe3mol% composition was the most unpredictable with respect to the
degradation rate, ion release and bacterial response, and the results did not fit clearly
between those obtained for the other compositions.
8. Conclusions
(a) Ternary P-Ca-Na and iron-containing phosphate glasses possess the following
predictable characteristics:
i. Degradation rate
ii. Ion release
iii. Effect on pH
iv. Effect on the response of S.aureus and S.epidermidis
(b) Phosphate glasses with a low Fe2O3 content (1-3mol%) degrade at a relatively
fast rate leading to rapid ion release with associated adverse effects on pH and
bacterial response.
(c) Fe4- and Fe5mol% glasses have the potential to provide a durable surface with a
relatively slow, steady rate of degradation leading to minimal build-up of ions
and thus reduced effects on pH and microbial growth.
(d) Fe4- and Fe5mol% seem to be the most suitable compositions of those
investigated for tissue engineering applications.Chapter 5: The Development of a Biomimetic Scaffold
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Chapter 5: Investigation Into the Biocompatibility of Iron
5mol% Glasses with Human Masseter Muscle-Derived Cell
Cultures and Development of a Biomimetic Scaffold
1. Introduction
It has been demonstrated that temporary phosphate-based glass fibre scaffolds can
provide the required architectural structure for skeletal muscle engineering (chapter 3).
Other scaffold parameters, such as the rate of degradation and the local environmental
effects of released products, are also vital to the engineering process. In the previous
study (chapter 4), the properties of a range of iron-containing glasses were investigated
in order to identify a more suitable composition in terms of degradation rate and ion
release response compared to the original composition (Al-Zn-P). Consequently, it was
established that Fe4- and Fe5mol% glasses could be suitable scaffolds for human
skeletal muscle engineering due to a linear rate of degradation and ion release, and
correspondingly minimal relative effects on pH and bacterial growth. This study
investigated the in vitro biocompatibility of human masseter muscle-derived cell
cultures with collagen-coated Fe5mol% glass disks. Biocompatibility was assessed in
terms of attachment, survival and differentiation on 2-D surfaces akin to standard cell
culture on tissue-grade plastic.
Matrigel
TM, employed in the preliminary investigations (chapter 3), is composed of
numerous ECM components and has been utilised in many studies of skeletal muscle
engineering (Barbero et al., 2001; Kim et al., 2003; Bunaprasert et al., 2003), but its
derivation remains a major drawback – extracted from the Engelbreth-Holm-Swarm
(EHS) mouse tumour, there will always be concerns with respect to the in vivo
consequences. Furthermore, it is difficult to quantify the growth factors present (Nicosia
and Ottinetti, 1990; Stiffey-Wilusz et al., 2001). Other naturally-derived materials, such
as gelatin and collagen, have also been used widely in the engineering of skeletal
muscle tissue (Okano and Matsuda, 1998b; Powell et al., 1999). In particular, acidic
solutions of collagen may be neutralised to form elastic gels of interconnected polymer
chain networks (Wallace and Rosenblatt, 2003). Collagen scaffolds have been usedChapter 5: The Development of a Biomimetic Scaffold
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successfully in vivo (Burke et al., 1981; Fang et al., 1996; Guerret et al., 2003; Hudon
et al., 2003), and as the major component of the skeletal muscle ECM, collagen was
used in conjunction with the glasses in this study.
Moreover, previous studies have demonstrated degrees of in vitro and in vivo success
with mesh scaffolds, with the majority highlighting the eternal problem of the lack of
unidirectional alignment of myofibres (Kamelger et al., 2004; Riboldi et al., 2005,
2008). Other studies of muscle engineering have utilised regular spaced, parallel fibre
arrays with a degree of success (Neumann et al., 2003). Hence, after establishing
biocompatibility, 3-D biomimetic scaffolds of parallel glass fibre arrays coated/encased
in collagen were created to provide the correct topographical arrangement (Figure 4)
considered to be conducive to functional skeletal muscle tissue formation.
2. Aims
(a) To assess the in vitro biocompatibility of Fe5mol% glass disks with human
masseter muscle-derived cell cultures in terms of the following:
i. Attachment
ii. Survival and proliferation
iii. Cell morphology
iv. Differentiation
(b) To produce a 3-D biomimetic composite Fe5mol% glass fibre/collagen scaffold
capable of encouraging the correct orientation, differentiation and maturation of
myofibres.
3. Hypotheses
(a) 2-D collagen-coated Fe5mol% glass disks are compatible with human masseter
muscle-derived cell cultures.
(b) 3-D composite Fe5mol% glass fibre/collagen scaffolds can provide the ideal
topographical and biological cues for the production of a human muscle tissue
analogous to native skeletal muscle.Chapter 5: The Development of a Biomimetic Scaffold
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4. Materials and Methods
The materials and methods utilised in this study are highlighted in Table 11.
Materials and Methods Cross-reference with Chapter 2
Cell culture Section 1.
Glass production Section 2.1.
Scaffold preparation Section 2.6.2.
Confirmation of myogenicity Section 3.1.
SEM Section 2.5.1.
CyQUANT
® assay Section 3.3.1.
alamarBlue
®assay Section 3.3.2.
qPCR Section 3.4.2.
Table 11 – Materials and Methods Utilised to Investigate Biocompatibility and the
Development of a Biomimetic Scaffold Cross-Referenced with Chapter 2
After confirming the myogenicity of the masseter explants from six patients (G01U,
O05Z, M04E, C06O, C07D, A08K), cells were expanded under standard culture
conditions. The study was divided into two parts, whereby part 1 investigated
biocompatibility on 2-D Fe5mol% glass disks over 14 days and part 2 looked at the
development of a composite biomimetic scaffold to improve on the skeletal muscle
engineering process over 21 days. The spacing of parallel aligned glass fibres for part 2
was kept at 40μm based on the findings of previous studies (Neumann et al., 2003). All
scaffolds were investigated in triplicate.
The masseter muscle-derived cells were seeded at a density of 4.5 x 10
3 cells/cm
2 onto
collagen-coated glass disks and placed in a humidified atmosphere of 5% CO2 in air at
37°C. The cell density for part 2 of the study was 1 x 10
6 cells/ml. The samples in part 2
were imaged under modulation contrast with the Leica DMIRB microscope. For all
parts of the study, the SGM was changed to DM following three days of proliferation to
encourage MPC fusion and hypertrophy. The DM was changed every three days.Chapter 5: The Development of a Biomimetic Scaffold
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4.1. Cell Attachment
Cell attachment on the disks was assessed at 3 and 6 hours using the CyQUANT
® assay
and the creation of a standard curve for each patient. At each timepoint, non-adherent
cells were gently washed away with PBS and the samples were stored at -80ºC until
required.
4.2. Cell Survival and Proliferation
To study the effects on cell survival and proliferation, the disks were washed gently
with PBS and stored at -80ºC on days 1, 2 and 3 post-seeding: the CyQUANT
® cell
proliferation assay was used on the frozen samples. In addition, the alamarBlue
® assay
was used on the same samples throughout the course of part 1 of the study to establish
metabolic activity, with cells on tissue culture plastic forming the controls.
4.3. Cell Morphology
Cell morphology was assessed at the various timepoints utilising SEM and modulation
contrast microscopy.
4.4. Cell Differentiation
Immunofluorescent  techniques  were  used  to  establish  the  presence  of  α-sarcomeric 
actin and neonatal MyHCs, in addition to investigation into the upregulation of skeletal
muscle-related genes on days 1, 3, 7, 10 and 14 for part 1. For the second part of the
study investigating the biomimetic scaffolds, assessment of gene upregulation was
undertaken on days 7, 14 and 21.
4.5. Statistical Analysis
SPSS (Version 14.0, SPSS Inc.) was used for descriptive statistics, including tests for
homogeneity of variances. Multiple groups of parametric data were compared with the
univariate ANOVA, followed by the Bonferroni and Games-Howell posthoc tests.
p<0.05 was considered significant. The Kruskal-Wallis test was used to compareChapter 5: The Development of a Biomimetic Scaffold
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multiple groups of non-parametric data and where the p-value was significant, the
Mann-Whitney U test was used to compare between groups.
5. Study Timeline
Figure 57 highlights the experiments undertaken to establish the biocompatibility of
human masseter muscle-derived cells with Fe5mol% glasses, and the cellular response
to certain glass fibre scaffold variables.
Confirmation of
myogenicity
Investigation into
biocompatibility
with Fe5mol%
collagen-coated
glass disks
Development of a
biomimetic
scaffold
Figure 57 – An Outline of the Experimental Procedures Undertaken to Examine
Biocompatibility and the Creation of a Composite Glass Fibre/Collagen Biomimetic Scaffold
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6. Results
6.1. Confirmation of Myogenicity
Cell cultures established from six masseter muscle biopsies were investigated for
myogenicity over a period of 14 days. Once again, single cells were grown to 100%
confluency. Desmin immunoreactivity confirmed the presence of MPCs, and following
the addition of DM, cells fused to form multinucleated myotubes positive for desmin
and α-sarcomeric actin (Figure 58).  
Figure 58 – Immunostaining Demonstrating Myogenicity of Cells (Patient G01U)
Cells were stained with the nucleic stain, DAPI (blue). MPCs were identified by association with
desmin (green) and at the later timepoints, multinucleated myotubes co-expressed desmin and
-sarcomeric actin (red).
(Magnification 63x, scale bar 25m)
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6.2. Part 1: Biocompatibility with Fe5mol% Disks
6.2.1. Cell Attachment
The CyQUANT
® assay was used to assess cell attachment and survival, and a standard
curve was generated for each patient. The standard curve for patient C06O is depicted
(Figure 59), however, all curves demonstrated excellent correlation between
fluorescence and cell number enabling accurate determination of cell numbers on disks.
The cell seeding density was 4.5 x 10
3 cells/cm
2, which amounted to an average of 8 x
10
3 cells/disk, allowing for slight variability in disk surface area. After gentle dispersion
and removal of the non-adherent cells, the median number of attached cells by 3 hours
was 6144 (range 2626-7733) demonstrating 77% attachment efficiency (Figure 60). By
6 hours, this had increased to a median of 92% indicating good affinity of the cells for
the collagen coating on the disks.
6.2.2. Cell Survival and Proliferation
Investigation into proliferation over a 3-day period showed an increase in cell number
from 24 hours (p<0.001, Figure 61). There was statistical insignificance between 48 and
72 hours suggesting no increase in total cell nuclei acids (p>0.05). Due to the relatively
high initial cell seeding density and proliferation occurring by 48 hours, it was probable
that cell differentiation was taking place at 72 hours.
The alamarBlue
® assay was undertaken on the same samples over the entire
experimental period. Although the metabolic activity of the cells on the disks was less
than that on the tissue culture plastic at all timepoints (Figure 62), the graphs followed
the same pattern indicating a comparable increase in cell metabolism over the
experimental period and, therefore, assumed low toxicity. Interestingly, there was a
statistically significant increase between days 1 and 7 (p<0.001) for cell metabolic
activity on both the glass disks and tissue culture plastic, which was followed by a
plateau between days 7 and 10. A small increase in activity from day 10 to 14 was only
significant for the cells on the tissue culture plastic (p<0.01).Chapter 5: The Development of a Biomimetic Scaffold
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Figure 59 – Standard Curve Demonstrating Fluorescence in Relation to Cell Number
The standard curve presented is for patient C06O and shows excellent correlation. Cell numbers
on the disks were calculated using the following equation: y + 7.504
x = 0.011
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Figure 60 – Cell Attachment on Collagen-Coated Fe5mol% Disks
The attachment efficiency was on average 75% at 3 hours and further improved by 6 hours
indicating good affinity of the seeded cells for the collagen coating.
(Pooled data for 6 patients, n=3)
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Figure 61 – Cell Proliferation on Collagen-Coated Fe5mol% Disks
There was an increase in nuclei acid amount (*** p<0.001), and thus cell number, from day 1.
(Pooled data for 6 patients, n=3)
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Figure 62 – Cell Metabolic Activity Over the 14-day Experimental Period
The metabolic activity of the cells on both the disks and tissue culture plastic followed a similar
trend. Nonetheless, there was a statistically significant difference between the two conditions at all
timepoints investigated (** p<0.01, *** p<0.001).
(Pooled data for 6 patients, n=3)
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6.2.3. Cell Morphology
SEM investigation into cell morphology on the collagen-coated disks demonstrated
good cell spreading and attachment (Figure 63A). In some areas, cells had assumed
end-to-end contact analogous to that seen just prior to cell fusion into multinucleated
myotubes (Figures 63B and C). There was the surface cracking of the disks observed
during the bacterial studies, and it is possible that the processing methods for the SEM
investigations may have contributed to this appearance.
6.2.4. Cellular Differentiation
6.2.4.1. Gene and Protein Expression
6.2.4.1.1. Desmin and -Sarcomeric Actin Immunoreactivity
Immunofluorescent imaging of the cells on the collagen-coated disks demonstrated the
presence of desmin-positive cells at day 1 and myotube-like structures expressing -
sarcomeric actin by day 14 (Figure 64). Importantly, there was poor unidirectional
myotube alignment on the 2-D surfaces, which is essential for the required functional
output of any engineered skeletal muscle tissue.Chapter 5: The Development of a Biomimetic Scaffold
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Figure 63 – SEM Images of Cells on Fe5mol% Glass Disks (Patient M04E, Day 14)
Figure 63A depicts a cell (green arrow) attached to the surface of the disk, which also exhibits
surface cracking (red arrow). Figure 63B demonstrates cells (green arrows) attaining end-to-end
contact (yellow arrows). Figure 63C is at higher magnification to illustrate this critical contact
made by the cells.
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Figure 64 – Immunofluorescent Images of Cells on 2-D Collagen-Coated Fe5mol% Disks
(Patient O05Z)
There were single desmin-positive cells (yellow arrows) on day 1 (green staining), and by day 10,
there were multinucleated myotubes (red arrows) associated with desmin (green) and  sarcomeric
actin (red). The nature of the disk surface retained the secondary antibody resulting in a degree of
background fluorescence.
(Magnification 20x, scale bar 50m)
Day 1
Day 10 Day 14
Day 7Chapter 5: The Development of a Biomimetic Scaffold
202
6.2.4.1.2. Upregulation of the MRF Genes
There was upregulation of the MyoD gene indicating a commitment to myogenesis,
such that by day 7 there was a statistically significant increase compared to days 1 and 3
(p<0.001) (Figure 65). Interestingly, there was a plateau between days 7 and 10, and
then a decrease with the expression of the MyoD gene at day 14 less than day 10
(p<0.05). This plateau corresponded well to that observed with the alamarBlue
® assay
suggesting no further cell determination and proliferation. The level of MyoD gene
expression at day 14 did not fall below that expressed at day 1 (p<0.01).
Myogenin gene expression demonstrated a steady increase from day 3 (p<0.001)
beyond that of MyoD gene expression, confirming its appearance late in the
differentiation process. There was corresponding protein expression of the MRFs, as
determined by immunofluorescent imaging (Figure 66).
6.2.4.1.3. Upregulation of the MYH Genes
Expression of the MYH3 (embryonic) gene was detected at day 1, however, the greatest
increase was between days 7 and 10 (p<0.001) (Figure 67). The upregulation of the
perinatal gene (MYH8) was first noted on day 7, and there was a statistically significant
increase with time (p<0.001) (Figure 69). The detection of the developmental MYH
genes was in concordance with the stages of in vivo myogenesis with respect to the
initial appearance of the embryonic form followed by the neonatal form. The expression
of the MYH genes coincided with the temporal appearance of myogenin. Significantly,
there was no discernable upregulation of any other MYH genes associated with human
craniofacial skeletal muscle. There was corresponding protein expression of the
developmental MyHCs (Figures 68 and 70).Chapter 5: The Development of a Biomimetic Scaffold
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Figure 65 – MyoD and Myogenin Gene Expression on Collagen-Coated Fe5mol% Disks
Figure 65 demonstrates the gene expression of MyoD and myogenin. There was upregulation of
the MyoD gene, which reached a plateau between days 7 and 10. Thereafter, there was a decrease
in expression. The myogenin gene expression increased throughout the experimental period and
the later expression relative to MyoD mimics that occurring in vivo.
(Pooled data for 6 patients, n=3)
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Figure 66A – MyoD Expression on Collagen-Coated Fe5mol% Disks
(Patient M04E, Day 10)
Figure A depicts cell nuclei labelled with DAPI (blue stain, green arrows), whereas figure B shows
MyoD1 immunopositivity (green stain, red arrows). Figure C is the overlay of MyoD1 and DAPI-
positive cells (yellow arrows). Figure D demonstrates -sarcomeric actin immunopositivity in
association with the MyoD1-positive cells.
(Magnification 20x, scale bar 50m)
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Figure 66B – Myogenin Expression on Collagen-Coated Fe5mol% Disks
(Patient O05Z, Day 14)
Figure A depicts cell nuclei labelled with DAPI (blue stain, green arrows), whereas figure B shows
myogenin-positive cells (green staining, red arrows). Figure C is the overlay of myogenin and
DAPI-positive cells (yellow arrows). Figure D demonstrates -sarcomeric actin immunopositivity
in conjunction with the myogenin-positive cells.
(Magnification 20x, scale bar 50m)
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Figure 67 – Expression of the MYH3 (Embryonic) Gene on Collagen-Coated Disks
There was expression of the embryonic (MYH3) gene from day 1, but the most significant
increase was from day 7 (*** p<0.001).
(Pooled data for 6 patients, n=3)
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Figure 68 – Embryonic MyHC Expression on Collagen-Coated Fe5mol% Disks
(Patient G01U, Day 14)
Figure A depicts cell nuclei labelled with DAPI (blue, arrows), whereas figure B shows embryonic
MyHC-positive cells (purple) and figure D shows -sarcomeric actin immunopositivity (red).
Figures C and E are overlays of DAPI with embryonic MyHC and -sarcomeric actin respectively.
Figure F is the overlay. (Magnification 20x, scale bar 50m).
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Figure 69 – Expression of MYH8 Gene on Collagen-Coated Disks
The upregulation of the MYH8 gene was identified from day 7, and there was a statistically
significant increase with time (*** p<0.001).
(Pooled data for 6 patients, n=3)
***
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Figure 70 – Expression of Perinatal MyHC on Collagen-Coated Disks
(Patient C07D, Day 14)
Figure A depicts cell nuclei labelled with DAPI (blue stain, yellow arrows), whilst figure B
demonstrates perinatal MyHC immunopositivity (yellow stain) and figure D shows -sarcomeric
actin immunopositivity (red stain). Figures C and E are overlays of DAPI with perinatal MyHC
and -sarcomeric actin respectively. Figure F is the overlay.
(Magnification 20x, scale bar 50m).
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6.3. Part 2: The Creation of a Biomimetic Scaffold
Scaffold architecture is an important factor in any skeletal muscle engineering
approaches, and it has been established that ECM coated parallel arranged fibres can
support recapitulation of the native muscle structure. Nonetheless, the transfer of fibre
scaffolds can prove cumbersome and as an additional investigation fibres were also
contained within a collagen matrix to provide a more manageable system.
6.3.1. Macroscopic Examination
The collagen and composite collagen/glass fibre scaffolds were unsecured throughout
the experimental period, and macroscopic examination demonstrated contraction of the
scaffolds with time. The collagen control scaffolds contracted considerably by day 21,
such that the final volume of the engineered ‘tissue’ was a fraction of the original (3 x 1
x 0.4cm) restricting adequate restoration of any significant sized defect (Figure 71A).
The composite scaffolds also contracted with the collagen ‘rolling’ along the short axis
and contracting along the long axis to reveal tufts of glass fibres. These exposed fibre
ends, although not actually tendinous attachments, could provide support for co-cultures
of muscle-derived cells and tendon fibroblasts in the future (Figure 71B). Despite the
width of the engineered construct reducing to approximately one third of the initial
seeded scaffold at day 1, the reduction in length was small due to the presence of the
glass fibres. The whole construct was very manipulable in comparison to the collagen
control scaffolds and the secured glass fibre-only scaffolds.
6.3.2. Microscopic Examination
All the constructs were studied under modulation contrast and SEM to assess cell
morphology. It was apparent that cell orientation remained random at all times within
the control collagen gels (Figure 72A), whereas within the composite collagen/glass
fibre scaffolds, the cells assumed a unidirectional position parallel to the long axis of
the glass fibres (Figure 72B). By day 17, large myotube structures were present on the
collagen-coated glass fibres (Figure 72C). The SEM investigations showed good cell
attachment and spreading on the composite scaffolds indicating viability (Figure 72D).Chapter 5: The Development of a Biomimetic Scaffold
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Figure 71 – Macroscopic Images of the Collagen Control and Composite Collagen/Glass
Fibre Scaffolds (Patient G01U)
Illustration 71A depicts the collagen-only scaffolds on day 21 – there was a considerable degree of
contraction in all dimensions. Illustration 71B shows the composite glass fibre/collagen scaffolds
on day 21. The construct contracted and rolled along the short axis, however, the amount of
contraction along the long axis was limited by the presence of the glass fibres. Significantly, the
tufts of fibres exposed at the construct ends could provide support for co-cultures of muscle-
derived cells and tendon fibroblasts in order to create tendinous attachments (yellow arrows).
(Scale bar 5mm)
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Figure 72A and B – Cell Morphology Within the Various Scaffold Arrangements
Figure 72A indicates the random cell orientation (yellow arrows) within the collagen scaffold, and
figure 72B shows the cell alignment parallel the glass fibres (pink arrows) within the composite
scaffolds on day 14.
Figure 72C and D – Myotube Formation on Collagen-Coated Glass Fibres and Cell
Morphology on Composite Scaffolds
Figure 72C shows a large floating myofibre-like structure (6.77mm length) (green arrow) secured
at either end (blue arrows) on the collagen-coated secured glass fibres on day 17. The SEM
micrograph (D) demonstrates attached cells (red arrows) on the surface of the composite scaffolds
on day 21.
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6.3.3. Cellular Differentiation
6.3.3.1. Gene Expression
6.3.3.1.1. Upregulation of the MRF Genes
The univariate ANOVA confirmed an interaction between the scaffold type and time
(p<0.001, f=6.180, df 4,175), and further analysis demonstrated a statistically
significant difference between MyoD gene expression on all the scaffold types on day 7
(Figure 73). Gene expression on the glass fibres was greater than the control collagen
(p<0.001, 95%CI 17.1-52.8) and composite scaffolds (p<0.01, 95%CI 12.8-48.9). There
was also greater expression of the MyoD gene on the composite scaffolds compared to
the control scaffolds (p<0.05, 95%CI 0.8-7.3). Importantly, MyoD expression on the
collagen-coated glass fibres demonstrated a decrease by day 14, whereas the greatest
increase in gene expression on the composite and control scaffolds was between days 7
and 14, such that all the scaffolds were comparable on day 14 (p>0.05, f=1.769, df 2,53)
and day 21 (p>0.05, f=0.476, df 2,57). The relative decrease in expression on the
collagen and composite scaffolds mirrored that seen on the 2-D collagen-coated disks,
and indicates the decrease seen during the latter stages of in vivo myogenesis.
With respect to myogenin gene expression, there was also an interaction between the
scaffold type and time (p<0.001, f=10.242, df 4,174) (Figure 74). On day 7, the
expression was greatest on the collagen-coated glass fibres compared to the control
collagen (p<0.01, 95%CI 227.8-905.5) and the composite scaffolds (p<0.01, 95%CI
221.4-899.1). Further, the composite scaffolds had greater expression than the control
scaffolds (p<0.001, 95%CI 2.8-10.0). On day 14, the glass fibres still demonstrated
greater gene expression than the controls (p<0.05, 95%CI 13.9-216.0) despite the drop
from day 7. However, by day 21, there was no difference between the scaffold types
(p>0.05, f=0.682, df 2,60).Chapter 5: The Development of a Biomimetic Scaffold
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Figure 73 – MyoD Gene Expression on all Scaffold Types Over 21 Days
There was a statistically significant difference between the scaffold types on day 7, such that the
expression on the collagen-coated glass fibres was greater than that on the composite (p<0.01) and
collagen (p<0.001) scaffolds. The composite scaffolds also expressed greater amounts than the
collagen scaffolds (p<0.05). Nonetheless, with a decrease on the glass fibres and an increase on the
other scaffold types, there was no difference in expression from day 14 (p>0.05).
(Pooled data for 2 patients, n=3)
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Figure 74 – Myogenin Gene Expression on all Scaffold Types Over 21 Days
There was greater expression on the collagen-coated glass fibres scaffolds on day 7 (p<0.01). The
composite scaffolds also expressed more myogenin gene than the controls on day 7 (p<0.001). On
day 14, the glass fibres expressed more myogenin gene than the controls (p<0.05), despite the
decrease from day 7. There was no difference between scaffold types on day 21 (p>0.05).
(Pooled data for 2 patients, n=3)
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6.3.3.1.2. Upregulation of the MYH Genes
MYH1 gene (MyHC-IIX/D) expression was only detected on the collagen-coated glass
fibres on day 7 (Figure 75), however, by day 14 all scaffold types expressed the MYH1
gene with the glass fibre scaffolds demonstrating greater expression than the composite
(p<0.01, 95%CI 1.6-5.9) and control collagen scaffolds (p<0.01, 95%CI 1.8-6.2). By
day 21, only the controls expressed less of the MYH1 gene than the collagen-coated
glass fibres (p<0.05, 95%CI 0.4-8.6).
Significantly, both types of scaffolds utilising glass fibres expressed the MYH2 gene
(MyHC-IIA) on day 7, albeit in differing amounts (p<0.01) (Figure 76). By day 14,
there was initial expression of the MYH2 gene on the control scaffolds, but in a smaller
amount compared with the glass fibre (p<0.01, 95%CI 2.2-7.3) and composite scaffolds
(p<0.01, 95%CI 0.1-0.6). The difference in expression was still significant between the
glass fibre and composite scaffolds (p<0.01, 95%CI 1.8-6.9). Nonetheless, an increase
in MYH2 gene expression by day 21 resulted in no difference between the scaffold
types (p>0.05, f=0.113, df 2,58).
Analysis of the embryonic (MYH3) gene expression demonstrated an interaction
between the sample type and time (p<0.001, f=5.763, df 4,173). Further study
confirmed greater expression of the MYH3 gene on the collagen-coated glass fibres
compared with the composite scaffolds (p<0.01, 95%CI 2.1-16.1) and the controls
(p<0.01, 95%CI 2.5-16.5) on day 7 (Figure 77). There was an increase on all scaffold
types between days 7 and 14, but there was still greater expression on the collagen-
coated fibres compared with the control (p<0.01, 95%CI 8.0-29.4) and the composite
scaffolds (p<0.01, 95%CI 5.0-26.5). Additionally, there was a statistically significant
difference between the composite scaffolds and controls on day 14 (p<0.01, 95%CI 0.7-
5.1). The increase observed from 7 and 14 days for all the scaffold types mirrored the
response seen on the 2-D disk surfaces, and the CT obtained was similar for the
composite and control scaffolds. MYH3 gene expression decreased between days 14
and 21 on the collagen-coated glass fibres, such that there was no difference between
the scaffold types at the final timepoint (p>0.05, f=0.422, df 2,55).Chapter 5: The Development of a Biomimetic Scaffold
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Figure 75 – MYH1 Gene Expression Over 21 Days
On day 14, all the scaffolds expressed the MYH1 gene, with the glass fibre scaffolds
demonstrating greater amounts (p<0.01). By day 21, only the control scaffolds expressed less than
the glass fibres (p<0.05).
(Pooled data for 2 patients, n=3)
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Figure 76 – MYH2 Gene Expression on all Scaffold Types
There was a difference in expression of the MYH2 gene on days 7 and 14 between the glass fibre
and composite scaffolds (p<0.01). On day 14, the control scaffolds demonstrated upregulation of
the gene, albeit at statistically significantly lower levels than the other scaffold types (p<0.01). By
day 21, there was no difference in expression between the scaffold types (p>0.05).
(Pooled data for 2 patients, n=3)
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Figure 77 – MYH3 Gene Expression Over 21 Days
The expression of the embryonic gene on the collagen-coated glass fibres was greater than the
other scaffold types on days 7 and 14 (p<0.01). Although, the level of expression increased
between days 7 and 14, the composite scaffolds also had statistically greater levels than the control
scaffolds on day 14 (p<0.01). Once again, with the decrease in expression on the glass fibres
balanced by the increase in expression on the other fibre types, there was no difference on day 21
(p>0.05).
(Pooled data for 2 patients, n=3)
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The expression of the MYH6 gene (MyHC-) was minimal relative to the other MYH
genes (Figure 78). Specifically, expression was detected on the collagen-coated glass
fibres from day 7, but all scaffold types demonstrated upregulation of the gene on day
21, with the glass fibres differing significantly to the control scaffolds (p<0.05, 95%CI
0.04-0.8).
With respect to the MYH7 gene (MyHC-I), the univariate ANOVA demonstrated
interaction between the sample type and time (p<0.001, f=11.172, df 3,107) (Figure 79).
On day 14, there was upregulation of the MYH7 gene on all the scaffolds, nonetheless,
there was a significant difference between expression on the glass fibre scaffolds
relative to the control (p<0.001, 95%CI 50.6-121.7) and the composite scaffolds
(p<0.001, 95%CI 48.7-119.9). Overall, MYH7 gene expression on the glass fibres
paralleled that of the embryonic gene (MYH3) expression (Figure 77). Although there
was a decrease by day 21, the glass fibres still exhibited greater MYH7 gene expression
than the control scaffolds (p<0.05, 95%CI 0.2-47.8).
Analysis of the expression of the MYH8 gene (perinatal) confirmed interaction between
the time and scaffold type (p<0.001, f=8.966, df 3,124) (Figure 80). On day 7, the
expression of MYH8 (perinatal) gene on the collagen-coated glass fibres was greater
than on the composite scaffolds (p<0.01). However, by day 14, there was expression of
the MYH8 gene on all the scaffolds with a statistically significant difference between
the controls and the glass fibre (p<0.05, 95%CI 1.3-56.2) and composite (p<0.01,
95%CI 2.4-11.3) scaffolds respectively. On day 21, there was no difference in MYH8
gene expression between the scaffold types (p>0.05, f=0.692, df 2,52).Chapter 5: The Development of a Biomimetic Scaffold
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Figure 78 – Expression of the MYH6 Gene on all Scaffold Types Over 21 Days
All the scaffold types expressed the MYH6 gene on day 21 – there was a statistically significant
difference between the collagen-coated glass fibres and collagen-only control scaffolds (p<0.05).
(Pooled data for 2 patients, n=3)
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Figure 79 – The Expression of the MYH7 Gene Over 21 Days
The MYH7 gene was expressed on all the scaffolds on day 14, with the collagen-coated glass fibre
scaffolds demonstrating greater levels than the other scaffold types (p<0.001). Although the level
of expression decreased on the glass fibre scaffolds by day 21, there was still a significant
difference to those levels expressed on the collagen control gels (p<0.05).
(Pooled data for 2 patients, n=3)
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Figure 80 – MYH8 Gene Expression on all Scaffold Types
There was greater expression on the glass fibre scaffolds compared to the composite scaffolds on
day 7 (p<0.001). By day 14, all the scaffold types expressed the MYH8 gene, such that the glass
fibres (p<0.05) and the composite scaffolds (p<0.01) exhibited higher levels than the control
collagen-only scaffolds. There was no difference on day 21 between the scaffold types (p>0.05).
(Pooled data for 2 patients, n=3)
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7. Discussion
Biomaterial scaffolds have been frequently employed in skeletal muscle engineering
processes to provide initial support and specific biophysical cues. A linear rate of
degradation tailored to the rate of tissue formation is advantageous in order to allow the
precisely formed mature tissue to function properly, as the scaffold disappears.
Nonetheless, the provision of a relatively stable surface in the initial stages is essential
for cells to adhere. Previous research has suggested that protein coatings can improve
surface stability and degradation (Canham et al., 1999; Low et al., 2006), but
dependency on factors, such as coating thickness, make this unpredictable. Collagen, a
major constituent of the skeletal muscle ECM, has been used successfully in many
tissue engineering applications (Vandenburgh et al., 1989; Okano et al., 1997; Okano
and Matsuda, 1998a; d’Aquino et al., 2009; Watanabe et al., 2010) and has been
demonstrated to be less effective at surface protection enabling the actual biomaterial
degradation rate to be relied upon (Low et al., 2006). The first part of this study
concentrated on establishing the biocompatibility of human masseter muscle-derived
cells with collagen-coated degradable phosphate-based glass disks containing
Fe5mol%. The crucial role of ECM coatings for skeletal muscle engineering purposes
has been highlighted previously (Cronin et al., 2004; Kamelger et al., 2004).
Molecular modifications of any biomaterial can elicit specific interactions with cell
integrins, thus directing cell attachment, proliferation, differentiation and ECM
production and organisation. There was good cell attachment on the disks by 12 hours.
Cell proliferation occurred over 48 hours, but plateaued by 72 hours – it is probable that
cell differentiation and fusion was occurring by this timepoint, due the initial high cell
seeding density (O’Neill and Stockdale, 1972). The stages of MPC proliferation and
differentiation into multinucleated myofibres involve the expression of specific
transcription factors and signalling systems related to these events, and indeed there was
increased expression of the MyoD and myogenin genes (Weintraub et al., 1991;
Rudnicki et al., 1992; Nabeshima et al., 1993; Rudnicki et al., 1993) from day 1. In
accordance with studies highlighting the importance of the correct spatial and temporal
expression of MRFs, MyoD gene expression exhibited an increase and then a decrease,
whereas myogenin expression increased and persisted throughout the experimentalChapter 5: The Development of a Biomimetic Scaffold
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period (Weintraub, 1993; Yablonka-Reuveni and Rivera, 1994, 1997; Anderson et al.,
1998; Cooper et al., 1999).
Differentiation on the disks was confirmed by the presence of α-sarcomeric actin, with 
myotubes arranged in a random fashion comparable to MPC differentiation on 2-D
gelatin-coated coverslips. Additionally, the SEM images confirmed the surface cracks
and grooves observed in the bacterial studies, and no indication of any defined cell
orientation. Only upregulation of the developmental myosin heavy chain genes was
evident suggesting no significant further myotube maturation and associated function
(Butler-Browne et al., 1988; Sciote et al., 1994; Sciote and Kentish, 1996), most likely
due to the lack of contiguous myotubes and the desired functional inputs. However, the
pattern of cell metabolic activity on the collagen-coated disks over the 14-day
experimental period was identical to that on collagen-coated tissue culture plastic, albeit
at a lower level.
The main aim of any tissue engineering process is to produce a 3-D construct analogous
to that of native tissue. Individual cells can adapt to the local microenvironment, as
demonstrated in 2-D culture, but there is an inability to organise on a 3-D scale. The use
of 3-D scaffolds can define the requisite spatial, biological and physical cues enabling
cells to assume a higher level of orientation (Langer and Vacanti, 1993; Fuchs et al.,
2001; Isenberg et al., 2008). As aforementioned, the structural organisation of skeletal
muscle is a key factor governing and maintaining tissue function. The parallel myofibre
arrangement may be replicated by degradable phosphate-based glass fibres. It is
important to recognise that the cell response is not only dependent on glass composition
(Salih et al., 1999; Ahmed et al., 2004c; Abou Neel et al., 2007), but also fibre size
(Abou Neel et al., 2005; Bitar et al., 2008) and spacing (Neumann et al., 2003). After
confirmation of cell biocompatibility in 2-D, a biomimetic scaffold was produced
comprised of parallel arranged Fe5mol% glass fibres of 10-20µm diameter with an
average spacing of 40µm.
Secured glass fibres were coated in collagen to mimic the architecture of skeletal
muscle and aid cell adhesion (Li et al., 2002). Glass fibres were also encased within
uncompressed collagen gels as an alternative, once again mimicking the muscle
structure. Solitary collagen gels are friable and difficult to manipulate (Wallace andChapter 5: The Development of a Biomimetic Scaffold
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Rosenblatt, 2003), hence other researchers have combined gels with additional
elements, such as sponges and fibres in order to improve upon the physical and
biological properties (Weinberg and Bell, 1986; Moriyama et al., 2001; Atala et al.,
2006). The collagen network itself enables cell retention by physical entrapment
(Wallace and Rosenblatt, 2003), thus ensuring a relatively high cell density compared to
numbers attaching to glass fibres with a thin coating. Nevertheless, a significant
discovery was the ability of the coated glass fibres to support large myofibre-like
structures compared to the composite scaffolds and the control collagen scaffolds.
Furthermore, there was earlier upregulation of the skeletal muscle-related genes
associated with differentiation and maturation (MyoD, myogenin and MYH) compared
to the control and composite scaffolds. The later expression seen with the other
scaffolds is almost certainly due to the necessary initial matrix degradation by the
seeded cells enabling cell migration leading to end-to-end fusion of MPCs (Chin and
Werb, 1997; Kherif et al., 1999; El Fahime et al., 2000; Lewis et al., 2000). Due to
technical limitations, it was difficult to confirm myogenic differentiation within the 3-D
constructs utilising immunofluorescent techniques. However, the opposite was true with
the 2-D system whereby myogenic differentiation was confirmed by immunofluorescent
identification of myogenin, which corresponded to upregulation of the associated gene.
It could be extrapolated that up-regulation of the myogenin gene within the 3-D
constructs was indicative of differentiation as demonstrated in 2-D (Figure 81). Also,
increased expression of the myogenin gene was coincident with the addition of IGF-I,
which has been shown to increase myogenic differentiation (Florini et al., 1991).
The in vivo expression of the different myosin isoforms within skeletal muscle is
developmentally regulated, with neonatal and embryonic isoforms appearing first
followed by adult fast and slow isoforms in fast and slow muscles respectively (Whalen,
1985; Grounds, 1991). Interestingly, it has been demonstrated that these transitions in
vivo do not necessarily take place in vitro, as demonstrated by the persistence of only
the developmental forms (Bader et al., 1982; Matsuda et al., 1983). The introduction of
a neural input has supported the expression of fast isoforms in vitro (Ecob-Prince et al.,
1986). The phenomenon of developmental MyHC expression was seen on the 2-D
collagen-coated disks, but the fast, slow and -cardiac MyHC genes were expressed on
the 3-D scaffolds confirming the important influence of certain topographical cues. To
note was the greater cell density used for the 3-D scaffold, which may have also playedChapter 5: The Development of a Biomimetic Scaffold
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Day 1 Day 10 Day 14
Figure 81 – Myogenic Differentiation in 2-D and 3-D
Figure A shows the presence of single desmin-positive cells on glass coverslips (day 1), which
fused by day 7-14 into differentiated myotubes (Magnification 63x, scale bar 25m). Figure B
demonstrates myogenin gene upregulation on collagen-coated Fe5mol% disks with time, which
correlates with myotube formation on coverslips. Figure C confirms myogenin immunopositivity
on the collagen-coated disks on day 14 (scale bar 25m, magnification 20x). In particular, the
yellow arrows depict DAPI and myogenin staining, and the red staining is associated with -
sarcomeric actin confirming myogenic differentiation. Myogenin gene upregulation was noted on
all the 3-D scaffolds (Figure D) by day 14, and by extrapolation of the 2-D findings, could be
considered to indicate myogenic differentiation (scale bar 25m, magnification 63x).
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a role in the expression of certain genes. Furthermore, there will always be a delay
between gene expression and the appearance of the related protein.
As well as the degradation rate and by default the surface stability dictating MPC
response, the stiffness of the substrate is a parameter of consideration. The mechanical
compliance (flexibility) of the scaffold, especially over time as it degrades, will strongly
influence the gene expression of anchorage-dependent cells, such as MPCs (Engler et
al., 2004, 2006; Boontheekul et al., 2007; Ingber et al., 1994; Discher et al., 2005). It
has been demonstrated that MPCs on compliant substrates, such as collagen, will striate
(Engler et al., 2004). However, Mitrossilis et al. (2009) have indicated that although
alignment occurs on elastic substrates, the cell shape and traction forces are along the
direction of highest stiffness. They concluded that MPCs respond to the rigidity of the
surroundings based on the acto-myosin contractility. On the contrary, cells can also
apply forces to the scaffold through cytoskeleton-ECM interactions leading to changes
in behaviour (Kong et al., 2005; Wang and Lin, 2007). The uncompressed collagen gel
had a relatively low density enabling cell migration and cell-cell contact: the contraction
of the control collagen and composite scaffolds was likely to be due to cell migration,
and perhaps contraction of myotubes at the later timepoints (Georges and Janmey,
2005). Confirmation of upregulation of the skeletal muscle genes associated with
differentiation and maturation can only lend to the theory of myofibre contraction
playing a role in the latter stages.
The importance of mechanical compliance is further emphasised by the gene expression
on the collagen-coated glass fibres over the experimental period. Regardless of the
greater upregulation of the genes investigated at the early timepoints compared to the
control collagen gels and composite scaffolds, there was a rapid decrease from day 7. It
is highly probable that the stiffness of the glass fibres prevented further myotube
contraction resulting in these structures detaching from the fibres. These findings should
be accounted for in further modification of these scaffolds for skeletal muscle
engineering applications.
It is important for any engineered construct to be easily manipulated – the control
scaffolds contracted considerably and were extremely friable. Furthermore, there was a
random cell alignment making these solitary floating collagen gels of limited use forChapter 5: The Development of a Biomimetic Scaffold
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skeletal muscle engineering purposes. However, the composite scaffolds indicated
better cell alignment and the gel rolled along the short axis to produce a malleable
construct. Contraction of the gel along the long axis of the glass fibres revealed tufts of
fibres similar to tendons, producing a realistic muscle ‘organoid’.
The viable volume of any engineered tissue is dependent on the diffusion distance for
the exchange of nutrients and metabolic waste (Folkman and Hochberg, 1973, Lalan et
al., 2002), and this is a fundamental criterion for a successful scaffold. Low density
collagen gels can provide a porous structure enabling these processes to occur (Li et al.,
2002), and this is further enhanced as the glass fibres degrade to leave channels.
Previous studies utilising gelatin/PCL scaffolds have shown good cell infiltration, due
to the presence of the gelatin providing for a more favourable environment for cell
attachment and proliferation (Zhang et al., 2005).
It has been demonstrated in this study that MPC behaviour differs in 2-D and 3-D. A
detailed understanding of the interactions between biomaterials and the cells of choice
is crucial. The creation of a biomimetic scaffold derived from both natural and synthetic
materials has provided specific topographical and biological cues for the production of a
human craniofacial skeletal muscle analogue. The composite scaffold has demonstrated
the ability to provide a flexible, manipulable construct exhibiting the architecture of
native skeletal muscle and markers of myofibre formation and maturation. There is
great potential to modify this ‘smart’ scaffold to optimise the resultant engineered
tissue. In particular, not only are parallel arrays of glass fibres important for the
alignment of myofibres, but spacing may also be another important parameter as
demonstrated by other researchers (Neumann et al., 2003).Chapter 5: The Development of a Biomimetic Scaffold
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8. Conclusions
(a) Collagen-coated 2-D Fe5mol% glasses are compatible with human masseter
muscle-derived cell cultures in terms of attachment, survival, differentiation and
expression of the developmental myosin heavy chains.
(b) 3-D biomimetic scaffolds consisting of glass fibres and collagen can be
produced and provide important biological and physical signals conducive to in
vitro skeletal muscle formation – in particular, compared to 2-D surfaces, genes
associated with myofibre function/maturation are upregulated.Chapter 6: Refinement of the Biomimetic Scaffold
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Chapter 6: Refinement of the Biomimetic Scaffold
1. Introduction
The previous study (chapter 5) confirmed the biocompatibility of human masseter
muscle-derived cells with phosphate-based Fe5mol% glasses. Further investigation
involved the production of a biomimetic scaffold consisting of parallel arrays of glass
fibres coated or encased within collagen. Over a period of 21 days, macroscopic and
microscopic examination revealed the presence of parallel aligned cells and eventually,
myotube-like structures. The assessment of gene expression confirmed the upregulation
of the skeletal muscle-associated genes of differentiation and maturation. In particular,
the composite scaffold comprising of glass fibres within the collagen gel provided a
manipulable skeletal muscle analogue.
Additional modifications of any biomimetic scaffold are possible in order to produce
the ideal engineered muscle tissue. Fibre dimension, influencing the available surface
area, will play a role in cell adhesion and previous research has suggested that 30m is
the optimal fibre diameter for the desired cell response (Bitar et al. 2008). Although
surface roughness can contribute to cell attachment, it has been established that the
incorporation of collagen I, as a coating or gel, provides the correct biological cues for
MPC adhesion, orientation and migration. Specifically, the previous investigation
demonstrated clearly that parallel arrays of collagen-coated glass fibres can present the
appropriate biophysical guidance to support cell alignment and the eventual formation
of myotube-like structures. However, the spacing between the glass fibres is a
parameter that may be altered and is related to the physical dimensions of the cell –
interestingly, in solution and within the gels, the fibres did ‘clump’ together, such that
the chosen 40m spacing was not always achieved. Neumann et al. (2003) have
established that there is a range of spacing conducive to myofibre formation and
alignment. Therefore, it was determined that further refinement of the biomimetic
scaffold should involve analysis of the spacing between fibres in terms of cell
attachment and survival, alignment in relation to the long axis of the secured glass
fibres and cell differentiation.Chapter 6: Refinement of the Biomimetic Scaffold
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Further, the data from chapter 5 indicated that collagen-coated glass fibres provided the
correct cues for earlier cell differentiation and maturation compared to the collagen
control and composite scaffolds. Importantly, the limited mechanical compliance of the
secured coated fibres resulted in a general decrease in gene expression between days 7
and 14, such that there was no difference between the various scaffold types. As another
modification of the biomimetic scaffold, it was determined that seeded collagen-coated
glass fibres should be embedded within a collagen gel on day 7 in order to enhance the
maturation of the formed tissue above that of the other scaffolds produced at the start of
the experimental period. Additionally, the cell viability within the constructs was
monitored and the contraction profile of the scaffolds quantified throughout the
experimental period, as the size of the engineered construct is a factor of relevance.
2. Aims
(a) To investigate the effect of glass fibre spacing in terms of the following:
i. Attachment
ii. Survival
iii. Alignment
iv. Differentiation
(b) To reproduce the 3-D biomimetic composite Fe5mol% glass fibre/collagen
scaffold after establishing the optimal fibre spacing.
(c) To investigate the 3-D scaffolds in terms of:
i. Cell viability
ii. Contraction profile
iii. Cell morphology
iv. Differentiation and maturationChapter 6: Refinement of the Biomimetic Scaffold
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3. Null Hypotheses
(a) Glass fibre spacing has no effect on attachment, survival, alignment and
differerentiation.
(b) There is no difference between the 3-D scaffold combinations in terms of cell
viability, contraction, cell morphology and cell differentiation and maturation.Chapter 6: Refinement of the Biomimetic Scaffold
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4. Materials and Methods
The materials and methods utilised in this study are highlighted in Table 12.
Method Cross-reference with Chapter 2
Cell culture Section 1.
Glass production Section 2.1.
Scaffold preparation Section 2.6.2.
Confirmation of myogenicity Section 3.1.
SEM Section 2.5.1.
CyQUANT
® assay Section 3.3.1.
alamarBlue
® assay Section 3.3.2.
qPCR Section 3.4.2.
Table 12 – Materials and Methods Used for Investigation into Refinement of the Biomimetic
Scaffold Cross-Referenced with Chapter 2
The myogenicity of masseter muscle explants (G01U, C07D, A08K) was confirmed and
cells were expanded under standard culture conditions. The first half of the study
investigated the effect of glass fibre spacing on cell attachment, survival, alignment and
differentiation over 14 days. The glass fibres were spaced at 20, 40 and 60m; after
being transferred from the drum of the fibre-pulling rig, they were secured to custom-
manufactured stainless steel frames (22 x 22 x 1mm) prior to collagen coating. The
second part of the study examined the refined biomimetic scaffold in terms of cell
viability, contraction profile and cell differentiation and maturation over a 21 day
period. All scaffolds were investigated in triplicate.
The masseter muscle-derived cells were seeded at a density of 1 x 10
5 cells/cm
2 onto
collagen-coated glass fibre scaffolds and placed in a humidified atmosphere of 5% CO2
in air at 37°C. The cell density for part 2 of the study was 1 x 10
6 cells/ml. For bothChapter 6: Refinement of the Biomimetic Scaffold
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parts of the study, the SGM was changed to DM following three days of proliferation to
encourage MPC fusion and hypertrophy. The DM was changed every three days.
4.1. Cell Attachment
Cell attachment on the glass fibres was assessed at 3 and 6 hours using the CyQUANT
®
assay and a standard curve created for each patient. At each timepoint, the non-adherent
cells were washed away with PBS and the fibres were removed from the frames and
stored in a 24 well plate at -80ºC until required.
4.2. Cell Survival and Proliferation/Metabolic Activity
To study the effects on cell survival and proliferation, the fibre scaffolds in the first half
of the study were washed with PBS on days 1, 2, 3, 7, 10 and 14 post-seeding. The
fibres were removed from the frames and stored in a 24 well plate at -80ºC: the
CyQUANT
® cell proliferation assay was used on the frozen samples. In addition, the
alamarBlue
® assay was used on the same samples throughout the course of both parts of
the study to establish metabolic activity.
4.3. Cell Alignment and Morphology
Modulation contrast images of the different spaced scaffolds were captured on days 1,
3, 7, 10 and 14, and all cells in 20 random fields were assessed using the Image J
software (Version 1.42, National Institutes of Health). The angle created between the
long axis of the cell and that of the nearest glass fibre was measured. Additionally, the
fibre spacing associated with that particular cell was also measured and recorded. All
the measurements were repeated one month apart. Furthermore, the glass fibre scaffolds
were fixed on days 1, 3, 7, 10 and 14 for SEM imaging.
Cell morphology within the scaffolds used in the second part of the study was analysed
utilising modulation contrast microscopy.Chapter 6: Refinement of the Biomimetic Scaffold
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4.4. Cell Differentiation
Immunofluorescent  techniques  were  used  to  establish  the  presence  of  α-sarcomeric 
actin, in addition to investigation into the upregulation of MRF and developmental
MYH genes on days 1, 3, 7, 10 and 14 for part 1. For the second part of the study,
investigation into upregulation of the MRF and skeletal muscle-associated myosin
heavy chain genes was undertaken on days 1, 3, 7, 14 and 21.
4.5. Contraction Profile
Macroscopic images of the collagen control, composite and embedded glass fibre
scaffolds were taken on days 1, 3, 7, 14 and 21 utilising a Canon 300D camera. The
Image J software was used to quantify the width and length of the scaffolds, with
repeated measurements undertaken one month later.
4.6. Statistical Analysis
SPSS (Version 14.0, SPSS Inc.) was used for descriptive statistics, including tests for
homogeneity of variances, and the data were analysed utilising the following tests:
(a) Multiple groups of parametric data were compared with the univariate ANOVA,
followed by the Bonferroni and Games-Howell posthoc tests. p<0.05 was
considered significant. The Kruskal-Wallis test was used to compare multiple
groups of non-parametric data and where the p-value was significant, the Mann-
Whitney U test was used to compare between groups.
(b) The difference in contraction between the collagen control and composite
scaffolds was analysed with the independent two sample t-test up to day 14.
(c) Measurement repeatability was analysed using the paired two sample t-test,
Pearson correlation coefficient and Bland and Altman plot.Chapter 6: Refinement of the Biomimetic Scaffold
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5. Study Timeline
Figure 82 highlights the experiments undertaken to investigate the effect of fibre
spacing and the outputs of the refined biomimetic scaffolds.
Confirmation of
myogenicity
Investigation into
variable spacing
of collagen-
coated glass
fibres
Investigation of
the refined
biomimetic
scaffold
Figure 82 – An Outline of the Experimental Procedures Undertaken to Examine the
Influence of Fibre Spacing and the Outputs of the Refined Biomimetic Scaffold
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6. Results
6.1. Part 1: The Effect of Fibre Spacing
6.1.1. Cell Attachment Efficiency
As highlighted, fibre spacing is a parameter that can influence cell attachment
efficiency. In order to investigate this, standard curves were compiled to enable
quantification of the actual numbers of cells attached to glass fibres at 3 and 6 hours in
accordance with the investigations undertaken on the 2-D collagen-coated disks. The
standard curves demonstrated excellent correlation between fluorescence and cell
number, thus enabling accurate determination of cell numbers on the glass fibres
(Figure 83). Interestingly, there was no difference in the numbers of attached cells on
the various spaced fibre scaffolds (p>0.05) (Figure 84). There was high cell attachment
efficiency on the 2-D collagen-coated disks, however, on the glass fibre scaffolds the
efficiency was, on average, 8% (range 1-18%) at 3 hours and 9% (range 1-20%) at 6
hours. It is evident that although the glass fibres can provide a high surface area:volume
ratio, the presence of spacing can affect cell attachment. It follows that the seeding
density would need to be higher in order to increase the number of adhered cells on the
glass fibre scaffolds.Chapter 6: Refinement of the Biomimetic Scaffold
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Figure 83 – Standard Curve Depicting Fluorescence in Relation to Cell Number
The standard curve for patient A08K is shown and demonstrates excellent correlation. The
following formula was used to calculate cell numbers on the fibre scaffolds: y – 37.86
x = 0.032
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Figure 84 – Cell Attachment at 3 and 6 Hours on the Glass Fibre Scaffolds
The actual cell numbers were calculated using the standard curves created – despite the range of
fibre spacing, there was no difference in the number of attached cells at 3 and 6 hours (p>0.05).
(Pooled data for 3 patients, n=3)
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Error bars: +/- 1 SE
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6.1.2. Cell Survival
Cell survival on the glass fibres scaffolds was measured utilising the CyQUANT
® and
alamarBlue
® assays. Although the CyQUANT
® assay gave the actual cell numbers on
the various scaffolds at different timepoints, the alamarBlue
® assay investigated the
same samples throughout and also gave an indication of the metabolic activity of the
cells present on the base of the wells exposed to glass fibre dissolution products.
There was no difference in cell numbers on the different scaffold types on days 1, 3, 7
and 10 (Figure 85) (p>0.05). On day 2, there was a statistically significant difference in
the numbers of cells on the 40 and 60m spaced glass fibre scaffolds (p<0.05, 95%CI
570-8587), with an average of 52% more cells on the 40m spaced fibres. At the final
timepoint, there was an average of 53% more cells on the glass fibres spaced at 20m
compared to those spaced at 60m (p<0.05, 95%CI 368-17633).
With respect to the metabolic activity, the graphs for the different scaffolds followed a
similar pattern with an increase in activity at the earlier timepoints, which then started
to plateau between days 10 and 14 (Figure 86). There was a difference on day 3, with
the cells in the wells containing 20m spaced glass fibres demonstrating greater
metabolic activity than those on the fibres spaced at 40m (p<0.05, 95%CI 6.11-83.95)
and 60m (p<0.05, 95%CI 0.33-56.47). At all other timepoints, there was no difference
between the range of fibre spacing (p>0.05). Significantly, the increase in overall
metabolic activity with time indicated that cells settled on the base of the wells were not
affected by any glass dissolution products.Chapter 6: Refinement of the Biomimetic Scaffold
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Figure 85 – Cell Survival on the Glass Fibre Scaffolds
The actual cell numbers were calculated using the standard curves created – the only differences
between the fibre spacings were on days 2 and 14 (* p<0.05). (Pooled data for 3 patients, n=3)
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Figure 86 – Metabolic Activity on the Glass Fibre Scaffolds
There was an increase in metabolic activity on all the samples investigated particularly during the
early stages. The graphs for the different fibre spacings follow a similar trend with the only
statistically significant difference on day 3 (* p<0.05). (Pooled data for 3 patients, n=3)
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6.1.3. Alignment in Relation to Fibre Spacing
The unidirectional orientation of MPCs and the ensuing myofibres is key to function,
and thus investigation of cell alignment in relation to fibre spacing was undertaken. The
process of scaffold production was complicated from the initial fibre-pulling stage,
utilising the custom-made rig and stepper motor, to securing the fibres onto the stainless
steel frames. Measurement repeatability of the fibre spacing and the alignment of the
cells in relation to the fibres was analysed using the paired two-sample t-test, the
Pearson correlation coefficient and the Bland and Altman plot. There was no difference
detected between the repeated measures for spacing (t-value=1.01, df 133, p>0.05) and
cell alignment (t-value=0.088, df 133, p>0.05). The Pearson correlation coefficient was
0.999 (p<0.001) for the two spacing measurements, and 0.996 (p<0.001) for the angle
measurements confirming excellent repeatability (Figure 87). Furthermore, the Bland
and Altman plots for spacing and cell alignment demonstrated acceptable coefficients of
repeatability with 95% of the differences within the limits of agreement (Figure 88).
The difference between the two measurements for fibre spacing was within 7.12m,
and the difference between the two measurements for cell alignment was within 2.96.Chapter 6: Refinement of the Biomimetic Scaffold
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Figure 87 – Scatter Plots Demonstrating Correlation Between the Two Repeated Measures
for Spacing (A) and Cell Alignment (B)
Both the plots demonstrated excellent correlation, and thus high repeatability.
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Figure 88 – Bland and Altman Plots for Repeatability
Illustration A depicts the Bland and Altman plot for repeated measures of fibre spacing, whereas
illustration B depicts the plot for repeated measure of cell alignment in relation to the glass fibre
orientation. The different spaced fibre scaffolds are highlighted in colour (see key). The coefficient
of repeatability was acceptable with 95% of the differences for both spacing and cell alignment
within the limits of agreement.
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There was a large variation in the spacing produced and this was due to the fibres
‘clumping’ together when immersed in solution, a phenomenon noticed in previous
studies, and fibre movement during the stages of scaffold production (Table 13). Table
14 outlines the average cell alignment (angle) in relation to the glass fibres – it is clear
that, despite the wide range of spacing, the 20 and 40m spaced fibres resulted in
overall good cell alignment.
Scaffold spacing
(m)
Actual average spacing when
immersed in solution (+/- 1 SD)
(m)
Range (m)
20 81.52 +/- 41.94 20.25-158.51
40 98.41 +/- 47.31 30.65-215.36
60 202.25 +/- 114.70 57.76-441.11
Table 13 – Actual Fibre Spacing for the Different Scaffold Types
Scaffold spacing
(m)
Cell alignment in relation to glass
fibre direction (+/- 1 SD) () Range ()
20 11.92 +/- 15.89 0.00-67.00
40 18.37 +/- 15.81 0.00-67.77
60 25.13 +/- 20.40 0.00-83.00
Table 14 – Cell Alignment in Relation to Fibre Spacing
The association between cell alignment and the degree of fibre spacing was examined
on days 3 and 14. The scaffolds composed of fibres spaced at 60m had poorer cell
alignment at both timepoints compared to the other fibre spacings (Figures 89 and 90).
Significantly, the cell orientation on the 20 and 40m spaced glass fibre scaffolds was
comparable on day 3, however, by day 14, the fibres spaced at 20m supported better
cell alignment (Figure 90). In general, spacing greater than 150m did not seem to
support the desired cell alignment. SEM images confirmed the unidirectional cell
positioning on the 20m spaced glass fibre scaffolds (Figure 91).Chapter 6: Refinement of the Biomimetic Scaffold
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together, however, there were large numbers of cells in good alignment (yellow arrows) and the
presence of the occasional myotube (pink arrow). Figure C depicts fewer cells on the 40m spaced
fibres, albeit also in good alignment, and figure D shows the random cell orientation on the 60m
spaced fibres (yellow arrows).
(Magnification 10x, scale bar 100m)
Fibre spacing (m) A
B C
D Figure 89 – Cell Alignment in Relation to
Fibre Spacing (Day 3) (Patient G01U)
Figure A demonstrates the degree of cell
alignment parallel to the long axis of the glass
fibres on day 3. Although some of the cells
were not orientated in the desired direction, the
majority of the cells on the 20 and 40m
spaced scaffolds had favourable alignment.
Figure B shows cells on the 20m spaced
fibres – some of the fibres were ‘clumped’
MyotubeChapter 6: Refinement of the Biomimetic Scaffold
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although there were fewer cells compared to the 20m scaffolds, there was still good cell
alignment (arrows). Qualitative examination revealed the 60m spaced fibre scaffolds to generally
have very few attached cells, nonetheless, figure D shows an area where the fibres had moved
together enough to support favourable cell attachment and alignment (yellow arrows).
(Magnification 10x, scale bar 100m)
Fibre spacing (m) A
Figure 90 – Cell Alignment in Relation to
Fibre Spacing (Day 14) (Patient G01U)
Figure A shows the relationship between fibre
spacing and cell orientation – generally, spacing
up to 150m supported good alignment. The
different scaffold types are distinguished by the
colour scheme. Figure B shows numerous cells
positioned parallel to the long axis of the 20m
spaced fibres (yellow arrows). Figure C shows
cells on the 40m spaced glass fibre scaffolds –
B C
DChapter 6: Refinement of the Biomimetic Scaffold
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Figure 91 – SEM Images of Cells on the 20m Spaced Glass Fibre Scaffolds (Day 7)
(Patient C07D)
The images demonstrate adhered cells (red arrows) on the collagen-coated glass fibres in a parallel
orientation to the long axis of the glass fibres (green arrows).Chapter 6: Refinement of the Biomimetic Scaffold
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6.1.4. Cellular Differentiation
6.1.4.1. Gene and Protein Expression
6.1.4.1.1. Desmin and -Sarcomeric Actin Immunoreactivity
Immunofluorescent imaging of the cells on the collagen-coated glass fibres
demonstrated the presence of myotube-like structures co-expressing -sarcomeric actin
and desmin by day 14 (Figure 92). Significantly, these multinucleated structures were
attached and aligned parallel to the long axis of the glass fibres. Qualitative observation
suggested that there were more uniformly aligned myotubes on the 20m spaced fibres.
Figure 92 – Myotube Formation on Glass Fibres Spaced at 20m (Patient G01U, Day 14)
Cells were stained with the nucleic stain, DAPI (blue stain, green arrows). Multinucleated
myotubes were evident adhered along the length of collagen coated glass fibres (yellow arrows).
There was desmin and -sarcomeric actin immunopositivity, and both images are composites of
the separate images taken with the Leica software.
(Magnification 20x, scale bar 25m)Chapter 6: Refinement of the Biomimetic Scaffold
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6.1.4.1.2. Upregulation of the MRF Genes
The univariate ANOVA demonstrated a difference in MyoD gene expression on the
scaffold types with time (p<0.001, f=9.602, df 4,84). Detailed analysis revealed the
gene expression on the 20m spaced fibres to be greater on days 7 and 14 than on days
1 and 3 (p<0.01) (Figure 93). With respect to the 40m spaced fibres, the only
difference was between days 1 and 3 (p<0.05). Interestingly, there was no difference in
the level of gene expression on the 60m spaced fibre scaffolds over time. The levels
detected were akin to those confirmed on the 2-D disks in chapter 5, despite the higher
seeding density on the glass fibre scaffolds. Importantly, there was no significant
difference in the levels of MyoD gene expression between the different spaced glass
fibre scaffolds (p>0.05, f=1.200, df 2,84).
Investigation into the expression of the myogenin gene as an indicator of terminal
differentiation revealed upregulation of the gene on all the scaffold types on day 14.
There was no significant difference between the different fibre spacing (p>0.05,
f=1.734, df 2,16).Chapter 6: Refinement of the Biomimetic Scaffold
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Figure 93 – MyoD Gene Expression on the Spaced Glass Fibre Scaffolds
Gene expression on the 20m spaced fibres was greater on days 7 and 14 than days 1 and 3
(** p<0.01). On the 40m spaced fibres, there was greater expression on day 3 than day 1
(* p<0.05), whereas there was no difference in expression over time on the 60m spaced fibres
(p>0.05). Although the 20 and 40m spaced glass fibre scaffolds seemed to express more of the
MyoD gene compared to the 60m scaffolds, there was no statistically significant difference
between the different fibre spacings (p>0.05).
(Pooled data for 3 patients, n=3)
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6.1.4.1.3. Upregulation of the Developmental MYH Genes
Upregulation of the MYH3 (embryonic) gene was detected from day 1 (Figures 94 and
95). There was no difference in the level of expression over the experimental time
period on the 20m spaced fibre scaffolds (p>0.05). On the other hand, the levels of
expression on the 40 and 60m spaced glass fibre scaffolds differed with time. In
particular, the gene expression on day 10 was less than that on days 1 and 7 on the
40m scaffolds (p<0.05), and MYH3 gene expression on day 1 was greater than on
days 3 and 14 on the 60m scaffolds (p<0.05). There was no difference between the
different spaced fibre scaffolds over the entire experimental period (p>0.05, f=1.872, df
2,74).
The perinatal (MYH8) gene and related protein were detected on the 20 and 40m
scaffolds on day 14 with no difference between the levels of expression (t=2.034, df 3,
p>0.05) (Figure 96). The later expression of the neonatal (MYH8) gene compared to the
embryonic (MYH3) gene followed the temporal expression observed on the 2-D
collagen-coated Fe5mol% disks.Chapter 6: Refinement of the Biomimetic Scaffold
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Figure 94 – MYH3 Gene Expression on the Spaced Glass Fibre Scaffolds
Gene expression on the 40m spaced fibres was greater on days 1 and 7 than on day 10
(* p<0.05). On the 60m spaced fibres, there was greater expression on day 1 than on days 3 and
14 (* p<0.05), whereas there was no difference in expression over time on the 20m spaced fibres
(p>0.05). Furthermore, there was no statistically significant difference between the different fibre
spacings (p>0.05).
(Pooled data for 3 patients, n=3)
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Figure 95 – Embryonic MyHC Immunoreactivity on Collagen-Coated Glass Fibres
(20m Spacing) (Patient G01U, Day 14)
Figure A demonstrates nuclei in blue (yellow arrows), whereas Figure B identifies MyHC3 expression
(purple stain, red arrows). Figure C is a composite image of the DAPI stained nuclei and cells positive for
embryonic MyHC. Figure D shows -sarcomeric actin immunopositivity (blue arrows), and Figure E is a
composite image of the stained nuclei and actin stained cells. Figure F is a composite image of the DAPI
stained nuclei and cells positive for embryonic MyHC and -sarcomeric actin – these cells are attached to
the collagen-coated glass fibres and are orientated along the length of them (green arrow).
(Magnification 20x, scale bar 50m).
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Figure 96 – Expression of Perinatal MyHC on Collagen-Coated Glass Fibres (20m
Spacing) (Patient O05K, Day 14)
Figure A depicts cell nuclei labelled with DAPI (blue stain, yellow arrows), whilst figure B
demonstrates perinatal MyHC immunopositivity (yellow stain) and figure D shows -sarcomeric
actin immunopositivity (red stain). Figures C and E are overlays of DAPI with perinatal MyHC
and -sarcomeric actin respectively. Figure F is the overlay – the cells are attached parallel to the
glass fibres (green arrow).
(Magnification 20x, scale bar 50m).Chapter 6: Refinement of the Biomimetic Scaffold
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6.2. Part 2: The Refined Biomimetic Scaffold
It was deemed that the 20µm spaced glass fibre scaffolds were produced with a more
consistent spacing and were the best at supporting the desired cell attachment and
alignment, as determined qualitatively and quantitatively. Therefore, further
investigations into the biomimetic scaffold utilised glass fibres spaced at 20µm.
6.2.1. Metabolic Activity
The metabolic activity of the cells within the scaffolds was assessed using the
alamarBlue
® assay. There was a statistically significant difference in activity over the
length of the experimental period (Figure 97). The collagen-only scaffolds
demonstrated less activity on day 3 compared to all the other timepoints (p<0.05).
Interestingly, the glass fibre scaffolds also showed a reduction in activity on day 3,
which was significantly less than that on days 1, 7 and 21 (p<0.05). Furthermore, there
was another drop in activity on day 14, which was significantly different to days 1, 7
and 21 (p<0.01). The composite scaffolds demonstrated an increase in metabolic
activity such that on day 7 there was greater activity than on days 1, 3 and 21 (p<0.05),
and on day 14 there was greater activity than on days 3 and 21 (p<0.01). The trend in
metabolic activity for the composite scaffolds mirrored that of the collagen-only
scaffolds. The late-embedded glass fibre scaffolds showed an increase from days 14 to
21, however, this was not statistically significant (p>0.05).
There was a significant difference in the metabolic activity between the scaffold types
(p<0.001, f=86.853, df 3,9); in particular, the glass fibres scaffolds had greater activity
than the collagen-only and composite scaffolds for all the timepoints investigated
(p<0.001). Furthermore, the glass fibres demonstrated greater activity than the
embedded glass fibre scaffolds on days 14 and 21 (p<0.01). Although the composite
scaffolds followed a similar trend in activity to the collagen control scaffolds, this was
at a higher level with a significant difference on days 3, 7 and 14 (p<0.001). The
embedded glass fibres showed greater levels of metabolic activity than both the
composite and collagen-only scaffolds on days 14 (p<0.05) and 21 (p<0.001). Most
importantly, the levels were maintained over the 21 day period indicating good cell
viability within all the scaffold types.Chapter 6: Refinement of the Biomimetic Scaffold
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Figure 97 – Metabolic Activity for the Different Scaffold Types Over a 21 Day Period (n=3)
There was a significant difference between the scaffold types at all the timepoints investigated.
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6.2.2. Contraction Profile
The preliminary investigations revealed considerable contraction of the scaffolds, which
can preclude the production of an adequate sized tissue for use as a test-bed, and
ultimately implantation. The contraction of the scaffolds was monitored throughout the
21 day experimental period and assessed in a qualitative and quantitative manner.
Figure 98 depicts the collagen control, composite and late-embedded glass fibres at the
different timepoints. It was apparent that the unsecured collagen-only scaffolds
contracted along the length and the width in a constant fashion. The composite
scaffolds, composed of glass fibres within a collagen gel, contracted considerably along
the width. The contraction along the length was more limited and revealed the ends of
the glass fibres from day 1. Interestingly, the glass fibres embedded within collagen
matrix on day 7 showed little contraction in any direction on day 14, but by day 21 had
contracted along the length to also reveal the ends of the glass fibres.
The contraction of the scaffolds was also quantified in terms of the width, length and
visible surface area remaining as a percentage of the original size. Measurement
repeatability for width and length was analysed using the paired two-sample t-test, the
Pearson correlation coefficient and the Bland and Altman plot. There was a significant
difference detected between the repeated measures for width (t-value=3.13, df 35,
p<0.01) and length (t-value=4.03, df 35, p<0.001) suggesting an element of bias.
Importantly, the difference between the means for the two measures of width was
0.2mm, and 0.3mm for the two repeated measures of length, which was relatively small.
The Pearson correlation coefficient was 0.981 (p<0.001) for the width measurements,
and 0.999 (p<0.001) for the length measurements suggesting excellent repeatability
(Figure 99). Furthermore, the Bland and Altman plots for spacing and cell alignment
demonstrated acceptable coefficients of repeatability with 95% of the differences within
the limits of agreement (Figure 100). The difference between the two measurements for
width was within 0.64mm, and the difference between the two measurements for length
was within 1.46mm.Chapter 6: Refinement of the Biomimetic Scaffold
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Figure 98 – Macroscopic Views of the Scaffolds Over the 21 Day Experimental Period
The images show the overall contraction from day 1 of all the scaffolds. The original size of all the
scaffolds on day 0 was 10 x 30mm. It is evident that the collagen-only scaffolds () contracted
along the width and length, whereas the contraction of the composite () and embedded glass
fibres () scaffolds was limited along the length due to the presence of the glass fibres. With time,
the ends of the glass fibres became exposed (arrows).
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Figure 99 – Scatter Plots Demonstrating the Correlation Between Repeated Measures for Width
(A) and Length (B)
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Figure 100 – Bland and Altman Plots for Repeatability
Figure A depicts the Bland and Altman plot for repeated measure of width, whereas Figure B
depicts the plot for repeated measure of length. The different scaffold types are highlighted in
colour (see key). The coefficient of repeatability was acceptable with 95% of the differences for
both width and length within the limits of agreement.
Collagen control
Composite scaffold
Embedded glass
fibres
B
AChapter 6: Refinement of the Biomimetic Scaffold
263
Table 15 outlines the percentage of scaffold remaining in terms of the original width,
length and surface area at the end of the 21 day experimental period. It was clear that
the collagen-only scaffold experienced considerable contraction along both the length
and the width, whereas this was not evident for the composite and embedded glass fibre
scaffolds.
Scaffold type Width (+/- 1 SD)
(%)
Length (+/- 1 SD)
(%)
Visible surface area
(+/- 1 SD) (%)
Collagen-only 38.16 +/- 1.83 34.66 +/- 1.80 13.23 +/- 1.04
Composite 35.19 +/- 3.60 86.13 +/- 4.74 30.37 +/- 4.24
Embedded glass fibres 73.00 +/- 7.43 94.22 +/- 2.42 68.86 +/- 8.25
Table 15 – The Measurements for the Scaffold Types at the End of the 21 day Experimental
Period
The values presented are a percentage of the original values – it is apparent that the collagen and
composite scaffolds underwent considerable contraction along the width. The collagen-only
controls also demonstrated substantial contraction along the length, which was not experienced by
the composite scaffolds. The embedded glass fibres contracted to a relatively minimal degree,
however, they were only monitored for the latter part of the experimental period.
Analysis into the reduction in width and length, and hence surface area, confirmed a
significant decrease with time for the collagen-only scaffolds (p<0.001) (Figure 101A-
C). In particular, with respect to the decrease in width, there was a significant difference
between all the timepoints investigated (p<0.05) except for day 3: this timepoint
corresponded with the drop in metabolic activity observed (Figure 95), which may
account for the lack of significant contraction between days 3 and 7. The decrease in
length of the collagen-only scaffolds was significant between all timepoints (p<0.05),
with the exception of days 3 and 14 – once again, there was a lack of contraction
between days 3 and 7 consistent with the drop in metabolic activity on day 3.
The composite scaffolds showed a significant decrease in width between day 1 and days
7, 14 and 21 (p<0.05). The reduction in width on day 3 was only significantly greater
than the width on day 21 (p<0.01), thus indicating a diminished rate of contraction.
Significantly, the only difference in the reduction of length of the composite scaffolds
was between days 0 and 21 (p<0.01).Chapter 6: Refinement of the Biomimetic Scaffold
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The embedded glass fibres demonstrated no significant reduction in length, however,
there was a difference between the original width and that measured on days 14 and 21
(p<0.05).
There was a difference between the scaffold types over the experimental period. With
respect to the change in width, the collagen-only scaffolds demonstrated less
contraction than the composite scaffolds on days 1 and 7 (p<0.01). The reduction in the
length of the composite scaffolds was significantly less than the collagen-only scaffolds
on days 1, 3 and 7 (p<0.01). On days 14 and 21, the embedded glass fibre scaffolds
exhibited less reduction in width compared to the collagen and composite scaffolds
(p<0.001). However, in addition to the embedded glass fibre scaffolds, the composite
scaffolds demonstrated less reduction in length compared to the collagen-only scaffolds
on days 14 and 21 (p<0.001).
Both the composite and embedded glass fibre scaffolds demonstrated less decrease in
surface area than the collagen-only scaffolds on day 14 (p<0.05). By day 21, although
the collagen-only scaffolds had less of the original surface area remaining in relation to
the composite scaffolds (p<0.05), the embedded scaffolds retained the majority of the
original visible surface area compared to the other scaffold types (p<0.001).Chapter 6: Refinement of the Biomimetic Scaffold
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Figure 101 –
Graphs
Demonstrating
Reduction in
Width, Length
and Visible
Surface Area
(n=3)
Figure A depicts the
percentage reduction in
width over time, whereas
Figure B is the percentage
reduction in length.
Figure C demonstrates
the reduction in visible
surface area, as a function
of the length and width.
The composite and
collagen-only scaffolds
underwent the greatest
reduction, particularly in
width, mainly during the
first part of the
experimental period.
A
B
C
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6.2.3. Cell Morphology
The scaffolds were monitored under modulation contrast microscopy throughout the
experimental period. The orientation of the cells within the different scaffolds mirrored
the findings of the preliminary study into the creation of a biomimetic scaffold (chapter
5). Figure 102 highlights the general observations on day 14 where the cells within the
collagen control scaffolds maintained a random orientation. On the contrary, the cells
within the composite and embedded glass fibre scaffolds demonstrated a unidirectional
orientation parallel to the long axis of the glass fibres. The collagen-coated glass fibres
also supported a similar cell alignment alongside the glass fibres, and furthermore, there
was evidence of multinucleated myotubes.Chapter 6: Refinement of the Biomimetic Scaffold
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(Magnification – Figures A-E 10x, F 20x, G 40x, scale bar 100m (A-E), 50m (F,G))
A
F E
D C
B
G
Figure 102 – Cell Morphology Within the
Different Scaffolds on Day 14 (Patient G01U)
Figure A depicts the random cell
orientation within the collagen control
scaffolds (blue arrows). There was good
cell alignment in all the other scaffold
types (composite B-D, embedded fibres E,
glass fibres F-G) with the cells assuming a
position parallel to the long axis of the
glass fibres (pink arrows). Additionally,
there was the presence of multinucleated
myotubes (green arrows).Chapter 6: Refinement of the Biomimetic Scaffold
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6.2.4. Cellular Differentiation
6.2.4.1. Expression of the MRF Genes
Univariate ANOVA of MyoD gene expression demonstrated an interaction between
scaffold type and time (p<0.001, f=7.807, df 9,125) (Figure 103). On day 1, the gene
expression was significantly greater on the glass fibres than on the collagen control
(p<0.001, 95%CI 25.737-68.982) and composite (p<0.01, 95%CI 12.476-60.801)
scaffolds. There was an increase in expression on day 3, with a significant difference
between the glass fibres and collagen-only scaffolds (p<0.01, 95%CI 13.891-85.486).
On day 7, the composite scaffolds demonstrated greater upregulation of the MyoD gene
than the collagen controls (p<0.001, 95%CI 107.744-225.232) and the glass fibres
(p<0.05, 95%CI 17.438-193.915). This was sustained such that the composite scaffolds
had higher levels of expression than the collagen controls (p<0.01, 95%CI 75.658-
323.799) and the late embedded glass fibres (p<0.05, 95%CI 31.296-282.840) on day
14. There was an increase in the gene expression on the glass fibres between days 7 and
14 leading to significantly greater levels than the collagen-only (p<0.05, 95%CI 54.282-
198.774) and embedded glass fibre (p<0.05, 95%CI 6.543-161.192) scaffolds.
Significantly, there was a decrease in levels by day 21 with the only difference between
the composite scaffolds and the collagen-only (p<0.001, 95%CI 3.31-6.164) and
embedded glass fibre (p<0.01, 95%CI 16.575-63.094) scaffolds.
There was also an interaction in myogenin gene expression between scaffold type and
time (p<0.001, f=6.682, df 9,115) (Figure 104). There was no difference in expression
levels on days 1 and 3 (p>0.05). However, the sharp increase in myogenin gene
expression on the glass fibres resulted in a significant difference compared to the
collagen controls (p=0.05, 95%CI 0.001-8.330) on day 7, which was further sustained
on day 14 (p<0.05, 95%CI 0.094-6.364). Additionally, the composite scaffolds
exhibited higher levels of the myogenin gene than the collagen controls (p<0.05, 95%CI
1.290-9.592) and embedded glass fibres (p<0.05, 95% CI 0.497-8.877) on day 14. Gene
expression increased on the collagen controls from day 14 to 21, whereas levels on the
embedded glass fibres were maintained. Importantly, there was a decrease in the levels
of myogenin gene expressed on the glass fibre and composite scaffolds, which was
statistically different between the two types (p<0.001, 95%CI 0.562-1.158).Chapter 6: Refinement of the Biomimetic Scaffold
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Figure 103 – MyoD Gene Expression on the Scaffolds Over 21 Days
The MyoD gene was expressed by all the scaffolds – the collagen control scaffolds demonstrated
less upregulation of the gene compared to all the other scaffold types over the 21 day period.
(Pooled data for 3 patients, n=3)
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Figure 104 – Myogenin Gene Expression on the Scaffolds Over 21 Days
The myogenin gene was also expressed by all the scaffolds and there was a significant difference
from day 7. Interestingly, the glass fibre and composite scaffolds exhibited a large increase in gene
expression greater than the collagen controls on days 7 and 14. The only difference on day 21 was
between the composite and glass fibre scaffolds (p<0.001).
(Pooled data for 3 patients, n=3)
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6.2.4.2. Expression of the MYH Genes
The MYH1 (MyHC-IIX/D) and MYH6 (MyHC-) genes were not expressed by any of
the scaffolds throughout the 21 day experimental period. The MYH2 (MyHC-IIA) gene
was expressed on only the glass fibre scaffolds on day 7, and this level of expression
remained fairly constant until day 21 (Figure 105). From day 14, there was expression
on all the scaffolds with a significantly higher amount demonstrated on the composite
scaffolds as opposed to the collagen controls (p<0.05, 95%CI 0.477-7.449) and
collagen-coated glass fibres (p<0.05, 95%CI 0.167-8.418). With the decrease by day 21,
there was no difference in MYH2 gene expression between the scaffold types (p>0.05).
MYH3 (embryonic) gene expression was noted from day 1, and there was a significant
interaction between the scaffolds and time (p<0.001, f=4.324, df 9,124) (Figure 106).
On day 1, the collagen controls expressed less of the gene than the glass fibres
(p<0.001, 95%CI 2.756-7.743) and composite scaffolds (p<0.01, 95%CI 4.124-17.028).
Between days 1 and 3, despite the increase in the MYH3 gene expression on the
collagen-control, the composite scaffolds had significantly greater levels than the
collagen (p<0.01, 95%CI 1.919-12.814) and glass fibre (p<0.05, 95%CI 1.137-11.706)
scaffolds. Interestingly, there was a decrease in levels between days 3 and 7 on all the
scaffolds, which corresponds to the reduction in metabolic activity noted at this time.
On day 14, once again the collagen controls expressed significantly less MYH3 gene
than the glass fibre (p<0.01, 95%CI 3.982-13.439) and composite (p<0.05, 95%CI
7.467-52.559) scaffolds. The decrease in gene expression on the composite scaffolds
between days 14 and 21 led to a significant difference only in relation to the collagen
controls on day 21 (p<0.05, 95%CI 0.696-14.511).Chapter 6: Refinement of the Biomimetic Scaffold
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Figure 105 – MYH2 Gene Expression on the Various Scaffolds Over 21 Days
Only the glass fibres expressed the MYH2 gene on day 7. Thereafter, all the scaffolds had
expression of the gene, with day 14 demonstrating a significant difference between the composite
scaffolds and the collagen-only and glass fibre scaffolds (p<0.05).
(Pooled data for 3 patients, n=3)
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Figure 106 – MYH3 (Embryonic) Gene Expression on the Scaffolds Over 21 Days
The MYH3 gene was expressed on all the scaffolds during the period of investigation.
Specifically, the composite and glass fibre scaffolds demonstrated higher levels than the collagen-
only controls. Interestingly, there was a drop in expression on all the scaffolds between days 3 and
7 corresponding to the dip observed in metabolic activity. Further, the late-embedded glass fibres
exhibited good levels of the MYH3 gene.
(Pooled data for 3 patients, n=3)
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The MYH7 (MyHC-I) gene was expressed on all the scaffolds on day 14, and also on
day 21, with the exception of the collagen controls (Figure 107). There was no
interaction between the scaffolds and time (p>0.05, f=2.351, df 2,34). Furthermore,
there was no difference between the levels of the MYH7 gene expression on the various
scaffolds (p>0.05, f=1.425, df 3,34).
The univariate ANOVA of MYH8 gene (perinatal) expression demonstrated an
interaction between the scaffolds and time (p<0.01, f=6.175, df 2,43) (Figure 108).
Although the gene was expressed on all the scaffolds on day 14, there was a significant
difference: in particular, the collagen control scaffolds exhibited less of the gene than
the composite (p<0.05, 95%CI 7.504-57.045) and late embedded glass fibre (p<0.05,
95%CI 0.832-13.188) scaffolds. The glass fibres did not express the MYH8 gene on day
21, whereas the composite scaffolds still had greater levels of expression than the
collagen controls (p<0.01, 95%CI 3.856-12.556).Chapter 6: Refinement of the Biomimetic Scaffold
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Figure 107 – MYH7 Gene Expression on the Scaffolds Over 21 Days
Although there was expression of the MYH7 gene on the scaffolds, there was no difference
between the levels quantified.
(Pooled data for 3 patients, n=3)
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Figure 108 – MYH8 Gene Expression on the Scaffolds Over 21 Days
The glass fibres only expressed the MYH8 (perinatal) gene on day 7, whereas the other scaffold
types continued expressing the gene on day 21. Importantly, the collagen control scaffolds
exhibited lower levels than the composite and late-embedded fibre scaffolds on day 14 (p<0.05).
On day 21, a difference was detected between the composite and collagen-only scaffolds (p<0.01).
(Pooled data for 3 patients, n=3)
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7. Discussion
Degradable 3-D scaffolds with the same architecture as the native tissue can facilitate
the seeded cells to assume the desired arrangement. Furthermore, the ability to modify
various parameters of such scaffolds lends flexibility to improve upon the outcome of
the in vitro engineered tissue. The previous study (chapter 5) demonstrated that
collagen-coated glass fibres provided key biophysical cues promoting early cell
differentiation and upregulation of muscle-specific genes relative to the other
conditions. Additionally, factors affecting the success of any fibre scaffold include fibre
diameter and spacing. Bitar et al. (2008) demonstrated that a fibre diameter of 30µm
was conducive to good cell attachment: the available surface area for attachment is a
function of the diameter and also determines the rate of degradation. Studies of skeletal
muscle engineering have suggested a wide range of spacing able to support myotube
alignment (Neumann et al., 2003), but fibre spacing also governs the efficiency of cell
attachment. Hence, a modification of the biomimetic scaffold involved investigation
into the effect of fibre spacing, with further research involving the best option.
Additionally, there was a decrease in gene expression on the glass fibre scaffolds with
time related to the low compliance leading to probable cell detachment. Therefore, in
order to maximise the potential of the engineered craniofacial skeletal muscle tissue, the
current study aimed to embed some seeded glass fibres scaffolds within collagen matrix
7 days post-seeding.
The process of glass fibre scaffold production is laboured and can lead to changes in the
scaffold variables. Interestingly, when immersed in solution, the fibres did tend to move
together due to capillary action. Nonetheless, it was determined that a range of 20-
150µm supported the required cell alignment, as judged by quantitative assessment of
the long axis of the cells in relation to the glass fibre orientation (Figures 87 and 88). It
was apparent that the cell seeding density needed to be higher compared to that used on
2-D surfaces to increase the efficiency of cell attachment (Figures 58 and 82). There
will always be a balance between the ideal fibre spacing and the requirement to keep the
scaffold material to a minimum, such that early tissue development and growth is
supported, but the material does not preclude maturation and function. Although there
was no significant difference between the different spaced fibre scaffolds, qualitativeChapter 6: Refinement of the Biomimetic Scaffold
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examination did confirm better cell alignment and the presence of myotube-like
structures on the 20µm scaffolds.
For part 1 of the study, upregulation of the MyoD gene was noted on the collagen-
coated scaffolds from day 1, and was consistent with that observed on the 2-D collagen-
coated Fe5mol% disks. There was no difference in expression between the various
scaffolds. There was an overall drop in expression between days 7 and 10, which related
to the decrease in cell number on the scaffolds at this timepoint and further suggested
cell detachment due to low compliance of the glass fibres. The decrease at this time
supported the findings in chapter 5, and confirmed the importance of embedding the
seeded fibres in order to preserve and enhance skeletal muscle tissue formation by the
provision of a compliant scaffold (Engler et al., 2004, 2006). Myogenin gene expression
followed the temporal appearance determined by numerous investigations of
myogenesis (Smith et al., 1993, 1994; Yablonka–Reuveni and Rivera, 1994, Yablonka–
Reuveni et al., 1999) – identified only on day 14, there seemed to be greater average
expression on the 20 and 40µm scaffolds compared to the 60µm spaced fibres,
however, no significant difference was noted.
Only the expression of the developmental MyHC genes on the glass fibre scaffolds was
investigated to ensure analogy to the native human masseter muscle. The embryonic
MyHC gene was expressed on all the scaffolds from day 1, and as expected, this
decreased over the experimental period. Further, the neonatal gene was identified at the
later timepoint of day 14 on all the scaffolds. The temporal expression of the
developmental MyHC genes followed that exhibited on the 2-D disks. It is likely that
the relatively poor cell attachment efficiency on the scaffolds led to the unexpected
lower and perhaps delayed upregulation of the genes investigated.
Overall, the 20µm spaced glass fibres supported better cell attachment and alignment,
as noted qualitatively, and displayed evidence of cell differentiation. Although, there
was variability in spacing of the scaffolds examined, it was determined that refinement
of the biomimetic scaffold should involve 20µm fibre spacing.
The collagen control and composite scaffolds were reproduced in a reliable fashion,
however, late embedding of the seeded glass fibres proved to be awkward in an attemptChapter 6: Refinement of the Biomimetic Scaffold
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to maintain sterility. Even so, the fibres were embedded in a parallel manner.
Investigation of the cell viability, as assessed by a measure of the metabolic activity,
revealed a significant difference between the various scaffolds. Uncompressed collagen
was used in the scaffolds compared to other studies where compressed collagen has
been used in an attempt to increase the relative cell density (Abou Neel et al., 2006;
Kayhanian et al., 2009). Thus, due to the greater H2O content and hence porosity, the
uncompressed collagen should allow for better transfer of nutrients and waste products
than compressed collagen. It was expected that the seeded collagen-coated glass fibre
scaffolds would have the greatest metabolic activity, due to the presence of some seeded
cells attaching to the base of the wells and the excellent flow-through of products. As
aforementioned, the ratio of collagen fibrils to water content determines the actual cell
density of the scaffold. Therefore, the greater contraction of the collagen controls
resulted in higher cell density leading to a scaffold less efficient in the flow-through of
nutrients and waste products (Okano et al., 1997). To clarify this point, the composite
scaffolds had less overall contraction and greater metabolic activity than the collagen
controls. Additionally, the late-embedded glass fibres demonstrated minimal contraction
and higher metabolic activity than both the collagen and composite scaffolds.
Importantly, the glass fibres present in the scaffolds did not have deleterious effects on
cell viability.
There was a decrease in activity on all the scaffolds on day 3, and it is likely that the
cells were still adapting to their new environment (Dado and Levenberg, 2009).
Thereafter, the increase in activity indicated greater cell mobility and remodelling of the
ECM, although this would need to be confirmed by, for example, changes in MMP
levels (Lewis et al., 2000). The decrease in activity on the collagen-coated glass fibres
on day 14 suggested further cell detachment, highlighting again the need to maintain the
cells on the fibres by encasing them in collagen on day 7. Crucially, the activity of the
cells within the collagen control and composite scaffolds was maintained throughout the
experimental period.
All the collagen-based scaffolds contracted due to intrinsic cellular forces produced
during migration and eventually, the contraction of myotubes anchored within the ECM
(Strohman et al., 1990; Dennis and Kosnik, 2000; Huang et al., 2005). Indeed, the
deformation of seeded collagen gels due to cell-induced mechanical forces has beenChapter 6: Refinement of the Biomimetic Scaffold
280
demonstrated in previous studies (Levy-Mishali et al., 2009). The reduction in the
contraction rate between days 3 and 7, particularly of the collagen-only scaffolds, was
related to the decrease in metabolic activity noted on day 3. The contraction of the
collagen control scaffolds produced an unsatisfactory construct for use as a test-bed,
and ultimately implantation. Additionally, the random cell orientation would preclude
the desired force vector. The collagen-coated glass fibres obviously supported a parallel
arrangement conducive to the required cell/myotube alignment, nonetheless, these
scaffolds would still be difficult to manipulate. It was evident that the composite and
late-embedded scaffolds provided for a manipulable construct that was limited in its
contraction by the presence of parallel arrays of the glass fibres. Critically, the
restriction of the direction of contraction along the length and the compliance of the
constituent biomaterials allowed for the overall unidirectional alignment of
cells/myotubes (Strohman et al., 1990). The engineered tissue has to be of an adequate
size to be of any use as a test-bed or for implantation. Numerous methods have been
employed in order to reduce the degree of inevitable contraction of collagen-based
scaffolds, such as the inclusion of fibres (Zhang et al., 2005) and in vitro ‘pre-
conditioning’ prior to implantation (Awad et al., 1999; Moriyma et al., 2001; Moon et
al., 2008). It is clear that the composite and late embedded glass fibres offered a tissue
approaching 3cm in length. Of great significance was the consistent exposure of the
ends of the glass fibres resembling tendons of native muscle: skeletal muscle is attached
to bone via tendinous attachments, thus, the potential to create such attachments for
these in vitro formed muscle tissue analogues would further lend towards a more
realistic model with the emergence of certain fibre types and function.
The commitment to differentiation was demonstrated on all the scaffolds by
upregulation of the MyoD gene from day 1, which then decreased over the experimental
period in accordance with the temporal appearance during in vivo myogenesis
(Rudnicki et al., 1992, 1993; Rudnicki and Jaenisch, 1995; Cooper et al., 1999).
Specifically, the collagen-coated glass fibre scaffolds had greater expression than the
composite scaffolds early on, however, this was the reverse by day 7. All the scaffolds,
including the embedded glass fibres, demonstrated greater MyoD expression than the
collagen-only scaffolds. Myogenin appears later in the myogenic process (Smith et al.,
1993, 1994), and by day 7 there were increased levels on the glass fibre and composite
scaffolds confirming myofibre formation. There was a significant decrease by day 21,Chapter 6: Refinement of the Biomimetic Scaffold
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with the exception of the large increase in gene level exhibited by the collagen controls.
Importantly, the expression of the MRF genes on all the scaffolds was consistent and
reproducible on the biomimetic scaffolds utilising 40µm fibre spacing (chapter 5) and
20µm fibre spacing (Table 16).
Day 1 Day 3 Day 7 Day 14 Day 21
MyoD MG MyoD MG MyoD MG MyoD MG MyoD MG
Collagen
     
         
Glass fibres
     
         
Composite
     
         
Embedded
fibres          
Table 16 – MRF Gene Expression on the 20 (yellow) and 40m (blue) Spaced Fibre Scaffolds
The preliminary study (chapter 5) investigated gene expression on days 7, 14 and 21, whereas the
refined scaffolds were investigated for gene expression from day 1. It was apparent that regardless
of the fibre spacing, there was upregulation of the MRF genes on all the scaffolds at all the
timepoints examined. (MG = myogenin)
The upregulation of the MYH genes can give an indication of myofibre function and
maturation. Moreover, with respect to native human masseter muscle, there is the
persistence of the developmental MyHCs into adulthood (Butler-Browne et al., 1988;
Sciote et al., 1994; Stål et al., 1994). The MYH3 (embryonic) gene was upregulated
from day 1, however, there was a decrease in levels between days 3 and 7, perhaps
related to the decrease in metabolic activity recorded on day 3. The collagen-coated
glass fibres and composite scaffolds had higher levels than the collagen controls
throughout the experimental period. Of note was the greater level of MYH3 expression
on the late-embedded glass fibres compared to the collagen-coated glass fibres. The
MYH8 (neonatal) gene was expressed later. The limited compliance resulted in
expression on the coated glass fibres only on day 14. The expression on the composite
scaffolds was maintained from day 14, and specifically, the embedded glass fibres
expressed greater levels than the collagen-only control scaffolds. Importantly, theChapter 6: Refinement of the Biomimetic Scaffold
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upregulation of the MYH genes was associated with upregulation of the myogenin
gene, a phenomenon noted in other studies of myogenesis (Smith et al., 1993;
Yablonka-Reuveni and Rivera, 1994, 1997). The scaffolds in the previous study also
displayed earlier upregulation of the MYH3 gene and later expression of the MYH8
gene. Interestingly, the expression of MYH8 on the biomimetic scaffolds utilising 20µm
fibre spacing was not as consistent as with the 40µm fibre spacing (Table 17).
The MYH1 and MYH6 genes were not identified in any of the scaffolds in this study; in
comparison, the preliminary biomimetic scaffolds utilising 40µm spaced fibres,
demonstrated late upregulation of the MYH1 and MYH6 genes. Interestingly, the
MYH2 gene was upregulated on only the 20µm spaced collagen-coated glass fibres on
day 7, nonetheless, there was expression on all the scaffolds from day 14. The
composite and late-embedded glass fibre had greater levels of the gene than the
collagen-coated glass fibres, once again confirming the lower compliance of the fibres
and thus lack of ability to sustain attachment of the potentially contractile myofibres.
The later expression of the MYH2 gene was also noted on the scaffolds utilising 40µm
spaced glass fibres (Table 17).
The MYH7 gene was present at the later time of day 14 on all the scaffolds, in line with
the previous study employing 40µm spaced glass fibres (Table 17). Importantly, the
gene was not present on the collagen-only scaffolds on day 21, and the late embedded
glass fibres demonstrated on average greater levels than the collagen-coated glass
fibres.
It is possible that the differences observed in gene upregulation between the preliminary
and refinement investigations could be due to the use of later cell passages in the
refinement studies.Chapter 6: Refinement of the Biomimetic Scaffold
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Day 1 Day 3 Day 7 Day 14 Day 21
MYH 1 2 1 2 1 2 1 2 1 2
Collagen
     
         
Glass fibres
     
         
Composite
     
         
Embedded
fibres    
MYH 3 6 3 6 3 6 3 6 3 6
Collagen
     
         
Glass fibres
     
         
Composite
     
         
Embedded
fibres    
MYH 7 8 7 8 7 8 7 8 7 8
Collagen
     
         
Glass fibres
     
         
Composite
     
         
Embedded
fibres    
Table 17 – MYH gene expression on the 20 (yellow) and 40m (blue) spaced fibre scaffolds
The preliminary study (chapter 5) investigated gene expression on days 7, 14 and 21, whereas the
refined scaffolds were investigated for gene expression from day 1. There was some variability in
the genes expressed on the scaffolds examined in the preliminary study (40m spacing) and the
refinement study (20m). Nonetheless, it was evident that the glass fibre-associated scaffolds had
earlier and better levels of gene expression than the collagen-only control scaffolds.Chapter 6: Refinement of the Biomimetic Scaffold
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The preliminary biomimetic scaffold has been refined and produced with good cell
viability, alignment and upregulation of genes associated with myofibre formation and
maturation. Although there was some variation between the studies undertaken with the
20 and 40µm spaced fibres, in relation to the collagen-only controls, the composite and
collagen-coated glass fibres have confirmed the importance of specific biological and
physical cues required in the engineering of skeletal muscle. Late embedding of the
glass fibres can help preserve the myofibre structures on the fibres and produce a more
compliant biomimetic scaffold. One particular study investigating the effects of IGF-I
and the related IGF binding proteins (IGFBPs), demonstrated greater release of IGF-I
and IGFBPs from avian MPCs when embedded within a 3-D collagen I matrix after
myofibre formation (Perrone et al., 1995). IGF-I can behave in an paracrine fashion and
has been implicated in MPC proliferation, fusion and hypertrophy (Florini et al., 1996;
Yang et al., 1996; Hawke and Garry, 2001). It was suggested that the stimulated release
of IGF-I by type I collagen may be responsible for its ability to stimulate in vitro
myofibre growth (Vandenburgh et al., 1988). It is possible that the late-embedded glass
fibres may offer a viable construct, however, the method for production requires
modification, such that myofibres attached to the parallel arranged glass fibres remain
intact.
Nevertheless, it is clear that a composite scaffold composed of glass fibres and collagen
matrix can aid in the production of an muscle ‘organoid’ that macroscopically looks like
skeletal muscle tissue with the appearance of tendon-like structures, and demonstrates
the micro-architecture required for the desired functional output. Furthermore, the
expression of skeletal muscle-related genes suggests that such a construct may be used
for testing by 14 days.Chapter 6: Refinement of the Biomimetic Scaffold
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8. Conclusions
(a) There is a range of spacing (20-150m) of collagen-coated Fe5mol% glass
fibres, which is conducive to unidirectional cell alignment and MPC
differentiation.
(b) The biomimetic scaffold can be reliably produced, and all the scaffolds
demonstrated good cell viability and evidence of MPC differentiation and
maturation.
(c) Glass fibres encased within collagen and the collagen-only control scaffolds
contracted over the period of investigation, however, the considerable
contraction of the control scaffolds would preclude use as a test-bed or for
implantation.
(d) The composite and late embedded glass fibre scaffolds may provide for a
realistic skeletal muscle analogue.Chapter 7: General Discussion, Conclusions, Future Work
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Chapter 7: General Discussion, Conclusions, Future Work
1. General Discussion
Absent or defective skeletal muscle, particularly of the craniofacial region, can lead to
poor function and aesthetics, and related psychological distress. The common
management approach is associated with limitations, such as considerable donor site
morbidity and lack of compatibility of the surgically transferred tissue leading to
inadequate restoration of function and aesthetics (Faulkner et al., 1994). Further, with
advancements in medical technologies and the emergence of new therapies, a
favourable host response needs to be established for success.
The process of in vivo myogenesis is associated with specific temporal and spatial
episodes of cell proliferation, migration and differentiation (Bladt et al., 1995; Hawke
and Garry, 2001). Importantly, adult muscle precursor cells (MPCs) can recapitulate
these processes offering skeletal muscle the capability to repair and regenerate in
response to insults, including trauma and exercise (Chargé and Rudnicki, 2004). This
research has reliably produced in vitro myotubes from human masseter muscle-derived
cell cultures. Harnessing this ability to regenerate, tissue engineering approaches may
be utilised for the production of an in vitro skeletal muscle analogue for use as a test-
bed, and ultimately implantation. The success of this technique relies on the balance
between a variety of key factors, including the status of the seeded cells and the
presence of growth factors. Although in the early stages relative to the engineering of
other tissues (e.g. skin and bone), investigators have demonstrated the potential of this
technique for the management of muscle-associated disorders.
Nonetheless, skeletal muscle is a tissue whereby function is intimately linked to
structure. The various studies undertaken worldwide into skeletal muscle engineering
have been hampered by numerous factors, including the lack of contiguous myofibres
and cell viability within larger constructs. It is clear that temporary biomaterial
scaffolds are essential to support the skeletal muscle engineering process on a macro-
and microscale. Biomaterials used specifically for the means of in vitro or in vivo
skeletal muscle engineering have relied on a number of interrelated properties toChapter 7: General Discussion, Conclusions, Future Work
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produce the ideal tissue (Figure 109). Passive scaffolds include collagen and alginate
gels, but limitations include the stiffness of the biomaterial precluding cellular
differentiation, and the poor unidirectional alignment of myofibres (Bach et al., 2004;
Boontheekul et al., 2008). Topographical (Clark et al., 1997; Boldrin et al., 2007;
Riboldi et al., 2008) and passive and active mechanical (Vandenburgh, 1982;
Vandenburgh et al.., 1989; Strohman et al., 1990; Cheema et al., 2005) approaches have
attempted to overcome the lack of myofibre alignment by the provision of biophysical
guides for the seeded cells, or extrinsic and intrinsic forces respectively.
Disappointingly, the actual viable size and biomaterial used have proved to be of
limited success. General drawbacks consist of the use of cell lines (Vandenburgh et al.,
1996; van Wachem et al., 1996; Okano et al., 1997; Okano and Matsuda, 1998) and
primary animal cells (Fuchs et al., 2003). This present research has focussed on the use
of degradable composite phosphate-based glass fibre-collagen matrix scaffolds for the
in vitro engineering of a realistic human craniofacial skeletal muscle construct, with the
aim of using the unique desirable properties of both material constituents to negate the
limitations posed.
The preliminary research has concluded that phosphate-based glasses are compatible
with human masseter muscle cell cultures. The ability to tailor the degradation rate to
that of tissue formation is essential, and this rate is closely linked to the glass
composition (Franks et al., 2002; Navarro et al., 2003). Significantly, the
biocompatibility of two separate compositions with human craniofacial skeletal muscle-
derived cells was established suggesting that modifications are possible and successful.
The vast number of in vitro and in vivo investigations of various combinations of tissues
and phosphate-based glass compositions further corroborate these findings (Uo et al.,
1998; Salih et al., 2000; Araujo et al., 2010).Chapter 7: General Discussion, Conclusions, Future Work
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Figure 109 – Scaffold Parameters for Successful Skeletal Muscle Engineering
IDEAL SCAFFOLD PARAMETERS FOR
SKELETAL MUSCLE ENGINEERING
ARCHITECTURE
Parallel fibre arrays.
Minimal effects of leached
products on:
local pH, potential to cause
infection/inflammation,
myofibre function.
Rate matched to that of
tissue formation.
Also the provision of a
stable surface in the
initial stages.
Correct spacing to
enable cells to align
alongside, but also to
eventually form a sheet
of cells.
DEGRADABLE
USE OF COMPOSITE
MATERIALS
Synthetic materials for
consistency.
Use of natural materials
to mimic the ECM and
provide a compliant
scaffold.
OTHER FACTORS OF
IMPORTANCE
Cell source (species, age,
primary or cell lines),
seeding density
Fibre diameter.
Neural/vascular inputs,
exogenous growth
factors
Cell mechanotransduction
leading to functionality and
scaffold remodellingChapter 7: General Discussion, Conclusions, Future Work
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Surface topology is a fundamental requirement for seeded muscle-derived cells to
assume the correct architecture. The importance of fibre scaffolds has been highlighted
in previous studies with the presence of parallel fibre arrays able to support myofibre
alignment (Cronin et al., 2004; Huang et al., 2006; Riboldi et al., 2008; Beier et al.,
2009). Fibres allow for a high surface area to volume ratio, and fibre diameter can also
play a role in the cell response (Kamelger et al., 2004; Bitar et al., 2008). During the
process of in vivo myogenesis, embryonic MPCs fuse together to form primary
myotubes, which are then used as a scaffold to support foetal MPC fusion (Wilson et
al., 1992). The presence of fibres within the scaffold can simulate primary myotubes,
thereby encouraging MPC fusion alongside. Significantly, the polymeric nature of
phosphate-based glasses lends itself well to fibre formation, and these fibres may be
produced in a parallel spaced arrangement. The research concluded that parallel-aligned
fibre arrays with a range of spacing (20-150m) encouraged unidirectional cell
alignment. Additionally, it has been shown that end-on cell contact is key for myotube
formation (Clark et al., 1992), and fibres can enable attached cells to assume this
configuration.
Surface chemistry is also a determinant factor in cell attachment and response
(Keselowsky et al., 2004). Although extracellular proteins may be adsorbed from media
onto the surface of the biomaterial scaffolds in an ad hoc manner, previous studies have
demonstrated the prerequisite of an extracellular matrix (ECM) coating of fibre
scaffolds for skeletal muscle engineering purposes (Neumann et al., 2003; Cronin et al.,
2004). The importance of the ECM cannot be stressed enough: it provides structural
integrity for cells through its physical presence and has biological effects through the
formation of key cytoskeletal-ECM bonds enabling two-way interactions (Kleinman et
al., 2003). The integrin-based adhesions allow cellular force-sensing leading to
intracellular signalling and the upregulation of important genes associated with
development.
The intimate relationship with the ECM enables myofibres to behave as a syncytium
generating force of a certain vector to the bone via tendinous attachments. Furthermore,
the availability of growth factors and mechanical compliance influence the myogenic
process, maintenance and function (Maley et al., 1995; Melo et al.,1996; Grounds et al.,Chapter 7: General Discussion, Conclusions, Future Work
291
1998; Mitrossilis et al., 2009). The importance of ECM coating (gelatin, Matrigel
TM,
collagen) of the glass fibre scaffolds was confirmed in this study. Collagen was chosen
as the final biological component of choice to simulate the ECM of native skeletal
muscle, due to the restrictions posed by Matrigel
TM (Nicosia and Ottinetti, 1990;
Stiffey-Wilusz et al., 2001). The ability to crosslink collagen fibrils can provide for a
more robust, compliant structure (Engler et al., 2004, 2006), and although cell
migration can be limited, with the appropriate cell seeding density, fusion will ensue
(Cheema et al., 2005). With time, the seeded cells will remodel and produce their own
ECM (Grounds, 1991). In addition, supplementation with growth factors, such as IGF-I
(Barbero et al., 2001; Brimah et al., 2004), can act synergistically with the collagen
mimicking the ECM of native skeletal muscle. The creation of a composite scaffold
comprised of glass fibres and collagen matrix (coating/gel) harnesses advantages of
both biomaterials – such combinations have been used previously in tissue engineering
applications (Zhang et al. 2005).
The assessment of an in vitro engineered skeletal muscle tissue as to how well it
represents the native tissue on a macro and molecular level is essential. The craniofacial
muscles differ to the limb skeletal muscles due to diverse embryological origins (Jheon
and Schneider, 2009). Nevertheless, the myogenic regulatory factors (MRFs) are
necessary for the myogenic process: MyoD is associated with the proliferative phase
and responsible for the determination and maintenance of the myogenic lineage and
myogenin is associated with, or just before, the appearance of sarcomeric myosin
(Smith et al.,1993; Yablonka–Reuveni and Rivera, 1994, 1997; Yablonka–Reuveni et
al.,1999). Importantly, the role of myogenin in skeletal muscle differentiation cannot be
compensated for (Hasty et al., 1993; Nabeshima et al., 1993). All the in vitro constructs
in this study exhibited the expression of MyoD and myogenin, thus confirming
recapitulation of the myogenic course. The proliferation and differentiation of the
masseter muscle-derived cells was also confirmed by the expression of the muscle-
specific markers, desmin and -sarcomeric actin.
Regenerating skeletal muscles show evidence of the developmental myosin heavy
chains (MyHC), however, due to the embryological origin and demands placed on the
masseter muscle, there is persistence of these MyHC isoforms into adulthood (Butler-
Browne et al., 1988; Sciote et al., 1994; Stål et al., 1994). The biopsies used in thisChapter 7: General Discussion, Conclusions, Future Work
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study were obtained from the anterior border of the superficial belly of the masseter
muscle, which has been demonstrated to have greater variability in fibre type (Serratice
et al., 1976). In addition, all cells used were from the  wave, passages 3-12 – cell
senescence can occur after a certain number of passages, and there was a possibility this
may have taken place with the considerable cell expansion required during the course of
the research. The expression of fibre types and size in vitro has been shown to be
dependent on environmental factors, such as neural input or mechanical forces
(Kobayashi and Askanas, 1985; Vandenburgh et al., 1988; DiMario and Stockdale,
1997). Specifically, cells grown on the 2-D collagen-coated disks only expressed the
developmental MyHCs. Of great significance was the ability of the in vitro 3-D
constructs in this study to express the developmental MyHC genes, but furthermore,
there was temporal expression of the fast, slow and  cardiac (intermediate) isoforms
akin to those found in native human masseter muscle (Butler-Browne et al., 1988;
Sciote et al., 1994; Stål et al., 1994). It is likely that the endogenous strain produced
within the biomimetic scaffolds influenced this expression (Strohman et al., 1990).
The production of complex tissue necessitates the use of smart scaffolds composed of
biomaterial combinations able to elicit the desired cellular response (Barrère et al.,
2008). The adaptation of biomaterials for tissue engineering purposes is an iterative
process, and explicitly, this research has developed a successful biomimetic scaffold for
human craniofacial skeletal muscle engineering. The composite glass fibre-collagen
scaffolds were compliant and provided for a manipulable, viable muscle organoid, with
an architecture similar to native skeletal muscle and assumed functional output, as
determined by the presence of markers of myofibre differentiation and maturation. The
production of a 3-D human craniofacial skeletal muscle test-bed can provide an
incredibly powerful tool for investigating the response to external manipulations.
2. Conclusions
(a) Human masseter muscle-derived cell cultures have the capability to form
myotubes in vitro.
(b) Phosphate-based glasses are compatible with human masseter muscle-derived
cells.Chapter 7: General Discussion, Conclusions, Future Work
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(c) Biomimetic scaffolds suitable for engineering craniofacial skeletal muscle may
be created from phosphate-based glass fibres coated or encased with a collagen
matrix. Specifically, these scaffolds have supported myogenic differentiation
and the expression of myosin heavy chain genes associated with native human
masseter muscle.
(d) The composite glass fibre-collagen biomimetic scaffolds may be further
modified to enhance the formation of the in vitro skeletal muscle tissue.
3. Future Work
This research has demonstrated that it is possible to produce a realistic human skeletal
muscle tissue for potential use as a test-bed. Nonetheless, there are a number of areas of
future work that should be studied to produce an even more comparable substitute for
in vitro testing and eventually implantation.
(a) The action of numerous growth factors in the myogenic process has been
discussed, and it may be possible to utilise combinations of growth factors in a
dose-dependent and temporal manner to maximise the stages of cell
proliferation, migration and differentiation (Barbero et al., 2001; Brimah et al.,
2004; Das et al., 2009). Furthermore, incorporation of other ECM components,
such as laminin, into the biomimetic scaffold may also improve upon the tissue
formed.
(b) Matrix turnover should be assessed in terms of the levels of the matrix
metalloproteinases (MMPs) and tissue inhibitors of the matrix
metalloproteinases (TIMPS). Additionally, upregulation of the IGF-I receptor
would indicate myotube hypertrophy.
(c) The strength and function of the engineered construct needs to be investigated.
The presence of scaffold material may interfere with the ability to measure
contractile force, and adjustments would need to be undertaken to overcome
this. Further, it is imperative that the glasses are stored in a dehumified chamber
to ensure there is mimimal breakdown prior to scaffold use.Chapter 7: General Discussion, Conclusions, Future Work
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(d) The use of a bioreactor to simulate the in vivo environment should be
investigated to enable the engineered tissue to mature and remain viable at all
times.
(e) Under standard culture conditions, MPCs can differentiate and fuse thus limiting
the overall yield of useful MPCs. Fibroblasts can become the predominant cell
type, but it is possible to enhance the MPC:fibroblast ratio in primary cultures
and maintain the percentage of MPCs at >70% by preplating the cells at each
passage (Richler and Yaffe, 1970). Rando and Blau (1994) have demonstrated
that enriched cultures of primary MPCs, when compared to clonal cultures,
show no difference in the rates of proliferation, but do demonstrate a difference
in the rate of differentiation. Therefore, enriched MPC populations should be
investigated in conjunction with the biomimetic scaffold. The use of transfected
cells and stem cells is also an avenue to be explored for the production of a
muscle analogue in the management of congenital and acquired skeletal muscle
anomalies (e.g. muscular dystrophy).
(f) The ability to produce a viable functioning skeletal muscle tissue relies on
vascular and neural inputs and fixed bony attachments. The maximum diffusion
distance for the elimination of waste products, nutrition and gaseous exchange is
2-3mm (Folkman and Hochberg, 1973; Lalan et al., 2000). Hence, angiogenesis
is important and may be achieved by the use of co-cultures. Further, the
presence of neuronal cells is key to a highly differentiated functional tissue
(Bottinelli and Reggiani, 2000; Das et al., 2010). It is possible that as the glass
fibres degrade, channels are formed whereby neuronal and/or vascular cells can
infiltrate the formed tissue. Additionally, the ends of the exposed glass fibres
within the composite scaffolds may be seeded with tendon
fibroblasts/osteoblasts for the creation of entheses.Appendix A
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Appendix A: Glass Production
The glass compositions were based on the formula P50Ca40Na(10-X)FeXwhereby X = 0, 1,
2, 3, 4 and 5, and the start materials were NaH2PO4, CaCO3, P2O5 and Fe2O3. The
following outlines how the initial amounts were established for P50Ca40Na5Fe5 based on
the decomposition process and relative molecular mass (RMM). The start amounts for
the other compositions were calculated accordingly:
2NaH2PO4 Na2O + P2O5 + 2H2O
RMM 240 62 142 evaporation
mol% 62 142
240 = 0.258 240 = 0.592
 for 5mol% Na2O
0.05 x 62
0.258 = 12.01g NaH2PO4, which also gives 12.01 x 0.592 = 7.11g P2O5
 for 50mol% P2O5
0.5 x 142 = 71g, however, 71.0 – 7.11 = 63.89g P2O5
CaCO3 Na2O + CO2
RMM 100 56 evaporation
mol% 56
100 = 0.56
 for 40mol% CaO
0.4 x 56
0.56 = 40g CaCO3
Fe2O3 Fe2O3
RMM 159.69 159.69
 for 5mol% Fe2O3
0.05 x 159.69 = 7.98g Fe2O3Appendix B
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Appendix B: Stepper Motor Speed
The fibres were produced utilising a dedicated fibre-pulling rig (Figure 110) and spaced
by varying the speed of the stepper motor, as highlighted in Table 18, in relation to the
RPM of the drum.
Figure 110 – The Dedicated Fibre Production Rig
Fibre Spacing
RPM 20µm 40µm 60µm
800 10.7 Hz 21.3 Hz 32.0 Hz
1200 16.0 Hz 32.0 Hz 48.0 Hz
1600 21.3 Hz 42.6 Hz 64.0 Hz
Table 18 – Stepper Motor Speed for the Desired Fibre Spacing
Fibre pick-
up drum
FurnaceAppendix C
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Appendix C: Reagents and Suppliers
Anti- sarcomeric actin
(clone 5C5)
Sigma-Aldrich, U.K.
Anti-desmin (clone D33) DakoCytomation, U.K.
Anti-MyHC3 (clone F1:652) Enzo
®Life Sciences, U.K.
Anti-MyHC8 (clone WB-
MHCn)
Novocastra, U.K.
Anti-MyoD1 (clone 5.8A) Abcam, U.K.
Anti-myogenin (clone F5D) Abcam, U.K.
4-(2-pyridylazo) resorcinol Dionex, U.K.
alamarBlue
TM AbD Serotec
Antifade media Citifluor Ltd, U.K.
Bacto
TMAgar BD, U.K.
BSA Sigma-Aldrich, U.K.
Carbolite furnace
(RHF 1500)
Carbolite, Sheffield, U.K.
Carbon cement Agar Scientific, U.K.
Chemicals:
NaH2PO4, CaCO3, P2O5, Fe2O3,
NH4OH, CaCl2, Na4P2O7,
NaOH, NaNH3
BDH, Poole, U.K.
Na3PO4, Na3P3O9, Na5P3O10,
FeCl3, NaCl
Sigma-Aldrich, U.K.
Chloroform Sigma-Aldrich, U.K.
CPK assay kit Sigma-Aldrich, U.K.
Cy3 Stratech Scientific Ltd, U.K.
Cyquant
® Cambridge Bioscience, U.K.
DAPI Sigma-Aldrich, U.K.
Defibrinated horse blood E&O Lab Ltd, U.K.
DEPC water Ambion
®Appendix C
298
Dicor furnace Dentsply, UK
Differentiatial thermal analyser Setaram Labsys
TM
DMEM Invitrogen
TM, U.K.
DMSO Sigma-Aldrich, U.K.
Ethanol Sigma-Aldrich, U.K.
FCS PAA Labs, U.K.
Fibre rig furnace Lenton, U.K.
FITC Stratech Scientific Ltd, U.K.
Tissue Culture Flasks Nunc
Fluorescent microscope
(model DMIRB)
Leica Microsystems, U.K.
Fluoroskan fluorescence reader Labsystems, finland
Gelatin Sigma-Aldrich, U.K.
Gluteraldehyde Sigma-Aldrich, U.K.
High capacity cDNA RT kit Applied Biosystems, U.K.
HDMS Sigma-Aldrich, U.K.
IGF-1 3(ESR) Sigma-Aldrich, U.K.
Image J software (version 1.42) National Institutes of Health
Ion chromatography system
(ICS-1000 and ICS-2500)
Dionex, U.K.
Isopropyl alcohol Sigma-Aldrich, U.K.
Lysine Sigma-Aldrich, U.K.
Matrigel
TM BD Biosciences
MEM Invitrogen
TM, U.K.
Methanesulfonic acid Fluka, U.K.
Methanol Sigma-Aldrich, U.K.
MicroAmp
® 96-well reaction
plates and covers
Applied Biosystems, U.K.
Mixer mill Retsch GmBH, Germany
OnGuard IIA cartridge Dionex, U.K.
Parafilm
® Alpha Labs, U.K.Appendix C
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Paraformaldehyde Sigma-Aldrich, U.K.
PBS PAA Labs, U.K.
PCR universal mastermix Applied Biosystems, U.K.
pH colourley standard solutions BDH, U.K.
pH meter Orion, U.K.
BCA protein assay reagent kit ThermoScientific, U.K.
Penicillin/Streptomycin Invitrogen
TM, U.K.
Pt/10%Rh crucible (type 71040) Johnson Matthey, Royston, U.K.
PURELAB UHQ-PS Elga Labwater, U.K.
Pyridine-2,6-dicarboxylic acid Dionex, U.K.
Rat tail collagen First Link, U.K.
Rotary diamond saw Testbourne Ltd, Basingstoke, U.K.
RT PCR system 7300 Applied Biosystems, U.K.
S.aureus NCTC 6571
S.epidermidis NCTC 11047
SEM Cambridge, U.K.
SEM coating unit (model E5000) Polaron Equipment Ltd, U.K.
Silicon carbide paper Struers, U.K.
Sodium cacodylate buffer Sigma-Aldrich, U.K.
Spectrophotometer Ultraspec 2000, Pharmacia, Biotech
Stainless steel frames Rotary Engineering, Reading, U.K.
Taqman primers and probes:
MyoD1 (Hs00159528_m1)
Myogenin (Hs00231167_m1)
MYH1 (Hs00428600_m1)
MYH 2 (Hs00430042_m1)
MYH 3 (Hs00159463_m1)
MYH 6 (Hs00411908_m1)
MYH 7 (Hs00165276_m1)
MYH 8 (Hs00267293_m1)
18s rRNA (Hs99999901_m1)
Applied Biosystems, U.K.Appendix C
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Thermal cycler 100TM PTC MJ Research Inc., U.S.A.
Triton-X-100 Sigma-Aldrich, U.K.
TRIzol
® Invitrogen
TM, U.K.
Trypsin EDTA Invitrogen
TM, U.K.
TSB Oxoid Ltd, U.K.References
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